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Abstract    
Ischaemic stroke is a leading cause of death and disability in the developed world. 
Despite that considerable advances in experimental research enabled understanding 
of the pathophysiology of the disease and identified hundreds of potential 
neuroprotective drugs for treatment, no such drug has shown efficacy in humans. The 
failure in the translation from bench to bedside has been partially attributed to the 
poor quality and rigour of animal studies. Recently, it has been suggested that 
multicentre animal studies imitating the design of randomised clinical trials could 
improve the translation of experimental research. Magnetic resonance imaging (MRI) 
could be pivotal in such studies due to its non-invasive nature and its high sensitivity 
to ischaemic lesions, but its accuracy and concordance across centres has not yet been 
evaluated.  
This thesis focussed on the use of MRI for the assessment of late infarct size, the 
primary outcome used in stroke models. Initially, a systematic review revealed that a 
plethora of imaging protocols and data analysis methods are used for this purpose. 
Using meta-analysis techniques, it was determined that T2-weighted imaging (T2WI) 
was best correlated with gold standard histology for the measurement of infarct-
based treatment effects. Then, geometric accuracy in six different preclinical MRI 
scanners was assessed using structural phantoms and automated data analysis tools 
developed in-house. It was found that geometric accuracy varies between scanners, 
particularly when centre-specific T2WI protocols are used instead of a standardised 
protocol, though longitudinal stability over six months is high. Finally, a simulation 
study suggested that the measured geometric errors and the different protocols are 
sufficient to render infarct volumes and related group comparisons across centres 
incomparable. The variability increases when both factors are taken into account and 
when infarct volume is expressed as a relative estimate. Data in this study were 
analysed using a custom-made semi-automated tool that was faster and more reliable 
in repeated analyses than manual analysis.  
Abstract v 
Findings of this thesis support the implementation of standardised methods for the 
assessment and optimisation of geometric accuracy in MRI scanners, as well as image 
acquisition and analysis of in vivo data for the measurement of infarct size in 
multicentre animal studies. Tools and techniques developed as part of the thesis show 












Stroke is one of the deadliest diseases and very few options are available for treating 
affected patients. The identification of new treatments begins from animal studies 
that mimic the pathophysiology of human stroke. However, these studies lack the 
necessary quality to indicate which treatments are truly effective. In the future, 
animal studies could potentially involve participation of several research centres, 
which will bring improvements in their quality and reduce the number of animals 
used in research. One of the most important markers of the efficacy of treatments is 
their ability to reduce the size of stroke lesions. This can be measured using magnetic 
resonance imaging (MRI). This thesis aimed to examine how the size of lesions varies 
between different MRI scanners and determine which factors contribute mostly to 
this variation. It was found that different researchers use different MRI methods to 
evaluate lesions. At the same time, scanners that are routinely used in animal studies 
have different levels of accuracy, the variability in which is increased by the use of 
different MRI methods. Consequently, the observed variability in MRI causes a 
similar heterogeneity in the size of lesions across centres. The thesis proposes ways 
to improve the accuracy of MRI scanners and the concordance in the size of stroke 
lesions, which will permit implementation of studies involving several centres. Such 
studies will help identify new and exciting treatments for the millions of stroke 
sufferers across the world.
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Despite recent advances and discoveries in experimental research, stroke is one of the 
deadliest diseases in the world and limited options are available for its treatment. 
Multicentre animal studies utilising the diagnostic and prognostic strength of 
magnetic resonance imaging (MRI) could be the new paradigm, improving the 
understanding of stroke and shaping the future of its treatment. In this chapter, the 








2 1.1  Overview and Motivation  
1.1 Overview and Motivation 
As a disease affecting a large part of the human population, stroke has been a priority 
for many scientists in academia and a considerable research effort has enabled 
understanding of the underlying mechanisms and related pathophysiological 
changes during the progress of cerebral ischaemia. It was known since the late 1970s 
that the treatment of acute stroke is based on the rescue of the tissue at risk before the 
ischaemic cascade reaches its terminal event, the death of neurons and the 
development of the infarct. This turned the attention of stroke research into the 
development of drugs that target specific mechanisms of the cascade to protect 
neurons from dying. However, no neuroprotective drugs have been proven effective 
in the clinic, despite the fact that over half of 1026 drugs that were tested in animals 
showed efficacy (O'Collins et al., 2006). Today, only a handful of treatment regimens 
are of proven benefit in humans (Donnan, Fisher, Macleod, & Davis, 2008), but these 
are available only for a very small number of patients. It is estimated that the only 
effective pharmacological treatment, intravenous thrombolysis, reaches at most 7% 
of patients admitted to the hospital (Barber, Zhang, Demchuk, Hill, & Buchan, 2001; 
Schwamm et al., 2013), because it can only be administered within the first few hours 
after stroke onset and is contraindicated in those with a high risk of secondary 
complications (Davis & Donnan, 2009; Wardlaw, 2010). There is an urgent need for 
developing new and effective strategies for the treatment of acute stroke. 
Despite that the funds spent on stroke research saw a modest increase recently in the 
developed countries, the proportion of healthcare costs associated with the disease is 
still higher than the proportion of funds used for stroke research (Donnan et al., 2008; 
Luengo-Fernandez, Leal, & Gray, 2015; Rothwell, 2001). In 2012 in the UK, for 
example, the disease accounted for 13% of the combined costs of cancer, coronary 
heart disease, dementia and stroke management, but only 7% of corresponding 
funding was spent towards stroke research (Luengo-Fernandez et al., 2015). In 
contrast, cancer accounted for about 23% of healthcare costs but received almost two 
thirds of the available research funds. 
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It is believed that this decline of interest towards stroke resulted from a series of failed 
efforts to reproduce the positive results of experimental studies in clinical trials, 
which gradually dissuaded funding agencies and pharmaceutical companies from 
developing new therapeutic strategies. 
1.1.1 Translational failure in stroke research 
The bench to bedside failure in stroke has been attributed to a range of translational 
roadblocks, ranging from the inadequacy of animal models of stroke to mimic the 
human condition to poor experimental methodological quality and rigour and 
various forms of study and publication bias that falsely inflated the efficacy of 
interventions in animals, or understated their efficacy in clinical trials  (Dirnagl, 2006; 
Landis et al., 2012; Sena, van der Worp, Howells, & Macleod, 2007; van der Worp & 
Macleod, 2011).  
Animal models of stroke have intrinsic differences from human stroke, mostly related 
to the timing of phases of the ischaemic cascade and the duration of 
pathophysiological changes. While the onset of ischaemia can be precisely defined in 
animal models, this is not a straightforward task in humans. In addition, the site of 
occlusion and the extent of collateral supply between animals used in experiments 
are often homogeneous, but they vary greatly between patients. As of today, there is 
no animal model available that can mimic the complexity and dynamics of human 
stroke in an accurate and consistent manner (Canazza, Minati, Boffano, Parati, & 
Binks, 2014; Howells et al., 2010), therefore imaging and other biomarkers assessed in 
animals might not reflect similar biomarkers in humans. Despite the countless efforts 
to define a clinically relevant and predictive biomarker for tissue fate and late 
outcome, none is widely accepted as a gold standard. What is more, many preclinical 
trials focus on early evaluation of effects and ignore late outcome, which is more 
relevant to clinical investigation. On the other hand, some clinical trials have tested 
drugs under conditions where efficacy was not explicitly proved in animals, such as 
in comorbid patients or at a substantially longer time after the onset of stroke (Perel 
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et al., 2007). 
Infarct size is the most widely assessed outcome in both clinical and preclinical 
studies and assertion of efficacy is often based on its reduction in the treated cohort 
(Macrae, 2011). Preclinical studies tend to measure it at a single time point that could 
be one day or several weeks following stroke. Earlier time points are preferred as a 
means to avoid sample size shrinking due to animal death, minimise disease 
complications and decrease study costs (Krongold et al., 2015). However, infarct 
progression is a spatiotemporal process and late recanalization could potentially 
affect the size of the infarct after it was assessed, thereby rendering measured effects 
invalid (Macrae, 2011; Zanier et al., 2013). 
Preclinical studies of stroke have always been carried out locally and in controlled 
conditions, with the majority of them using young and healthy male rodents. 
Standardisation of the characteristics of animals used, housing and experimental 
methods may improve the homogeneity of outcome measures and thus the statistical 
power of a study, but can affect the reproducibility and the external validity of 
findings detrimentally (Richter, Garner, Auer, Kunert, & Wurbel, 2010; Richter, 
Garner, & Wurbel, 2009). In addition, systematic reviews showed that most animal 
studies use very small sample sizes and do not employ randomisation of treatment 
allocation and blinding of outcome assessment, techniques considered fundamental 
to internal validity and standard in clinical trials (Macleod et al., 2008; Perel et al., 
2007; Vesterinen et al., 2011). These could explain why published animal studies are 
more likely to report positive treatment effects, when that effect is not actually present 
(Dirnagl, 2006; Sena et al., 2007). Additionally, the efficacy of many drugs tested in 
animals might have been further inflated by failing to publish negative findings 
(Sena, van der Worp, Bath, Howells, & Macleod, 2010). 
 
  
1.1  Overview and Motivation 5 
1.1.2 Multicentre animal studies 
It is evident that current practice in experimental stroke lacks the necessary quality 
and rigour to move the translation of stroke treatments forward, and amelioration 
demands radical changes. It has recently been suggested that multicentre preclinical 
stroke trials with a similar design to randomised clinical trials can lead to 
improvements in the validity and generalisability of experimental findings (Bath, 
Macleod, & Green, 2009; Dirnagl & Fisher, 2012; Dirnagl et al., 2013; Howells & 
Macleod, 2012). A large multicentre study will not replace studies investigating 
mechanisms of pathophysiology and drug action, but can replace the numerous 
single-centre studies that measure the efficacy of the exact same treatment in similar 
conditions (Dirnagl et al., 2013). Participation of several preclinical centres will allow 
efficient monitoring of animals by concurrent assessment of different cohorts, thus 
not increasing the study duration significantly. Through the inclusion of a large 
sample of animals, the statistical power of the multicentre study will be significantly 
larger and will allow deduction of valid statistical inferences. Decisions regarding the 
implementation of clinical trials will then be based on better grounds, while 
potentially reducing the total number of animals killed and saving large amounts of 
money in the long run (Howells, Sena, O'Collins, & Macleod, 2012; Ioannidis et al., 
2014). Furthermore, multicentre animal studies can promote national or international 
collaboration and sharing of data and expertise between research groups, something 
considered common in clinical practice today (Dirnagl et al., 2013). 
MRI has recently become a favourite modality for the assessment of lesions in 
experimental stroke, as it allows in vivo brain imaging with excellent soft tissue 
differentiation. However, animal MRI scanners are far less common that clinical 
scanners and collaborations between institutions are still rather scarce. As such, there 
is a wide diversity of hardware, software, scanning protocols and image processing 
techniques that could possibly affect the equivalence of outcomes between centres. 
As an outcome assessment method, MRI must be standardised within and between 
centres to improve the accuracy and comparability of measured effects; this is 
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customary for large clinical imaging collaborations (Jack et al., 2008; Wintermark et 
al., 2008), but preclinical research has yet to reach this milestone.  
Identification of the best strategies for all aspects of a multicentre stroke study and 
development of relevant methods is expectedly a very challenging and arduous task. 
Recently, a consortium of neuroscientists and stroke experimentalists from around 
the world was set up with the aim of developing a framework for the design and 
implementation of multicentre stroke trials. This consortium, the Multicentre 
Preclinical Animal Research Team (Multi-PART; www.multi-part.org), took 
important steps towards sample selection, modelling of the disease, identification of 
relevant endpoints and determination of standardised procedures for behavioural, 
histological and statistical analyses. However, still no work has been done with the 
use of MRI for the assessment of infarct size.  
1.2 Aims of this Thesis 
In collaboration with Multi-PART, the main aim of this thesis is to examine the use of 
MRI for the measurement of infarct size in focal cerebral ischaemia and propose 
methods for improving its accuracy and reproducibility to facilitate multicentre 
animal stroke studies. Specific goals are to: 
 Systematically review the literature to determine the variability in methods 
used for the acquisition and analysis of MRI data for the measurement of 
lesion size.  
 Identify the MRI acquisition method providing the best estimate of infarct-
based treatment effect by comparison against gold standard post-mortem 
histological assessment using meta-analysis techniques. 
 Develop an MRI phantom and associated image analysis tools for the 
assessment of geometric accuracy in preclinical scanners. 
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 Develop a semi-automated tool for the assisted segmentation of the infarct in 
rodent MRI data and compare its performance against manual analysis and 
other common volumetric techniques. 
 Design and execute a multicentre study to compare geometric accuracy 
between different preclinical MRI scanners using a standardised and centre-
specific protocols, and record drifts in the performance over time. 
 Simulate in vivo data modelling the geometric errors in participating scanners 
and the differences in stroke protocols to examine their impact on infarct size 
across centres and related group comparisons. 
1.3 Thesis Outline 
The content of each of the remaining chapters is summarised below: 
Chapter 2 sets the scene by summarising relevant background information about 
focal cerebral ischaemia and the basic animal models used. The following section is 
devoted to the use of MRI in clinical and experimental stroke, with emphasis on 
methods used for the assessment of lesion size and particularly infarct size. The major 
challenges of infarct size quantification are finally described. 
Chapter 3 presents a systematic review and meta-analysis of the use of MRI in 
experimental stroke. MRI acquisition and post-processing methods for the 
measurement of ischaemic lesions are recorded and their heterogeneity is evaluated. 
The reporting of common study quality criteria and imaging information is also 
assessed. Finally, the MRI contrast technique that is best associated with gold 
standard histology for the measurement of infarct-based treatment effects is 
identified using meta-regression.  
Chapter 4 describes the procedure for the construction of a simple structural phantom 
and the development of accompanying phantom data analysis tools for evaluating 
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geometric accuracy in small animal MRI scanners. The performance of the tool is 
validated by analysis of scans simulating different linear scaling errors and levels of 
image quality. 
Chapter 5 describes the development of a simple threshold-based semi-automated 
tool for the analysis of rodent MRI data for the measurement of infarct size. The 
performance of the tool is compared against gold standard manual tracing of the 
boundary of the lesion and stereological point counting. 
Chapter 6 presents a multicentre study assessing geometric accuracy in six different 
scanners across Europe using the developed phantom and tools; this study was 
designed based on findings of the previous chapters. The short-term and long-term 
longitudinal variability in geometric accuracy over a period of six months in the 
worst-performing system following calibration is also evaluated. Finally, the impact 
of between-scanner variability on the quantification of infarct volume and infarct-
based statistical group comparisons is examined. Images corresponding to each 
system were generated by transforming a reference dataset of MRI scans in a rat 
model of focal cerebral ischaemia and were analysed using the tool described in the 
previous chapter.  
Chapter 7 summarises the main findings of this thesis and discusses their importance 
for animal stroke research. In addition, guidance to multicentre stroke studies 
regarding the use of MRI for the measurement of infarct volume is given and, finally, 





This chapter presents the main types of stroke, the pathophysiological processes 
involved and the major animal models employed in the laboratory for its assessment. 
A brief introduction to the fundamentals of signal detection and image formation in 
MRI is then presented, along with a description of common imaging methods used 
for the assessment of lesion in stroke. Particular emphasis is given to the 
measurement of infarct size, the most commonly assessed outcome in preclinical 
stroke trials. The chapter closes with a description of the main challenges and sources 
of error behind such measurements, some of which are addressed in the studies 






10 2.1  Stroke  
2.1 Stroke 
Almost 17 million people suffer a stroke each year in the developed world and more 
than a third of them die, whilst many others are left with serious and long-term 
disability (Mozaffarian et al., 2015). This makes stroke the second most common cause 
of death after coronary artery disease, accounting for 11.8% of total deaths worldwide 
(Mozaffarian et al., 2015). Although stroke mortality varies between geographic 
regions and race or ethnicity, and a steady reduction has been observed in the western 
countries the last few decades, the global burden of the disease is rising detrimentally 
(Mathers & Loncar, 2006). This is due to the fact that widespread pathological 
conditions, such as hypertension, diabetes, obesity and smoking, are major risk 
factors for stroke and are also on the rise (Duong, 2012b; Mozaffarian et al., 2015). At 
the same time, the disease accounts for more than 4% of healthcare costs in these 
countries, with costs expected to increase multifold over the next few decades 
(Donnan et al., 2008; Heidenreich et al., 2011; Mozaffarian et al., 2015). 
2.1.1 Definition and classification 
Stroke is defined as the loss of cerebral function, focally or globally, due to a sudden 
reduction of cerebral blood flow (CBF) arising from vascular disturbances (Sacco et 
al., 2013). Based on the cause of CBF reduction, stroke is classified into two major 
types, haemorrhagic and ischaemic. Haemorrhagic stroke is characterised by the 
spontaneous rupture of a small vessel due to the presence of an arterial aneurysm or 
a vascular malformation and occasionally due to persistent hypertension, leading to 
cerebral bleeding (Warlow, Sudlow, Dennis, Wardlaw, & Sandercock, 2003). In most 
cases, haemorrhagic stroke results in intracerebral haemorrhage and in a quarter of 
them subarachnoid haemorrhage; both account for about 13% of all human strokes 
(Mozaffarian et al., 2015). The most prevalent type of stroke is ischaemic and accounts 
for 87% of all cases. It results when a brain vessel is occluded either by an 
atherosclerotic plaque (thrombus) originating from the carotid artery or by an 
embolic clot carried from the heart into the brain via the bloodstream, restricting the 
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blood supply to the underlying tissue. While the majority of ischaemic strokes affect 
one of the large cerebral arteries, a quarter of them are lacunar and are characterised 
by occlusion of one of the penetrating arteries supplying the brain’s deep structures, 
often due to chronic hypertension (Warlow et al., 2003). Cerebral ischaemia is further 
classified by clinicians based on the duration of neurological deficits following 
occlusion. A transient ischaemic attack is followed by restoration of normal function 
before the first 24 hours post-stroke, whilst a permanent ischaemic stroke is 
characterised by symptoms persisting for longer than 24 hours (Donnan et al., 2008). 
The lack of accurate and reliable evidence renders this distinction rather arbitrary, but 
helps guide patient management in day-to-day clinical practice and categorise 
patients in epidemiological studies (Donnan et al., 2008; Warlow et al., 2003). 
For the clarity of this thesis, the term ‘stroke’ will refer to focal cerebral ischaemia 
hereafter and, therefore, any information presented may not be relevant or applicable 
to other forms of stroke. 
2.1.2 Pathophysiology 
The onset of stroke marks the beginning of a long sequence of molecular and cellular 
events taking place within the brain territory whose blood supply has been 
compromised, called the ischaemic cascade (Figure 2.1).  
As soon as CBF reduces critically, oxygen and glucose levels at the affected area fall 
and energy generation via production of adenosine triphosphate (ATP) becomes 
insufficient. At this acute stage, the depletion of energy results in dysfunction of ATP-
reliant ion pumps across the membranes of neurons and glia. Consequently, 
membrane potentials are lost and ion homeostasis is disrupted, causing an elevation 
of sodium, calcium and chloride ions in the intracellular space. Damage to the cells is 
further catalysed by the elevated calcium in the cytosol, by stimulating degradation 
of cytoskeletal proteins and release of enzymes, such as phospholipases which 
decompose membrane phospholipids. 
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Figure 2.1 Time course of ischaemic cascade.  
Various pathophysiological mechanisms follow cerebral ischaemia, initiating with 
excitotoxicity that damages neurons and glia, and triggers peri-infarct 
depolarisations, inflammation and apoptosis that lead to tissue death. Reprinted 
from Dirnagl, Iadecola, and Moskowitz (1999), with permission from Elsevier. 
At the same time, the excitatory neurotransmitter glutamate is excessively released 
by calcium-mediated exocytosis from presynaptic cells into the synaptic clefts that 
accelerates the movement of calcium into the cells (Dirnagl et al., 1999). The 
pathological process impairing neuron potentials by excessive stimulation of 
glutamate and enzymes triggered by energy depletion is called excitotoxicity. 
Accumulation of ions in the cells results in their swelling and the formation of 
cytotoxic oedema, an almost immediate aftermath of cerebral ischaemia (Durukan & 
Tatlisumak, 2007). Excess calcium also causes the generation of free radicals via 
phospholipases’ activity, which initiate lipid peroxidation in mitochondria and may 
cause deleterious alterations in deoxyribonucleic and ribonucleic acids (Brouns & De 
Deyn, 2009). These changes, along with cytoskeletal breakdown, make the cell 
membranes more permeable to the harmful molecules and gradually lead to cell 
necrosis and the formation of infarct (necrotic tissue). Cell death in less hypoperfused 
neighbouring tissue is mediated primarily via apoptotic pathways acting in a chain 
reaction. As experiments in rats revealed, apoptosis is also propagated in 
surrounding tissue by spreading peri-infarct depolarisations that occur 
spontaneously over the course of ischaemia (Dijkhuizen et al., 1999; Dirnagl et al., 
1999). 
Within a few hours following the development of the infarct, the endothelial junctions 
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that make up the brain’s blood-brain barrier (BBB) are disrupted and plasma proteins 
leak out of brain capillaries. This fluid penetrates into the parenchymal extracellular 
space leading to accumulation of vasogenic oedema and swelling of the brain, which 
marks the beginning of the subacute stage of stroke. While cytotoxic oedema is 
dominant the first few hours following stroke, it soon gives way to vasogenic oedema 
that can take up to 30% of the actual infarct size and can persist for several days 
(Gerriets et al., 2004; Swanson & Sharp, 1994). 
In the clinic, by the time a stroke patient is admitted for treatment, cell death may 
have already taken place at the end artery territory. The focus of clinicians is then 
turned onto salvaging the surrounding tissue that has been compromised, which will 
expectedly transit into a non-salvageable infarct within hours following stroke. 
Towards the differentiation of these two areas, Astrup and his colleagues were the 
first to introduce the concepts of ischaemic core and penumbra (Astrup, Siesjo, & 
Symon, 1981; Astrup, Symon, Branston, & Lassen, 1977). Using electrophysiological 
techniques, they examined somatosensory evoked responses to determine thresholds 
in CBF at which electrical activity was abolished in the baboon cortex. Their 
experiments suggested the existence of two thresholds; one for morphological 
damage and a less severe threshold for functional impairment. A CBF less than about 
15 ml/100g/min renders neurons non-functional and permanent damage occurs 
within minutes after stroke; this was referred to as the ischaemic core. At 20 
ml/100g/min, neuronal functionality is maintained, but evoked responses decline 
gradually when flow is reduced below this value and therefore marks the threshold 
for functional disruption. This region surrounds the ischaemic core and was defined 
as the ischaemic penumbra; while neurons in this region are functionally impaired, 
they are structurally intact and an increase in CBF can recover their signalling and 
normalise extracellular ionic activity (Astrup et al., 1981; Astrup et al., 1977). The 
limited perfusion of this region is maintained by small peripheral vessels and is 
enough to keep the cell membrane ion channels working to preserve the homeostasis 
needed for survival for several hours following stroke. Neuronal death in penumbral 
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tissue initiates if the blood flow decreases critically or if it is kept at insufficient levels 
for a prolonged period of time. As the penumbra might retrieve its normal 
functioning if CBF is restored, it is sometimes referred to as the ‘tissue at-risk’ and is 
today a well-established concept in stroke often used by researchers as a target for 
therapeutic interventions. Its accurate measurement is important in identifying 
patients who may benefit from thrombolytic treatment and in designing clinical trials 
(Campbell & Macrae, 2015; Duong, 2013). 
2.1.3 Rodent models of stroke 
The translation of stroke treatments to clinical trials begins from experimental studies 
of cultured cells and organotypic brain slices in vitro or animal models in vivo 
(Macrae, 2011). The study of stroke using animal models constitutes the gold standard 
for the understanding of the pathophysiology of the disease and the development of 
novel therapies and biomarkers (Sicard & Fisher, 2009). Highly controlled animal 
experiments ensure consistency in the site of arterial occlusion, the severity and 
duration of ischaemia, and pre- and post-ischaemia monitoring of outcomes using a 
plethora of assessment methods, either in vivo or post-mortem histological 
techniques. This comes in contrast with human stroke, where the delayed 
introduction of the patient into the clinic allows insufficient investigation of the 
disease during the acute phase, with assessment restricted to the use of in vivo 
methods. 
In animal models, stroke is artificially induced by occluding a cerebral artery and 
causing ischaemia in the underlying brain territory. Several species are used in 
preclinical stroke studies, including rodents, cats, rabbits and non-human primates. 
The choice is primarily based on the correlation between animal and human 
pathophysiology, but it is always driven by the availability of the animals, the ease of 
handling and by ethical and financial considerations. Consequently, while non-
human primates have gyrencephalic brains and great behavioural similarity to 
humans, they are very rarely used (Carmichael, 2005). The vast majority of 
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experimentalists perform their studies on mice and rats, which have low maintenance 
costs, husbandry and handling, can be bred in dedicated facilities for ensuring genetic 
consistency and develop equivalent patterns of infarct and functional deficits after 
stroke (Durukan & Tatlisumak, 2007; Howells et al., 2010). Mice offer superior genetic 
manipulation which is useful for studying the molecular pathophysiology. Rats, on 
the other hand, are better suited for modelling focal cerebral ischaemia because their 
size enables practical in vivo or ex vivo assessment, they possess a circle of Willis 
similar to that of humans and most rat models of stroke have small intra-strain 
variability allowing reproducible experiments (Canazza et al., 2014; Carmichael, 2005; 
Durukan & Tatlisumak, 2007; Sicard & Fisher, 2009).  
The cerebral artery most prone to occlusion in humans is the middle cerebral artery 
(MCA), accounting for 80% of cases in Caucasians (Warlow et al., 2003). For this 
reason, most rodent stroke models involve permanent or transient occlusion of this 
artery. The most commonly used rat model is the intraluminal filament method 
(Howells et al., 2010; Sicard & Fisher, 2009), firstly described by Koizumi, Yoshida, 
Nakazawa, and Ooneda (1986) and later modified by Longa, Weinstein, Carlson, and 
Cummins (1989). The procedure involves the introduction of a silicon rubber-coated 
monofilament into the external carotid artery, which is then inserted into the internal 
carotid artery and advanced to occlude the origin of the MCA. The filament can be 
kept in place to permanently occlude the artery, or carefully retracted to allow 
reperfusion of the ischaemic area, which is useful for modelling different durations 
of ischaemia and studying the effects of early or late reperfusion (Howells et al., 2010). 
This model does not require a craniotomy, but the filament can cause endothelial 
ruptures that lead to small haemorrhages or microbleeds, produced infarcts can have 
a highly variable size and associated animal mortality is often higher than other MCA 
occlusion (MCAO) models (Canazza et al., 2014). 
A range of other MCAO models are also available, offering different options 
regarding the duration of occlusion, the location and reproducibility of ischaemic 
injury; these include electrocoagulation of the proximal end of the artery (Robinson, 
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Shoemaker, Schlumpf, Valk, & Bloom, 1975; Tamura, Graham, McCulloch, & 
Teasdale, 1981), injection of clot-like particles to mimic embolic stroke (Kudo, 
Aoyama, Ichimori, & Fukunaga, 1982), and topical application of vasoconstrictor 
endothelin-1 to induce dose-dependent local ischaemia (Macrae, Robinson, Graham, 
Reid, & McCulloch, 1993; Sharkey, Ritchie, & Kelly, 1993). 
2.2 Magnetic Resonance Imaging in Stroke 
The findings of the early animal studies by Astrup and colleagues (Astrup et al., 1981; 
Astrup et al., 1977) gave birth to the idea that human stroke is characterised by cellular 
alterations and corresponding blood flow thresholds. This idea was confirmed when 
positron emission tomography (PET) was later used to measure blood perfusion and 
oxygen levels following cerebral ischaemia in humans (Baron et al., 1981; Marchal et 
al., 1993). Similar successes in mammalian stroke studies followed, which served as 
the catalyst that helped establish medical imaging into a necessity in preclinical and 
clinical studies to quantify the extent of infarcted and salvageable tissue and other 
physiological parameters, which are important for the testing of new interventions or 
guiding treatment procedures (Wardlaw, 2010). 
Until the 1990s only PET and computed tomography (CT) were utilised to visualise 
stroke lesion. PET scanners, however, are not readily available and related image 
processing is time-consuming, whilst the more widespread CT is not sensitive to the 
early ischaemic cascade and delivers a considerable radiation dose to patients 
(Ebinger et al., 2009). While MRI was relatively common by then, it took a few years 
for its potential in stroke to become apparent. The breakthrough came with the 
invention of more advanced techniques with clinical utility, namely diffusion-
weighted (DWI) and perfusion-weighted imaging (PWI). 
Today, MRI is a widely used diagnostic modality as it is non-invasive, radiation-free 
and offers excellent soft tissue differentiation. Brain imaging is one of its most popular 
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applications, where MRI protocols allow measurement of structural, metabolic, 
haemodynamic and functional characteristics of the brain during the progression of 
the disease. MRI findings are used to correlate structural alterations in the brain with 
late functional impairment due to stroke to aid the diagnosis of complications and the 
prognosis of tissue fate and stroke recurrence (Duong, 2013; Redgrave, Coutts, 
Schulz, Briley, & Rothwell, 2007; Wintermark et al., 2008). 
2.2.1 Basic principles of MRI 
2.2.1.1 Nuclear magnetic resonance 
MRI relies on the electromagnetic properties of atomic nuclei and the phenomenon of 
nuclear magnetic resonance (McRobbie, Moore, Graves, & Prince, 2006). Most MRI 
applications exploit the presence of hydrogen nuclei, the most abundant in the body. 
Each hydrogen nucleus consists of a single positively charged proton, which rotates 
around its own axis due to its spin, an intrinsic property of all subatomic particles. 
Therefore, the proton generates its own magnetic field called magnetic moment, 
forcing it to act as a tiny magnet when placed in an external magnetic field. 
An MRI scanner uses a large superconducting electromagnet which produces a very 
strong homogeneous magnetic field inside its bore. When a subject is placed in the 
scanner, its protons are aligned or anti-aligned with the field’s magnetic lines (Figure 
2.2). The direction of alignment with the magnetic field (𝛣0) is energetically beneficial 
and therefore a slightly larger number of protons are aligned than anti-aligned, which 
is enough to produce a net longitudinal magnetization pointing in the direction of 𝛣0 
(equilibrium magnetisation, 𝑀0). The magnetic field also exerts torque on the protons, 
causing them to precess around the field’s axis with a frequency called the Larmor 
frequency, 𝜔0. This is determined by the gyromagnetic ratio, 𝛾, which is unique for 
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each nucleus, and the strength of the field, 𝐵01, using the Larmor equation: 
𝜔0 = 𝛾𝐵0                                                                     (2.1) 
Most modern human scanners generate magnetic fields with a strength of 1.5 or 3 T 
and animal scanners 7 T or higher. For the hydrogen nucleus, 𝛾 = 42.6 MHz/T, thus 
the Larmor frequency falls within the radiofrequency (RF) range. 
 
Figure 2.2 Spin excitation and relaxation.  
MRI uses a Cartesian coordinate system of reference where the z axis is the 
longitudinal direction along the scanner’s bore and is perpendicular to the x-y plane 
(transverse plane). (a) At equilibrium the spins (blue arrows) precess randomly 
around z axis in one of two possible directions, but there is a net longitudinal 
magnetisation 𝑀0 (red arrow) towards the direction of the scanner’s magnetic field 
𝐵0. (b) When excited with a radiofrequency pulse, the spins momentarily gain phase 
coherence and transverse magnetisation 𝑀𝑥𝑦. (c) Following excitation, longitudinal 
magnetisation 𝑀𝑧 is slowly restored via T1 relaxation, while 𝑀𝑥𝑦 is reduced via T2 
relaxation (spin dephasing). Both of these mechanisms of relaxation follow 
exponential curves, as shown in (d) and (e) respectively. 
                                                          
1 𝐵0 typically refers to both the magnetic field direction and strength (in units of magnetic flux density: 
Tesla, T). 
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A magnetic resonance signal is then produced by exciting the protons using an RF 
coil emitting pulses with the Larmor frequency to achieve resonance condition. This 
flips the net magnetization vector of protons by usually 90° to gain transverse 
magnetisation. Excitation also induces phase coherence to protons, meaning that their 
magnetic moments are pointing in the same direction and they precess in synchrony. 
As soon as the excitation pulse is over, the protons slowly realign with 𝛣0 while losing 
phase coherence. During this process protons emit a weak radio signal that can be 
amplified and measured using an RF receive coil at various time points before they 
reach magnetic equilibrium.  
2.2.1.2 Relaxation 
The time protons need to reach equilibrium is known as relaxation time and is 
dependent on two major processes: (1) the spin-lattice interaction by which protons 
restore longitudinal magnetisation by dispersing energy into the surrounding atoms 
or molecules (termed T1 or longitudinal relaxation), and (2) the spin-spin interaction 
which dephases the spins as energy is dissipated by interactions between 
neighbouring protons (termed T2 or transverse relaxation) (Figure 2.2). T2 relaxation 
occurs faster than T1 relaxation and is enhanced by additional but less severe 
dephasing caused by field inhomogeneities, known as T2* relaxation.  
Hydrogen nuclei in the human body are found mostly in water and, therefore, the 
water content of each tissue type affects the rate of these relaxation mechanisms; this 
rate is determined by measurable relaxation times T1 and T2, that are specific to tissues 
and depend on 𝐵0. The difference in relaxation times between tissues allows the 
creation of images with a different intensity for each type. MRI acquisition can be 
weighted so that one of the two main relaxation processes determines the contrast 
between tissues; if T1 relaxation prevails, T1-weighted images are acquired, otherwise 
T2-weighted images are produced. 
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2.2.1.3 Spatial encoding and image formation 
The signal recorded by the RF receive coil comes from the entire sample. To localise 
the excited protons and produce an image, the signal is spatially encoded in each 
orthogonal direction using three additional coils surrounding the main magnet in the 
MRI machine, called gradient coils. For encoding in the slice direction, one of these 
coils applies a linearly varying magnetic field that when added to the main field 𝛣0 
produces a distribution of frequencies along this direction centred around 𝜔0. Since 
the sample has now a linearly varying resonance frequency, an RF pulse can be used 
to excite each slice of the sample at a time. The slice thickness is increased by 
increasing the bandwidth (BW) of the transmitted RF pulse or decreasing the strength 
of the slice selection gradient (typically 𝐺𝑧). After a slice has been selected, the other 
two gradient coils are used to encode in-plane information. The frequency encoding 
gradient (typically 𝐺𝑥) coil applies a linear magnetic field gradient to produce a 
similar variation in Larmor frequency as 𝐺𝑧, whereas the phase encoding gradient 
(typically 𝐺𝑦) coil applies a brief pulse in the perpendicular direction to induce a linear 
variation in the phase of protons. 𝐺𝑥 is applied during reception of the MRI signal, 
hence it is also called the readout gradient. Scanning can be performed in any 
orientation within the scanner and each of the three gradient coils is used to perform 
one of these functions accordingly. The application of the three gradients assigns 
unique information to protons in each voxel (a contraction of ‘volume’ and ‘element’), 
which is spatially decoded to produce the image; for this, signals are digitised and 
recorded in the spatial frequency domain in a complex mathematical matrix called k-
space, which is converted into an intensity image using the Fourier transform. Basic 
imaging planes and anatomical terms of location in brain MRI, as referred to in this 
thesis, are shown in Figure 2.3. 
A series of RF pulses and gradients is applied to a sample to generate an image; this 
is known as a pulse sequence. The duration and weighting of a pulse sequence is 
determined primarily by the time between the excitation and sampling (echo time, 
TE) and the time between successive excitations (repetition time, TR). Dozens of such  
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Figure 2.3 Imaging planes and anatomical terms of location in brain MRI. 
These are cross sections through 3-dimensional structural MRI images of (a) a 
human and (b) a rat, showing the (1) axial, (2) coronal and (3) sagittal imaging 
planes and anatomical terms of location. Due to differences in anatomy and 
positioning in the scanner (humans in the supine position and rodents in the prone 
position), the scanner’s orthogonal axes correspond to different anatomical 
directions. The figure shows the convention used in this thesis, where x, y and z 
indicate the positive direction. A indicates anterior; P, posterior; S, superior; I, 
inferior; R, right; L, left.  
sequences have been developed over the years; a routine MRI brain examination for 
stroke commonly consists of a battery of sequences for assessing various aspects of 
the disease. Common MRI techniques used for the assessment of lesion size are 
described in the following sections. 
2.2.2 T1- and T2- weighted imaging 
Structural MRI (sMRI) is by far the most widely used MRI technique, producing high 
resolution images in a short period of time for examining the anatomy and 
pathophysiology of the brain. T1-weighted (T1WI) or T2-weighted imaging (T2WI) are 
basic structural methods that can be used to differentiate between haemorrhagic and 
ischaemic strokes and facilitate treatment decisions in the clinic (Dijkhuizen & 
Nicolay, 2003; Duong, 2013). T1WI is often used along with the injection of 
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gadolinium (Gd) chelate-based paramagnetic contrast agents to assess BBB 
permeability. These agents accumulate in areas where BBB integrity has been 
compromised and enhance the T1-weighted signal by shortening the T1 relaxation 
time of these areas; this effect correlates with subsequent haemorrhagic 
transformation (Knight et al., 1998). In contrast, T2WI is sensitive to the presence of 
vasogenic oedema at 12 hours or later after occlusion of the artery (Figure 2.4). The 
oedema has a higher water content compared to surrounding normal tissue and its T2 
relaxation time is longer; as such, it looks more hyperintense (brighter) in the T2-
weighted image. Therefore, the technique is often employed for the visualisation of 
the oedema, which is a surrogate for necrotic tissue and can be used to indirectly 
measure infarct size in both humans and animals (Dijkhuizen & Nicolay, 2003; Farr 
& Wegener, 2010). Nevertheless, both T1WI and T2WI are avoided at the acute phase 
of stroke due to their poor sensitivity to early ischaemic injury (Wardlaw, 2010). 
 
Figure 2.4 Coronal brain MRI images in a rodent model of stroke.  
These are average MRI images for two different groups of mice that were subjected 
to 90 minutes of middle cerebral artery occlusion and scanned (a) during artery 
occlusion and (b) 3 hours later for apparent diffusion coefficient (ADC) quantification 
using diffusion imaging, cerebral flood flow (CBF) quantification using perfusion 
imaging, quantitative T1-weighted imaging (T1WI) and qualitative T2-weighted 
imaging (T2WI); mice were scanned again at 48 hours after stroke for T2WI alone 
(column on the right). ADC and CBF maps can identify reduced diffusion of water 
and perfusion of blood within minutes after stroke, whereas T1WI and T2WI are 
insensitive to early ischaemic changes. Late T2WI demarcates the infarct (bright), 
which is often larger than the ischaemic core on early ADC maps (dark). The shift 
of the midline of the brain towards the normal contralateral hemisphere in T2WI at 
48 hours is caused by swelling of the ipsilateral hemisphere. Adapted from Leithner 
et al. (2015), with permission from Wolters Kluwer.  
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Specific structural sequences produce quantitative MRI data that can be converted to 
maps quantifying T1 or T2 relaxation time in a voxel-wise manner, instead of showing 
intensity in arbitrary units. As these relaxation times are properties inherent to tissue, 
quantitative MRI maps are useful for identifying biomarkers that are comparable 
across centres. Alteration of T2 relaxation time throughout the course of ischaemia 
was shown to have predictive utility and can inform on changes in tissue status 
(Wegener et al., 2006). Quantitative maps are also used to derive thresholds of 
abnormality (Pham et al., 2010).  
2.2.3 Diffusion- and perfusion-weighted imaging 
In normal tissue, water molecules can diffuse relatively freely. In contrast, in the 
ischaemic region during the acute phase of stroke the diffusion of water is restricted 
as it shifts from the extracellular space into the cells due to disruption of ion 
homeostasis. DWI can detect areas where the movement of water is reduced or 
blocked within minutes and up to 6 hours following stroke, effectively providing a 
means for confirmation of occlusion (Dijkhuizen & Nicolay, 2003; Farr & Wegener, 
2010). Tissue with reduced diffusion at the acute stage of stroke indicates the presence 
of cytotoxic oedema and appears hyperintense in the diffusion-weighted image. 
Studies suggest that this lesion represents the non-salvageable ischaemic core (Albers 
& Fisher, 2011; Duong, 2013; Moseley et al., 1990). In the subacute and chronic phases 
of stroke the cytotoxic oedema subsides due to cell lysis and the DWI lesion becomes 
less hyperintense. Therefore, while the accuracy of the technique for depicting the 
extent of the infarct reduces with time, it can effectively be used to distinguish the 
acute from the later stages of stroke. 
From the raw DWI data, the apparent diffusion coefficient (ADC) map can be 
produced where the intensity of each voxel is relative to the vector sum of the phases 
of all diffusing molecules in the voxel, which represents the rate of diffusion. Since in 
the ischaemic area the diffusion of water in the extracellular space is restricted, it 
appears hypointense (dark) in the ADC map (Figure 2.4). The ADC map is generally 
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preferred to DWI for assessing early lesions as it is independent of the T2 shine-
through effect, a phenomenon that causes areas with long T2 values to appear bright 
in DWI images, even if they do not restrict diffusion. 
Several studies have established ADC thresholds for defining the tissue at risk and 
final infarct size in rodents (Meng, Fisher, Shen, Sotak, & Duong, 2004; Reid et al., 
2012; Shen, Meng, Fisher, Sotak, & Duong, 2003), but there is no consensus on the 
optimal values among the research community; imprecise thresholds may result in 
either inclusion of undamaged tissue or exclusion of infarcted areas. In addition, the 
hyperintense acute DWI lesion is more likely to represent glial rather than neuronal 
damage, since glial cells have a better chance of recovery and reopening of the 
occluded artery partially salvages the DWI lesion (Rivers & Wardlaw, 2005). This 
view is supported by clinical DWI studies, indicating that the technique provides 
inconsistent identification of infarct core (Kranz & Eastwood, 2009; Rivers et al., 2007). 
PWI is a different technique that exploits the magnetic properties of water in blood to 
detect its passage through the tissue. A common PWI method is arterial spin labelling, 
in which the blood in a specific brain area is magnetically ‘labelled’ and the adjacent 
slice encompassing the tissue of interest is imaged soon afterwards to detect the flow 
of the labelled spins. This technique is often used in rodent models of stroke (McCabe 
et al., 2009; Meng et al., 2004), as it is non-invasive and provides a direct assessment 
of CBF. Contrast bolus tracking is another PWI method used mostly in humans, 
where an exogenous Gd-based contrast agent is given to the subject intravenously to 
enhance the visualisation of the flowing blood in cerebral arteries (Wardlaw, 2010). A 
signal-time curve is obtained for each voxel while the contrast agent first passes 
through the brain; this can be processed to generate maps quantifying different 
parameters including CBF (Figure 2.4) and cerebral blood volume, among others 
(Kane et al., 2007).  
In spite of the versatility of perfusion imaging, Dani and colleagues state that the 
technique is highly variable between human subjects and would probably remain as 
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such even if it was standardised (Dani et al., 2011; Dani et al., 2012). In addition, it is 
not uncommon that the perfusion lesion includes areas of benign oligaemia that 
usually present no risk of infarction (Butcher et al., 2008). Identification of the most 
clinically useful PWI parameter and appropriate threshold for its definition is a 
subject of long and ongoing research (Albers & Fisher, 2011; Bandera et al., 2006; 
Bardutzky et al., 2005; Dani et al., 2011; Kane et al., 2007). 
The perfusion lesion is generally larger than the acute diffusion lesion. Areas of the 
perfusion lesion that look normal in the diffusion image form what is called the 
perfusion-diffusion (PWI/DWI) mismatch. This region is hypoperfused due to 
cerebral vascular occlusion (typically visualised by PWI-derived CBF maps) but 
excludes irreversibly damaged cells where neuronal signalling is disrupted and 
cytotoxic oedema has already been developed (typically indicated by DWI-derived 
ADC maps) (Campbell & Macrae, 2015; Duong, 2013). Such a tissue state coincides 
with the definition of the ischaemic penumbra by Astrup and colleagues (1981), thus 
the PWI/DWI mismatch is considered to be a promising non-invasive indicator of this 
region. Its feasibility as a possible target area for testing the efficacy of interventions 
has been demonstrated in various animal species (McCabe et al., 2009; Meng et al., 
2004). As such, the PWI/DWI mismatch early after stroke was successfully used in 
major clinical trials for the selection of subjects that were most likely to benefit from 
treatment (Albers et al., 2006; Davis et al., 2008), though its benefit was not shown in 
another trial (Hacke et al., 2009). In general, the lack of accurate definitions for both 
underlying MRI methods poses serious doubts about the use of the mismatch to guide 
treatment in routine clinical practice (Bandera et al., 2006; Butcher et al., 2008).  
2.2.4 Infarct size measurement 
Despite many attempts to develop advanced prognostic MRI biomarkers utilising 
multi-modal information for assessing the efficacy of potential therapeutics for stroke 
(Duong, 2012a), infarct size remains the primary outcome used (Farr & Wegener, 
2010; Macrae, 2011). It is known to be an important biomarker of the progression of 
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ischaemia and its measurement in the clinic is encouraged by current imaging 
recommendations (Wintermark et al., 2013). In both clinical and preclinical research, 
infarct size is often measured in parallel with functional and behavioural scores to 
assess early or late outcome (Macrae, 2011; Saunders, Clifton, & Brown, 1995; 
Schiemanck, Kwakkel, Post, & Prevo, 2006).  
Traditionally, histological and immunohistochemical methods have been employed 
to quantify the extent of the infarct in animals, by staining brain slices ex vivo using 
dyes, such as 2,3,5-triphenyl-2H-tetrazolium chloride (TTC), haematoxylin and eosin 
(H&E) or cresyl violet (Bederson et al., 1986; Liu, Zhen, Meloni, Campbell, & Winn, 
2009; Sommer, 2010). These approaches offer unparalleled structural detail and 
specificity, but involve time-consuming procedures and—as post-mortem analyses—
do not allow longitudinal assessment, which is important in stroke as ischaemia and 
infarction evolve substantially over time. While histology is still regarded as the gold 
standard for measuring infarct size (Csonka et al., 2010; Liu et al., 2009), the advent 
of high resolution animal MRI scanners for non-invasive in vivo assessment increased 
the popularity of MRI across preclinical centres. Studies reported excellent 
association between MRI and histology, with the former being able to predict 
histologically determined chronic infarct size when used in the first few days after 
stroke (Barone, Clark, Feuerstein, Lenkinski, & Sarkar, 1991; Peeling et al., 2001). 
As described earlier, the sensitivity of DWI to early cytotoxic effects allows its use in 
the acute period for imaging the ischaemic core, but this lesion size could be later 
reduced due to early reperfusion or increased due to prolonged ischaemia. Thus, the 
method of choice for the visualisation of the late infarct is T2WI. However, infarct size 
on T2-weighted data is confounded by the presence of vasogenic oedema, which 
accounts for about 30% of the total apparent hyperintensity and can lead to false-
positive results if not taken into account (Swanson et al., 1990; Swanson & Sharp, 
1994). Oedema causes swelling of the ipsilateral brain hemisphere; this peaks during 
the first 48 hours and can persist for up to seven days in rat MCAO models (Macrae, 
2011). A number of formulae have been devised and used over the years to correct 
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for this effect. The simplest of these is to normalise the infarct size with the ratio of 
the area of the contralateral hemisphere to that of the ipsilateral hemisphere (Leach, 
Swan, Eisenthal, Dopson, & Nobbs, 1993). Another method was devised by Swanson 
et al. (1990) and was later adapted by Lin, He, Wu, Khan, and Hsu (1993); it suggests 
that the size of the infarct can be approximated by subtraction of the healthy area in 
the ipsilateral hemisphere from the area of the whole contralateral hemisphere. Both 
of these methods assume that the oedema is present only within the infarcted tissue 
and were proposed for use on TTC-stained rodent brains, but since then they have 
been regularly applied on T2WI data as well (Barone et al., 1991). Gerriets et al. (2004) 
later developed a formula for correcting infarct volume extracted from MRI data 
specifically by making a number of assumptions based on in vivo observations. 
Accurate quantification of infarct size requires acquisition of a sufficient number of 
slices throughout the MCA territory, typically in the coronal plane, and the visible 
lesion area is traced in each slice. Formulae for correcting for brain swelling require 
measurement of the volume of both brain hemispheres as well. 
Infarct size is reported in published articles either as an absolute estimate, such as in 
units of volume (mm3 or μL), or as a relative estimate, for example the percentage of 
brain or contralateral hemisphere. Absolute estimates are useful for determining the 
precise infarct size variation between treated cohorts, but relative values permit 
straightforward comparison between studies using animals with different 
characteristics (Liu et al., 2009; Macrae, 2011). 
2.2.5 Limitations and sources of heterogeneity 
Heterogeneity in the anatomy and pathophysiology between animals, as well as the 
experimental procedures for modelling stroke and assessing outcome, are thought to 
be the primary contributors to lesion size variability between animals and centres (Liu 
et al., 2009). While scientists tend to use standardised protocols for these criteria, it 
has been argued that heterogeneity in some aspects of animal experimentation might 
help in mimicking the complex human condition as much as possible and improve 
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the generalisability of results (Richter et al., 2010; Richter et al., 2009). On the other 
hand, outcome assessment methods including MRI, can introduce a moderate but 
systematic bias in measurements if not properly calibrated or carried out. In a 
multicentre study where absolute measurements are primarily combined and the 
number of animals per group and per centre can be highly variable, such systematic 
differences between centres could render combined effects and, subsequently, 
conclusions inaccurate.  
Thus far, the use of MRI in experimental stroke has been highly heterogeneous 
between centres. Standardised guidelines to inform the conduct of imaging in human 
stroke clinical trials are available (Wintermark et al., 2008; Wintermark et al., 2013), 
but no such guidelines exist for experimental stroke. Below, important factors that 
could influence the measurement of infarct size using MRI are described. 
2.2.5.1 Anatomy, pathophysiology and stroke models 
For answering a research question, experimenters can choose the animal species and 
their strain, sex, age, size and comorbidity from a wide range of options; these can 
greatly influence the results of their study. When combined with inconsistencies in 
the conduct of experimental procedures, including surgery and occlusion of the 
artery, this heterogeneity can produce conspicuous variability in lesion sizes between 
preclinical studies and research centres (Liu et al., 2009; Walberer et al., 2006).  
In MRI, blood flow fluctuations and animal motion are known to introduce 
physiological noise that degrades the quality of data. During scanning, motion is 
adequately compensated by anaesthetising the animal and often by using dedicated 
animal cradles equipped with nose cones or stereotaxic ear bars to hold the animal’s 
head in place. However, it is known that most anaesthetics used during scanning 
have intrinsic neuroprotective effects themselves and could further affect lesion 
evolution and measured outcomes (Howells et al., 2010; Kawaguchi, Furuya, & Patel, 
2005; Macleod et al., 2009).  
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The sinuses, nasal cavity and ear canals of the head may introduce significant 
artefacts in MRI data. These air-filled cavities located rostral and ventral to the rodent 
brain give rise to local magnetic susceptibility effects that induce magnetic field 
inhomogeneities around the borders with tissue (air-tissue interface) and cause 
spatial distortions and ‘blooming’ of surrounding tissue, the extent of which depends 
on the type of pulse sequence.  
Quantification with basic T2-weighted sequences, including spin echo (SE) and fast 
spin echo (FSE), is also affected by the cerebrospinal fluid (CSF). Due to its high water 
content, CSF appears hyperintense similarly to the oedema and may confound the 
estimation of infarct size when the ventricles are adjacent to the lesion (see T2WI at 
48 hours following stroke in Figure 2.4). Fluid-attenuated inversion recovery (FLAIR) 
is a pulse sequence that suppresses the signal from CSF, but is generally a slower 
technique and its T2 signal change is poorly understood (Leigh & Krakauer, 2014), 
thus is not often used in experimental stroke. 
2.2.5.2 MRI equipment and acquisition parameters 
Preclinical MRI scanners make use of large magnets producing higher field strengths 
than clinical scanners. A higher field strength provides a better signal-to-noise ratio 
(SNR) in acquired data, which is important when scanning small animals as it permits 
the use of smaller voxels for high resolution imaging, but magnifies magnetic 
susceptibility artefacts.  
Gradient coil nonlinearities and RF coil loading effects can induce inhomogeneities in 
the magnetic field, which can produce spatial distortions and intensity variations in 
the images. Various types of coils exist for signal detection, which influence image 
quality in additional ways. Volume coils offer homogeneous intensity across the 
scanned region and are often used for human brain MRI, but are rarely used for 
imaging small animals because are impractical and introduce large amounts of noise. 
On the other hand, surface coils that sit on the top of the animal’s head are easier to 
use and have higher sensitivity to tissue that lies close to the coil, improving the SNR 
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within the brain. This sensitivity, however, compromises global intensity 
homogeneity by introducing a steep radial intensity gradient across the image. 
The heterogeneity in imaging protocols for the assessment of infarct size in 
experimental stroke has not been evaluated thoroughly, but some studies suggest that 
it could be very high. A systematic review of 141 diffusion MRI studies in stroke 
models found that only a quarter of them provided adequate information regarding 
imaging, the conduct and findings of which differed significantly (Rivers & Wardlaw, 
2005). Similar variability was observed in later systematic reviews of clinical 
multimodal MRI (Schiemanck et al., 2006), diffusion (Kranz & Eastwood, 2009) and 
perfusion imaging (Dani et al., 2011; Dani et al., 2012). 
It is reasonable to assume that this heterogeneity holds true for other MRI methods 
as well. Variation in the imaging plane and pulse sequence parameters affect image 
resolution, SNR and the contrast between normal and damaged tissue. Another 
important adverse result would be the inconsistency in partial volume effect (PVE). 
This artefact arises from the use of large voxel sizes (low resolution of acquired 
images); the larger the voxel the more tissue types it may represent. In the final image, 
the signal coming from contributing tissues is averaged, resulting in loss of detail and 
blurring which, consequently, could cause ambiguity in measurements (Ren, Shen, 
Bardutzky, Fisher, & Duong, 2004). High-resolution MRI can minimise tissue 
differentiation errors, but at the expense of SNR and speed of scanning. 
2.2.5.3 MRI quality assurance 
In order for MRI systems to perform optimally and acquired images to be of any 
clinical or preclinical use, scanners and coils must be subject to frequent and rigorous 
quality assurance (QA). This aims to identify sources of errors and measure their 
effects by scanning temporally stable objects called phantoms; measured effects are 
then compensated at regular intervals to avoid any drifts in the system’s performance 
(Firbank, Harrison, Williams, & Coulthard, 2000; Price et al., 1990). QA with daily and 
weekly or monthly tests has been the standard in clinical practice for years, with 
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various protocols being used to assess a number of important performance 
characteristics of the scanners by comparison with well-established criteria 
(American College of Radiology, 2015). However, the conduct of QA in preclinical 
centres is still very scarce and dedicated protocols are absent, with the majority of 
centres relying on annual maintenance of the systems by external service engineers. 
As a consequence, imaging performance between scanners may vary significantly 
and any changes in MRI endpoints assessed in longitudinal studies spanning over 
several months may be attributed, at least partially, to drifts in scanner performance, 
unbeknown to the experimenter. 
2.2.5.4 Image analysis 
MRI intensity variations described earlier are collectively known as bias field; this 
often rules out the use of automated tools for image analysis that rely on assumptions 
of global intensity homogeneity. For this reason, researchers prefer to measure lesion 
size by manually tracing the lesion in the images. Manual analysis itself is a laborious 
method with proven poor reliability and reproducibility in many applications, with 
variability between or within raters being common and significant (Ay et al., 2008; 
Galinovic et al., 2014). Amongst other factors, the experience and the subjectivity of 
judgement of the rater contribute mostly to infarct size variability; this effect is called 
observer bias. Simple methods to reduce it exist but were found to be rarely 
performed for the measurement of various outcomes (van der Worp et al., 2010; 
Vesterinen et al., 2011); these include blinding of analysis to group assignment and 
repetition by the same and at least another independent rater to confirm that 
measurements are repeatable and reproducible, respectively. 
Another potential limitation of current practice is inherent to the mathematical 
procedures used to estimate infarct volume, which lack specific guidelines. While the 
standard method for correcting for brain swelling or calculating relative estimates of 
infarct volume is by comparing it against the volume of the whole brain or a 
hemisphere (Lin et al., 1993), some choose to use the brain or hemispheric volume 
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measured only in slices where the infarct is present (Lestro Henriques et al., 2015). A 
possible incentive for this is to avoid the negating effect of formulae used to correct 
for brain swelling, when this is significant (McBride, Klebe, Tang, & Zhang, 2015). 
Inconsistencies in calculations could contribute to variability in reported infarct 
volume estimates and associated group comparisons, even when all other study 
characteristics are identical. 
Identification and complete elimination of the effect of all aforementioned sources of 
error is difficult—if not impossible—due to the fact that most of them appear 
concurrently and produce complex and unpredictable variation. Rather, it could be 
useful to alleviate those effects that arise from known sources and can be measured 
using simple and systematic approaches. The following chapters of this thesis will 
measure the variability in experimental stroke MRI and address some of the 
persisting contributing factors, to improve the reliability in the measurement of 










Systematic Review and Meta-Analysis 
of MRI in Experimental Focal Cerebral 
Ischaemia 
This chapter aims to assess previously published studies in animal models of stroke 
to record methods for MRI data acquisition and analysis for the quantification of 
ischaemic lesions. The heterogeneity and adequacy of reporting basic imaging 
parameters is evaluated, as well as the reporting of basic study quality criteria. 
Finally, via means of meta-analysis the MRI contrast technique that best correlates 
with gold standard histology for estimating infarct-based treatment effects is 
identified; this technique will form the basis of the studies described in later chapters.  
Parts of this chapter have been published or presented as: 
Milidonis, X., Marshall, I., Macleod, M. R., & Sena, E. S. (2015). Magnetic resonance imaging 
in experimental stroke and comparison with histology: systematic review and meta-analysis. 
Stroke, 46(3), 843-851. doi:10.1161/STROKEAHA.114.007560 
Milidonis, X., Marshall, I., Macleod, M. R., & Sena, E. S. (2015). Magnetic resonance imaging 
for the assessment of lesion size in experimental stroke: systematic review and meta-analysis. 
Presented at the 7th Annual Scientific Meeting of the Scottish Imaging Network: A Platform for 




34 3.1  Introduction  
3.1 Introduction 
MRI is an invaluable and versatile imaging tool used in both clinical and preclinical 
research. While its variability in clinical research was extensively documented and 
largely addressed, the heterogeneity of MRI in preclinical studies is not fully 
explored. As described in the previous chapter, many MRI techniques are sensitive to 
the consequences of early or late ischaemia and can provide information helpful for 
confirmation of occlusion, localization and tracking of the evolving ischaemia, or 
prognosis of late outcome (Dijkhuizen & Nicolay, 2003; Farr & Wegener, 2010; 
Wardlaw, 2010). Nevertheless, the traditional method for measuring the primary 
outcome in stroke, infarct volume, is post-mortem histological analysis of brain slices 
(Liu et al., 2009; Macrae, 2011; Sommer, 2010). This approach requires that a subgroup 
of animals be killed at an arbitrary time point after the induction of ischaemia; the 
choice of this time point is critical, as brain injury post-stroke is a spatiotemporally 
evolving process (Wegener et al., 2006). MRI, in contrast, is an alternative method 
allowing longitudinal in vivo assessment of the developing infarct with often faster 
preparation procedures and less-demanding measurement techniques. These factors 
could make MRI the preferred method in a multicentre setting where hundreds of 
animals could be used, but participating scanners and the techniques employed at 
each centre should be accurate enough to allow efficient comparison and pooling of 
measurements. 
As an initial step towards this endeavour, this chapter aims to determine the extent 
of the variability in MRI data acquisition and post-processing methods for the 
estimation of lesion size through a systematic review of published literature. 
Systematic review is a method used for the identification of all relevant studies in 
order to answer a particular research question (Sena, Currie, McCann, Macleod, & 
Howells, 2014). Critical appraisal of these studies is performed in a systematic and 
unbiased manner, in order to produce more meaningful summaries of current 
evidence than simple narrative reviews. As such, systematic review findings could 
generate hypotheses for, or drive the conduct of similar studies in the future. In 
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stroke, systematic reviews of data arising from preclinical studies may provide 
insight into the failure of translation by identifying potential gaps in knowledge and 
sources of error in methodology and reporting of findings. 
The second objective of this chapter is to examine the performance of recorded MRI 
methods for the measurement of infarct volume via comparison with gold standard 
histology. While several studies showed equivalence between MRI and histological 
infarct size measurements in rodents post-stroke (Barone et al., 1991; Gerriets et al., 
2004; Peeling et al., 2001), an alternative assessment by combining lesion-based 
treatment effects from multiple studies will provide more robust and accurate 
estimates of correlation. For this purpose, meta-analysis techniques are employed in 
this chapter. Meta-analysis uses data recorded in a systematic review to calculate 
weighted average estimates of effects and their confidence intervals (CI). Its potential 
in stroke is obvious; it may be used to give a clear view of the true efficacy of a 
treatment intervention and allow informed decisions to be made regarding whether 
this intervention should be taken forward into clinical trials (Sena et al., 2014). When 
used on data grouped according to various aspects of study design, such as the 
imaging method or the time of outcome assessment following stroke, meta-analysis 
can indicate how each of these factors influences average estimates. Finally, 
associations between two or more variables recorded in the systematic review can be 
examined using meta-regression (Vesterinen et al., 2014); this technique is used here 
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3.2 Methods 
3.2.1 CAMARADES database 
The Collaborative Approach to Meta-Analysis and Review of Animal Data from 
Experimental Studies (CAMARADES; www.camarades.info) group is an 
international consortium of experts in the field of experimental and translational 
medicine aiming to provide a framework for systematic review and meta-analysis of 
treatment interventions in animal models, following a similar standard to the one 
enforced on clinical reviews by the Cochrane Collaboration. Since its establishment 
in 2004, CAMARADES has been conducting systematic reviews of interventions 
tested in animal models of stroke, and was more recently expanded into other 
neurological diseases. Records of papers and extracted information are saved and 
analysed in a Microsoft® Access® data manager (2003, Microsoft Corp., Redmond, 
Washington, USA), which is accessed by all CAMARADES collaborators. At the 
commencement of this review (April 2014), this database held details of 1824 
publications describing 5329 experiments testing the efficacy of candidate drugs in 
focal cerebral ischaemia. The study described in this chapter was performed in 
collaboration with this group, based at the University of Edinburgh. 
3.2.2 Identification of relevant studies 
For systematic review, publications held in the CAMARADES database were 
searched to identify those that fulfilled pre-defined inclusion criteria: controlled 
studies of interventions in animal models of stroke where MRI was the outcome 
measurement method and lesion size the measured outcome. The full text of 
identified papers was then screened to select only the studies which determined 
lesion size in vivo and reported measurements in text or graphically. Articles 
published as abstracts or in languages other than English were also considered; the 
latter were translated.  
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For meta-analysis, the papers included in the systematic review were further screened 
to keep only those which reported use of post-mortem histological assessment of 
infarct size in addition to MRI. Studies were retained if histology was used 
immediately after MRI in the same cohort of animals, and measurements for 
treatment and control groups were provided for both methods.  
3.2.3 Data extraction 
To examine the heterogeneity in the conduct of MRI in the systematic review, a range 
of relevant parameters were extracted from all included articles, partially based on 
generic contemporary recommendations by Stout et al. (2013): the method of 
positioning the animal in the scanner, the anaesthetic used for scanning, the 
physiological parameters monitored during scanning, the field strength and 
manufacturer of the scanner, the type of RF coil, the type of pulse sequence and 
relevant parameters (TR, TE, field of view (FOV), matrix size, slice thickness, number 
of slices, number of signal averages (NSA)), the scan duration, the software used for 
image analysis, the method used for delineating the boundary of the lesion, the 
formula used for correcting for the presence of oedema (applicable to T2WI) and how 
the infarct size is reported (for example mm3 or percentage of brain volume). Other 
pulse sequence parameters were considered where appropriate, such as echo train 
length (ETL) for FSE sequence, or details of diffusion-sensitising gradients in DWI. 
The quality of image analysis was assessed by examining whether raters were blinded 
to group allocation and if analysis was repeated by multiple independent raters. 
Other meta-data were extracted, including the first author’s name, the year of 
publication, the journal and details regarding the animals and stroke model used: the 
animal species, the type of ischaemia, the intervention tested, the ischaemic side of 
brain and the cerebral artery that was occluded for ischaemia.  
As suggested by systematic review and meta-analysis guidelines (Sena et al., 2014), 
the quality of studies was also assessed; here, a published study quality checklist was 
used (Macleod, O'Collins, Howells, & Donnan, 2004), comprising the following 10 
38 3.2  Methods  
items: (1) publication in a peer-reviewed journal, (2) control of temperature during 
surgery and induction of ischaemia, (3) random allocation to treatment or control, (4) 
blinded induction of ischaemia, (5) blinded assessment of outcome, (6) use of 
anaesthetic without significant intrinsic neuroprotective activity, (7) use of comorbid 
animals (for example aged, diabetic or hypertensive), (8) sample size calculation, (9) 
compliance with animal welfare regulations and (10) statement of potential conflict 
of interests. Publications were awarded a single point for each of the items that they 
met, for a maximum score of 10. 
For meta-analysis, infarct size measurements for MRI and histology group 
comparisons were extracted from relevant papers. In this case, a ‘comparison’ is 
defined as the assessment of outcome in a treatment group as compared to a control 
group, which are given a dose of a drug or vehicle, respectively, at a given time before 
or after the induction of ischemia (Sena, 2010). For performing a comparison, the 
mean infarct volume, the standard deviation (SD) or standard error of the mean 
(SEM), and the number of animals per group were recorded. Where data were not 
given in the text, values were extracted from graphs using the graphical tool Paint 
(6.3, Microsoft Corp., Redmond, Washington, USA), based on provided scales or the 
values of the infarct size axis. Finally, the time point of assessing infarct size after 
occlusion of the artery was also noted. 
MRI scanner and sequence parameters described above were extracted once by 
myself and were randomly double-checked for confirmation. All other parameters 
were extracted previously by at least one CAMARADES reviewer, and were 
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3.2.4 Data analysis 
For systematic review, the percentage of studies reporting each study design and 
quality parameter was calculated. Several articles described the use of more than one 
MRI method (for example, T2WI, DWI or PWI); where relevant, the percentage of 
reported imaging parameters was calculated against the total number of MRI 
methods and not the total number of included articles. Since the choice of many 
imaging parameters is often influenced by the animal species used, the range and the 
median value of continuous parameters (scan duration and pulse sequence 
parameters, where applicable) were calculated separately for each species. Where 
values for the same parameter were reported in different units, they were converted 
to the same scale before pooling.  
In meta-analysis, if studies used a single control group and multiple treatment 
groups, the number of animals in the control group was divided by the number of 
treatment groups it served for performing appropriate comparisons (Vesterinen et al., 
2014). Then, the treatment effects were measured for both MRI and histology infarct 
size estimates as a normalised mean difference (NMD) (Vesterinen et al., 2014), 
representing the percentage improvement in the treated cohort (known as effect size 
(ES)). The DerSimonian and Laird random effects meta-analysis (DerSimonian & 
Laird, 1986) was used to pool treatment effects because substantial heterogeneity 
between studies was anticipated. The significance of heterogeneity between 𝑘 
groups/comparisons was assessed using the chi-squared (𝜒2) distribution with 𝑘 − 1 
degrees of freedom (df) (Vesterinen et al., 2014). The CAMARADES database and 
Microsoft Excel® (2013, Microsoft Corp., Redmond, Washington, USA) were used for 
calculations. Meta-regression was performed in Stata® (13, StataCorp, College Station, 
Texas, USA) using function metareg to assess the relationship between ESs 
determined histologically and by each MRI method (Harbord & Higgins, 2008). The 
proportion of the variance in the dependent variable (histological outcome) that is 
explained by variation in the independent variable (MRI) is indicated by an adjusted 
coefficient of determination, ?̅?2. The time of outcome assessment after stroke was 
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then included as a regression covariate to examine whether it accounts for some 
between-study heterogeneity and improves the model’s predictability. Statistical 
significance was set at p < 0.05. For a detailed description of the meta-analysis 
techniques and related formulae used in this study, see Appendix A.  
3.3 Results 
Figure 3.1 demonstrates the selection process for both systematic review and meta-
analysis. Fifty-seven studies using MRI in animal models of stroke were initially 
identified, two of which did not report measurement of lesion size and one performed 
ex vivo MRI; data were extracted from the remaining 54 studies, published between 
1994 and 2010 (references for all included papers are listed in Appendix B). One study 
was published in Chinese and was translated into English (2%). Two studies were 
published in abstract only (4%); to avoid data duplication, all articles were cross-
checked to verify that these two studies were not published in full as well. Most 
studies used rats (42, 78%), 11 used mice (20%) and one used baboons (2%), while all 
studies used MCAO models of focal cerebral ischaemia. Forty-five studies used T2WI 
(83%), 23 used DWI (43%), four used T1WI (7%), three used PWI (6%) and two used 
‘plasma volume imaging’ (4%), a type of perfusion imaging involving injection of a 
superparamagnetic contrast agent; one study did not state the method employed 
(2%). Overall, there were 78 different scanning protocols, with 19 articles (35%) 
reporting more than one method for assessing lesion size. Basic information 
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Figure 3.1 Flow chart demonstrating the selection process for relevant articles in 
the systematic review and meta-analysis.  
 
3.3.1 Study quality 
The median number of study quality items scored was 4 and the range was 0–6. Three 
studies gave a statement of potential conflicts of interest (6%), two reported blinding 
of the induction of ischaemia (4%), two the use of animals with comorbidities (4%) 
and no study reported a sample size calculation (Figure 3.2). Random allocation to 
group was reported in 18 studies (33%) and blinded assessment of lesion size in just 
9 studies (17%), despite the fact that some studies reported blinding of the assessment 
of outcomes other than MRI lesions; overall, 17 studies mentioned blinding of the 
assessment of at least one outcome (31%).  Control of animals’ temperature during 
surgery, compliance with animal welfare regulations and use of an anaesthetic 
without known neuroprotective activity were reported in the majority of reviewed
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Figure 3.2 Study quality criteria met by studies, sorted by overall prevalence. 
 
articles (41 articles, 76%; 38 articles, 70%; and 34 articles, 63%, respectively). A full 
report on study quality per article is given in Table B.2 in Appendix B. 
3.3.2 MRI acquisition 
Figure 3.3 shows the prevalence of various items related to MRI methodology in 
reviewed articles. Parameters were assessed for reporting either against the total 
number of articles (54) or against the total number of scanning protocols (78), where 
relevant. For this reason, it was assumed that if a study reported a scanner and 
specific equipment for imaging, a software for image analysis and information 
regarding animal positioning, anaesthetisation and monitoring of physiological 
parameters, these were applicable to all scanning protocols used in that study.  
Articles tended to report pulse sequence parameters more often than information 
regarding imaging equipment and procedures (Figure 3.3). However, the use of MRI 
between studies was highly heterogeneous, with a wide range of anaesthetics, 
scanner equipment manufacturers, scanner field strengths and types of RF coils 
reported. Surprisingly, 3 articles did not mention the scanner’s field strength (6%); 
the studies reporting the field strength used 1.5 T to 9.4 T magnets, with 4.7 T and 7  
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Figure 3.3 Prevalence of imaging items, sorted by overall prevalence.  
Items were assessed for reporting either (a) against the total number of articles or 
(b) against the total number of scanning protocols, where relevant. 
T being the most prevalent (15 of 51 studies, 29% each). Thirty-one articles reported 
the type of RF coil used (57%); from these, volume coils were the preferred type for 
both signal transmission and reception (17 studies, 55%), but surface coils or a 
combination of both types for signal transmission and reception were also commonly 
reported (7 studies, 23% each). Sixteen studies alone reported monitoring of 
physiological parameters during scanning (30%), with temperature being the most 
prevalent parameter (13 studies, 81%). Fifty-one articles reported the imaging plane 
or showed exemplar brain images (94%); this was the coronal plane for all (as shown 
in Figure 2.3). Interestingly, the side of the brain where ischaemia was induced was 
not mentioned in 12 studies (22%), while in some cases exemplar images shown in 
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the article conflicted with what it was reported in text. The prevalence for each 
different type of these MRI items is given in Table B.3 in Appendix B. 
T2WI and DWI were the two most commonly used MRI methods and the 
heterogeneity in their scanning parameters was large, as Tables 3.1 and 3.2 suggest. 
Considering rat T2WI alone, the TE ranged from 30 ms to 120 ms, the number of slices 
from six to 35, the slice thickness from 0.35 mm to 3 mm, the FOV from 22×22 mm2 to 
120×120 mm2 and the matrix size from 64×64 to 512×512. The range and median values 
for many corresponding parameters in mouse T2WI was slightly reduced, 
particularly TR, slice thickness, FOV and number of slices, as expected. Variation in 
DWI was similar to T2WI, and details of the diffusion-sensitising gradients were 
reported infrequently except for the b-factor; this ranged from 20 s/mm2 to 1898 s/mm2 
for rat imaging and 70 s/mm2 to 1224 s/mm2 for mouse imaging. Probably the most 
important parameter regarding the scanning protocol, the type of pulse sequence, 
was not reported for many protocols; articles failed to include it for 12 T2WI protocols 
(27%) and 11 DWI protocols (48%). Finally, the duration of the scanning protocol per 
animal was infrequently reported (7 T2WI protocols, 16%; 2 DWI protocols, 9%); this 
varied significantly for rat imaging (T2WI lasted from 1 to 9 minutes; DWI often took 
longer, with a range of 7 to 15 minutes). 
SE and FSE were the most commonly used types of pulse sequences for T2WI (14 of 
45 protocols each, 31%), four studies used a multi-slice multi-echo (MSME) sequence 
(9%) and one study used FLAIR imaging (2%). DWI sequences included conventional 
SE (6 of 23 protocols, 26%), SE echo-planar imaging (4 protocols, 17%), stimulated 
echo (1 protocol, 4%), and FSE (1 protocol, 4%). Surprisingly, there was not an 
important difference in the range of values reported for most parameters between 
different types of pulse sequences, as examined separately for each species; the 
prevalence of reporting did not differ much either. It is useful to note that TE was 
generally shorter for higher field strengths, while the slice thickness was slightly 
reduced; to the extent permitted by the relatively small number of studies reviewed, 
other parameters were not found to be dependent on field strength.  
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Table 3.1 MRI acquisition parameters for 45 T2WI protocols.  
Dash (–) indicates that the value cannot be calculated; ETL, echo train length; FLAIR, fluid-
attenuated inversion recovery; FOV, field of view; FSE, fast spin echo; n, number of protocols 
for which the parameter is reported; N, total number of protocols for which the parameter is 
relevant; NSA, number of sample averages; N/G, not given; TE, echo time; TI, inversion time; 
TR, repetition time. 
*The range was estimated by sorting the area (product) defined by the two values, and the 
most frequently reported value is given instead of the median.  
†Parameters applicable only to specific types of sequences.  
‡Some articles reported a range of values only; the reported minimum and maximum values 




Reported per                           
animal species, 
Species: n/N (%) 
Details per animal species, 
range (median) 
Type of pulse sequence 33/45 (73) Rat: 23/34 (68) 
Mouse: 9/10 (90) 




Scan duration (min) 7/45 (16) Rat: 5/34 (15) 
Mouse: 2/10 (20) 




TE (ms) 43/45 (96) Rat: 32/34 (94) 
Mouse: 10/10 (100) 




TR (ms) 43/45 (96) Rat: 32/34 (94) 
Mouse: 10/10 (100) 




Number of slices 27/45 (60) Rat: 18/34 (53) 
Mouse: 9/10 (90) 




Slice thickness (mm) 44/45 (98) Rat: 33/34 (97) 
Mouse: 10/10 (100) 




FOV* (mm×mm) 38/45 (84) Rat: 30/34 (88) 
Mouse: 7/10 (70) 






34/45 (76) Rat: 28/34 (82) 
Mouse: 5/10 (50) 




NSA 12/45 (27) Rat: 9/34 (26) 
Mouse: 2/10 (20) 




ETL for FSE† 5/14 (36) Rat: 3/8 (38) 
Mouse: 1/5 (20) 




TI (ms) for FLAIR† 0/1 (0) Rat: 0/1 (0) N/G (N/G) 
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Table 3.2 MRI acquisition parameters for 23 DWI protocols.  
Dash (–) indicates that the value cannot be calculated; ETL, echo train length; FOV, field of 
view; FSE, fast spin echo; n, number of protocols for which the parameter is reported; N, total 
number of protocols for which the parameter is relevant; NSA, number of sample averages; 
N/G, not given; TE, echo time; TR, repetition time. 
*The range was estimated by sorting the area (product) defined by the two values, and the 
most frequently reported value is given instead of the median.  
†Parameter applicable only to specific types of sequences.  
‡Some articles reported a range of values only; the reported minimum and maximum values 





Reported per                     
animal species, 
Species: n/N (%) 
Details per animal species, 
range (median) 
Type of pulse sequence 12/23 (52) Rat: 11/22 (50) 
Mouse: 1/1 (100) 
– (–) 
– (–) 
Scan duration (min) 2/23 (9) Rat: 2/22 (9) 
Mouse: 0/1 (0) 
7-15 (11) 
N/G (N/G) 
TE (ms) 17/23 (74) Rat: 16/22 (73) 
Mouse: 1/1 (100) 
33-100 (40) 
30 (30) 
TR (ms) 18/23 (78) Rat: 17/22 (77) 
Mouse: 1/1 (100) 
1000-4000 (3000) 
1000-1000 (1000) 
Number of slices 12/23 (52) Rat: 11/22 (50) 
Mouse: 1/1 (100) 
4-13 (8)‡ 
5 (5) 
Slice thickness (mm) 19/23 (83) Rat: 18/22 (82) 
Mouse: 1/1 (100) 
1-2 (1.5) 
0.5 (0.5) 
FOV* (mm×mm) 17/23 (74) Rat: 16/22 (73) 





17/23 (74) Rat: 16/22 (73) 
Mouse: 1/1 (100) 
64×64-256×256 (128×128) 
128×64 (128×64) 
NSA 4/23 (17) Rat: 4/22 (18) 
Mouse: 0/1 (0) 
2-4 (3) 
N/G (N/G) 
ETL for FSE† 1/1 (100) Mouse: 1/1 (100) 8 (8) 
Diffusion sensitivity,  
b-factor (s/mm2) 
18/23 (78) Rat: 17/22 (77) 




strength, G (mT/m) 
6/23 (26) Rat: 5/22 (23) 




duration, δ (ms) 
8/23 (35) Rat: 7/22 (32) 




separation, Δ (ms) 
6/23 (26) Rat: 5/22 (23) 
Mouse: 1/1 (100) 
13-50 (24.7) 
17.5 (17.5) 
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3.3.3 MRI post-processing 
Forty articles reported the use of an image analysis software for the measurement of 
lesion size (74%; Figure 3.3); 17 of these are academic (43%), 16 are commercial (40%) 
and 7 are custom-made tools (17%). For nine of the 23 diffusion protocols, ADC maps 
were created for assessing lesions (39%), while CBF maps were generated in all three 
perfusion studies (100%). Out of a total of 78 different imaging protocols, 51 gave 
some information regarding the method employed to determine the boundary of 
lesions in MRI images (65%); for 39 protocols a type of thresholding was used (76%), 
followed by manual tracing in 10 protocols (20%) and an automated contour tracing 
algorithm in just two (4%). However, no study employing manual analysis provided 
specific selection criteria for determining lesions. A range of thresholds were reported 
for T2WI, DWI and PWI data analysis, including absolute diffusion or perfusion 
thresholds for the latter two methods, or thresholds based on the intensity in the 
contralateral healthy brain hemisphere for all three methods. Voxels in T2WI data 
were commonly selected if intensity was higher than 2 SDs above the mean intensity 
in the healthy contralateral hemisphere, or higher than 1.25 times this mean intensity; 
no study provided reasonable justification for their use. A reduction of ADC by 20% 
or 29% compared to the contralateral values was often classified as abnormal, but 
only those who used the latter threshold justified its use: the selected region correlates 
with post-mortem infarct volume. All studies which analysed T2WI data via 
thresholding used volume RF receive coils, except for three studies which used 
surface coils to acquire quantitative T2 maps that are free of intensity inhomogeneities. 
An important confounding parameter to the estimation of infarct size from T2WI data 
is brain swelling, arising due to vasogenic oedema in the subacute and chronic phases 
of stroke; 44 of the 45 imaging protocols were used at time points after MCAO when 
brain oedema might have been present. Nevertheless, only for 11 of these (25%) a 
method for correction was reported; all are intended for use in histological assessment 
of infarct size and not MRI. Nine studies (82%) applied the formula by Swanson et al. 
(1990), while the other two studies (18%) normalised the observed lesion size by the 
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ratio of hemispheric volumes according to Leach et al. (1993). Furthermore, the 
quality of data analysis was poor in the vast majority of studies; in addition to 
infrequent blinding of image analysis (Figure 3.2), only one article reported analysis 
by multiple independent raters (2%; Figure 3.3). Lesion size was usually reported in 
articles as an absolute estimate of volume (for example mm3; 45 protocols, 58%), 
followed by a range of relative estimates. Table B.3 in Appendix B provides further 
details for various MRI post-processing parameters.  
3.3.4 Meta-analysis 
To determine the relationship between various MRI methods and current gold 
standard post-mortem histology for the estimation of infarct size, studies which 
reported use of a histological method right after MRI in the same cohort of animals 
were further selected. Fifteen out of the 54 reviewed publications used histology 
(28%); two of these did not kill the animals for histological analysis right after MRI 
and another study did not provide infarct size measurements for a control group, 
thus were excluded (Figure 3.1). Characteristics of the remaining 12 studies are given 
in Table 3.3. Forty-six MRI and 46 histology comparisons between corresponding 
treatment and control groups are described in these studies, comprising of 428 
animals that were assessed with MRI, 228 of which were then sacrificed for histology. 
Specifically, 11 studies performed T2WI (33 comparisons, 410 animals for T2WI and 
210 for histology) and six performed DWI (11 comparisons, 147 animals for DWI and 
105 for histology). Only one article reported T1WI and PWI (1 comparison each, 19 
animals for MRI and histology); the relationship between histology and these specific 
imaging methods could not be examined. Histological assessment of infarct size was 
performed with TTC staining in 10 studies and H&E or cresyl violet staining in one 
study each. For meta-analysis, an ES was estimated for each comparison and then all 
effects were combined to estimate the pooled ES for each method. Meta-regression 
was used to assess the relationship between corresponding MRI and histology effects; 
detailed meta-analysis methodology is described in Appendix A. 
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Table 3.3 Characteristics of studies included in meta-analysis. 
DWI indicates diffusion-weighted imaging; H&E, haematoxylin and eosin; T2WI, T2-weighted 
imaging; TTC, 2,3,5-triphenyl-2H-tetrazolium chloride. 
Table 3.4 shows the combined estimate of efficacy as an NMD from all MRI 
comparisons, MRI comparisons that were nested for identical cohorts (see Appendix 
A), T2WI and DWI comparisons, along with the corresponding histological 
comparisons. Overall, the reduction in lesion size assessed by the first two MRI 
approaches is almost identical to the reduction observed histologically. T2WI gives a 
slightly more conservative estimate of efficacy (22.2%) compared to histology (25.5%), 
whereas the improvement in lesion size for DWI is 42.4%, noticeably larger than the 
31.8% improvement determined by histology. The CIs of the T2WI estimate are 
narrower than histology, whereas DWI estimates vary more than histological 
estimates. The between-study heterogeneity in treatment effects is high, as suggested 
Study Species 
Histology        
method 













Goto et al. (2002) Mouse Cresyl violet DWI 1 21 
Nomura et al. (2005) Rat TTC T2WI 3 168 












Honma et al. (2006) Rat TTC T2WI 4 168 


















Li et al. (2008) Rat TTC T2WI 2 336 
Omori et al. (2008) Rat TTC T2WI 4 336 
Onda et al. (2008) Rat TTC T2WI 3 168 
Toyama et al. (2009) Rat TTC T2WI 7 168 
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by the significant p-values and large 𝐼2 for all combined ESs in Table 3.4. 
Meta-regression analysis is showcased in Table 3.5 and Figure 3.4. Overall, all 
imaging findings explain 56.6% of the observed variation in histological outcome, but 
nested MRI estimates in identical cohorts have a better correlation with histology. 
Nevertheless, the relationship is stronger for T2WI alone (explains 69.9% of variation 
in histology), whereas DWI performance is the poorest. Inclusion of the time of infarct 
assessment as an additional independent variable is not influencing the correlation 
between all MRI findings and histology, but improves the performance of T2WI and 
DWI meta-regression models.  
Table 3.4 Combined effect sizes based on MRI and histology infarct size. 
CI indicates confidence interval; DWI, diffusion-weighted imaging; 𝐼2, between-study 
heterogeneity (equation A.26); NMD, normalised mean difference; T2WI, T2-weighted 
imaging. 
*If a study used various MRI methods to scan the same cohort of animals at the same time, 
effect sizes were pooled to create a nested effect size; the final combined estimate was 











[95% CI] (%) 
p-value 𝑰𝟐 (%) 
All MRI 46 428 26.7 [22.6, 30.8] < 0.001 92.9 
  Histology 46 228 27.5 [21.3, 33.7] < 0.001 89.7 
Nested MRI* 34 428 23.3 [18.8, 27.8] < 0.001 93.2 
  Histology 34 228 26.0 [18.0, 33.9] < 0.001 91.6 
T2WI  33 410 22.2 [17.9, 26.5] < 0.001 93.7 
  Histology 33 210 25.5 [17.5, 33.5] < 0.001 91.8 
DWI 11 147 42.4 [30.9, 54.0] < 0.001 72.2 
  Histology 11 105 31.8 [24.0, 39.7] 0.002 64.7 
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Table 3.5 Meta-regression analysis of corresponding MRI and histology effect sizes. 
Histology was used as the dependent variable. CI indicates confidence interval; DWI, diffusion-
weighted imaging; ?̅?2, adjusted coefficient of determination; T2WI, T2-weighted imaging. 
*If a study used various MRI methods to scan the same cohort of animals at the same time, 
effect sizes were pooled to create a nested effect size (see Appendix A). 
 
 
Figure 3.4 Meta-regression of corresponding histological and MRI effect sizes.  
(a) All MRI, (b) nested MRI, (c) T2WI, and (d) DWI effect sizes were used as the 
independent variables. The size of the circles reflects the precision of each estimate; 
large circles indicate small standard error and thus larger weight in the regression. 
The coefficients of regression and determination are given in Table 3.5. NMD 
indicates normalised mean difference. 
 Time not a covariate  Time included as a covariate 
Method 
Coefficient        
[95% CI] 
p-value ?̅?𝟐 
 Coefficient        
[95% CI] 
p-value ?̅?𝟐 
All MRI 0.76 [0.52, 1.00] < 0.001 0.566  0.76 [0.52, 1.00] < 0.001 0.554 
Nested MRI* 1.04 [0.74, 1.34] < 0.001 0.672  1.07 [0.77, 1.37] < 0.001 0.680 
T2WI  1.08 [0.77, 1.38] < 0.001 0.699  1.13 [0.83, 1.44] < 0.001 0.724 
DWI 0.31 [-0.12, 0.73] 0.136 0.433  0.36 [-0.05, 0.78] 0.079 0.534 
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3.4 Discussion 
This systematic review of studies in animal models of stroke reveals great variability 
in MRI scanning parameters and post-processing methods used to assess lesion size. 
Reporting of methodology was assessed against several important items proposed by 
generic recommendations (Stout et al., 2013) and other items applied specifically to 
stroke; these covered the animal handling procedure for scanning, pulse sequences 
used and image analysis methods. Information about scanning equipment and basic 
pulse sequence parameters, such as TR, TE and slice thickness, were adequately 
reported, but information regarding the animal positioning, the physiological 
parameters monitored and methods for ensuring accurate and reproducible image 
analysis was limited. The heterogeneity in imaging systems and software for analysis 
is not in itself a cause for criticism and would not pose serious threats to the internal 
validity in single centre studies, but limits their external validity and may affect 
comparisons in multicentre studies, as suggested by various clinical MRI studies 
(Kivrak et al., 2013; Takao, Hayashi, & Ohtomo, 2013; Wurnig et al., 2013). However, 
detection bias in analyses carried out in the reviewed studies was potentially large, 
as only in one study image analysis was repeated by two independent raters and in 
only nine studies blinding of this procedure to group allocation was performed, 
introducing dubiety to reported measurements. Study quality was assessed using a 
standard approach (Macleod et al., 2004); most items were often not reported, despite 
the availability of recommendations before publication of the majority of articles 
(Macleod et al., 2009; Stroke Therapy Academic Industry Roundtable (STAIR), 1999). 
It is known that experimental stroke studies which do not report these study quality 
items may overstate treatment effects (Macleod et al., 2008). 
Meta-analysis aimed to determine the reliability of MRI methods for determining 
infarct size, by examining the correlation of treatment effects based on infarct sizes 
measured by MRI and gold standard histology. Study characteristics and design were 
matched across the examined comparisons as much as possible by considering 
measurements performed in the same cohort of animals at the same time using both 
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methods. In addition, it was assumed that the various histological methods used 
provide equivalent estimates of infarct size (Barone et al., 1991; Bederson et al., 1986; 
Tureyen, Vemuganti, Sailor, & Dempsey, 2004). Excess heterogeneity between studies 
was accounted for by using random effects meta-analysis (DerSimonian & Laird, 
1986). Due to the small number of studies satisfying the meta-analysis inclusion 
criteria, assessment of infarct size at various time points following stroke was 
considered (Table 3.3). This is useful in capturing possible temporal changes in 
outcome; indeed, the inclusion of time in the T2WI and DWI meta-regression models 
improved their predictability, suggesting that infarct-based treatment effects vary 
during the first two weeks after the onset of ischaemia. This finding emphasises that 
the selection of appropriate time points for assessing outcomes is a crucial element of 
the design of animal studies. While early time points help minimise attrition and 
reduce overall study costs, treatment effects measured early might be of poor validity 
and usefulness. The pronounced change in the adjusted coefficient of determination 
in the DWI meta-regression model could imply that this method is a less reliable 
indicator of the effectiveness of tested interventions, but it might have arisen from the 
small number of comparisons used, which precludes derivation of safe conclusions. 
Predictability of nested MRI comparisons was superior to that of all MRI 
comparisons, possibly due to the absorption of DWI effects by the more accurate 
T2WI for studies that used both. 
Nevertheless, meta-analysis suggests that T2WI can be used effectively as an in vivo 
alternative to histology for the assessment of infarct size at least up to two weeks 
following stroke, despite the fact that T2WI-based measurements of absolute infarct 
volume in primary articles were often larger than corresponding histology estimates. 
This could be attributed to the observation that none of the included studies applied 
a correction to take into account the increased vasogenic oedema, which is not present 
in post-mortem histological slices as fixation may shrink the lesioned tissue (Barone 
et al., 1991; Gerriets et al., 2004). The narrower confidence limits of the combined 
T2WI-based effects suggest that this method may also have greater statistical power 
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than histology, and hence require fewer animals.  
In contrast, DWI lesion volume did not correlate well with histological infarct 
volume, giving larger estimates of ES. This method is sensitive to the restricted 
diffusion of extracellular water due to the abnormal swelling of cells (cytotoxic 
oedema) at the early stages of stroke progression (Campbell & Macrae, 2015; 
Dijkhuizen & Nicolay, 2003; Farr & Wegener, 2010; Wardlaw, 2010). According to the 
meta-analysed studies, DWI lesions were larger than corresponding histology lesions 
at 21 hours and smaller in the chronic phase of stroke, agreeing with a previous 
systematic review suggesting that the extent of the infarct generally increases despite 
early DWI lesion normalisation (Rivers & Wardlaw, 2005). 
This study intended to use stratified meta-analysis to examine the impact of 
individual imaging parameters on meta-regression models to refine the relationship 
between MRI and histology. The small number of studies included in meta-analysis 
and the variety of experimental methods used (related to species, stroke model and 
MRI methods) precluded such analysis, since stratification of studies by various 
criteria often led to groups consisting of a single study. The significant variability in 
MRI methodology raises questions about the best way to apply each MRI contrast 
technique, and whether measurements from different studies are comparable. It 
should be acknowledged, however, that the optimal scanning protocol must be a 
compromise between resolution, anatomical coverage, contrast between normal and 
injured tissue, and speed, in order to allow accurate quantification of lesion size while 
minimizing the duration of anaesthesia received by animals for MRI. As shown by 
this systematic review, the values of many imaging parameters should be chosen at 
least according to the animal species and the field strength of the scanner used. 
This might be the first systematic review and meta-analysis of MRI in animal models 
of stroke, but it comes with a few limitations. Firstly, there is a lack of specificity by 
including studies utilizing any MRI technique for assessing various types of lesions 
at various time points. The primary objective of the study was to provide an overview 
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of the use of the modality in preclinical stroke research and examine whether this 
could be a limiting factor in data pooling in meta-analyses or multicentre animal 
studies; findings clearly support this hypothesis. Future studies should focus on 
individual MRI techniques or outcomes. Rivers and Wardlaw (2005) reviewed the use 
of DWI in animal stroke studies and identified a similarly incomplete reporting of 
experimental details. They also examined whether DWI could provide information 
regarding tissue viability by comparison with various histopathological markers, but 
their assessment was limited in description of findings reported in reviewed papers. 
Dani et al. (2012) assessed the reporting of PWI in human stroke and found poor 
consistency between studies. Perfusion imaging co-registered with diffusion imaging 
is a technique for identifying the salvageable ischaemic penumbra (represented by 
the mismatch of the two images), which provides a hypothetical target for reperfusion 
therapies. This concept has been subject to significant scrutiny in both clinical and 
preclinical research but no widely accepted definition exists (Dani et al., 2011). This 
could partially explain the small number of PWI protocols recorded in this review. 
There have been calls for consensus in the use of DWI and PWI for defining the 
penumbra in humans and in animals (Campbell & Macrae, 2015; Rivers & Wardlaw, 
2005); however, there is a more pressing case, demonstrated here, for consensus in 
the use of more routine MRI techniques. 
Secondly, assessed studies were identified in a single database comprising a non-
exhaustive list of studies in animal models of stroke. However, these were previously 
identified and included in this database based on criteria that did not relate to the 
imaging methodology, and therefore the articles examined here can be considered 
representative of experimental stroke imaging studies in the literature. Few 
experiments assessed infarct size using both histology and MRI at corresponding time 
points (46 of 5329 comparisons), and this did not allow exploration of the impact 
imaging parameters have on the relationship between MRI and histological outcome 
measures. A systematic review seeking to identify all such studies would enable such 
analysis, but is likely to require screening of a large number of publications. 
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This study suggests that the variability between studies in the use of MRI for the 
assessment of lesion size is significant. A strong correlation between histology and 
T2WI was found for estimating treatment effects based on infarct size, suggesting that 
utilising a standardised T2WI scanning protocol and associated data post-processing 
techniques for quantification of infarct size is feasible and should be considered in 
future multicentre animal studies. Acknowledging the insufficient methodological 
description in imaging papers, Stout et al. (2013) recently published generic 
guidelines for the reporting of imaging information in preclinical papers. However, 
specific guidelines for the use and reporting of MRI methodology in experimental 
stroke are needed, similar to those developed for the conduct of human stroke 
imaging (Wintermark et al., 2008; Wintermark et al., 2013). This would permit exact 
replication of the experiments and analyses and would support the use of imaging 








Construction of an MRI Phantom and 
Development of a Data Analysis Tool  
This chapter describes the development of tools for the assessment of geometric 
accuracy in preclinical MRI scanners in the context of stroke imaging. Specifically, the 
chapter presents the procedures regarding the construction of a small sMRI phantom 
and the development of an automated method for the analysis of related MRI images. 
Phantom scanning is performed using a standardised pulse sequence based on rat 
T2WI, as recorded in the preceding systematic review. The tools described here are 
used in Chapter 6 to perform a multicentre MRI study. 
Parts of this chapter have been presented as: 
Milidonis, X., Lennen, R. J., Jansen, M. A., & Marshall, I. (2014). Gradient scaling on preclinical 
magnetic resonance imaging scanners assessed with a dedicated phantom. Presented at the 20th 
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4.1 Introduction 
Chapter 3 revealed a large heterogeneity between studies in the use of MRI in 
experimental stroke. However, the true impact of this heterogeneity on the 
assessment of infarct size or any other morphological outcome can only be assessed 
by scanning the same subjects using different scanners or protocols. One way to 
perform this is by scanning a group of animals that have been subjected to cerebral 
ischaemia. However, cerebral ischaemic damage is a spatiotemporally evolving 
process happening at a fast rate during the first few days post-onset (Loubinoux et 
al., 1997; Neumann-Haefelin et al., 2000; Wegener et al., 2006; Zanier et al., 2013), 
while many animals die in later stages of the disease; such variability does not allow 
reproducible scanning of the same animal. In this case, a QA approach by scanning 
an MRI phantom would be more suitable; a phantom is a temporally stable object 
with known characteristics that permits reliable assessment of outcomes between or 
within scanners.  
Despite that animal studies in stroke often measure morphological outcomes in sMRI 
data to evaluate the efficacy of tested interventions or examine new concepts of 
pathophysiology (Farr & Wegener, 2010; Zille et al., 2012), standardised QA 
approaches employing phantoms for monitoring and optimising the performance of 
scanners on a routine basis have not yet been developed. QA has almost always been 
an invaluable tool in clinical MRI practice, with performance tests carried out daily 
(American College of Radiology, 2015; Gunter et al., 2009). In preclinical centres, such 
tests are rarely performed by the personnel and most rely on annual maintenance of 
the systems by external engineers. As a result, systematic drifts in scanner 
performance during a lengthy stroke experiment may not be detected and accounted 
for. Such drifts could subsequently cause geometric distortions in images and further 
degradation of image quality, amongst others, with direct effect on the measurement 
of morphological outcomes. When these effects are combined with the large 
variability in scanning protocols and image processing methods used across centres, 
an effective comparison of outcomes across centres becomes almost impossible. The 
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impact of these shortfalls in experimental stroke will become more apparent in the 
future, when multicentre studies might be the new paradigm (Bath et al., 2009; 
Dirnagl & Fisher, 2012; Dirnagl et al., 2013). Multicentre studies have high demands 
for accurate and reproducible measurements in all participating centres for efficient 
pooling of data and derivation of valid conclusions, but unless the use of MRI is of a 
sufficient standard these requirements cannot be met. 
The main objective of this thesis is to examine how geometric accuracy in preclinical 
scanners affects the quantification of infarct size and relevant comparisons between 
scanners. Towards this endeavour, a multicentre MRI QA study examining the 
between- and within-scanner variability was designed and carried out (Chapter 6); 
this chapter aims to describe the development of tools and methods that were central 
to this study. A simple structural phantom and accompanying methods for the 
acquisition and unbiased analysis of phantom data are presented, with the 
assessment of geometric accuracy being based on the measurement of two QA 
criteria: dimensions and volume. The development of the phantom scanning protocol 
was driven by findings of the systematic review and meta-analysis presented in 
Chapter 3; specifically, the phantom resembles the size and T2 relaxation time of the 
rat MCA territory—the most widely used species in experimental stroke—and the 
QA pulse sequence is based on recorded T2WI parameters in this species (Table 3.1). 
The work presented here could encourage the introduction of simple and rigorous 
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4.2 Quality Assurance Protocol 
4.2.1 Phantom 
Ideally, assessment of between- and within-scanner variability in a multicentre QA 
study requires construction of an identical phantom for each centre; based on this, a 
number of phantoms were constructed according to the following criteria: 
 high inter-phantom precision to allow comparable assessment of geometric 
accuracy 
 size similar to that of the rat MCA territory and small enough to be used with 
any type and size of RF coil for rat MRI 
 durable and with minimal water absorption to be temporally stable 
 made with materials with low magnetic susceptibility to minimise distortion 
artefacts  
 easy to construct with cheap and readily available materials 
Probably the only materials that satisfy all these criteria are LEGO® (Billund, 
Denmark) bricks; there are two types of plastics used for their manufacturing, 
transparent polycarbonate and opaque acrylonitrile butadiene styrene (ABS) 
polymers. These polymers are diamagnetic like water (Osswald & Menges, 2010; 
Wapler et al., 2014) and have high impact strengths and minimal water absorption 
properties (0.15% and 0.20-0.40% over 24 hours respectively) (Shackelford, Han, Kim, 
& Kwon, 2015). LEGO bricks are manufactured by injection moulding using high 
precision moulds, giving the pieces an excellent final geometrical tolerance of just 
20μm (Quercioli, Tiribilli, Mannoni, & Acciai, 1998).  
For the phantoms, 2×2 bricks made of transparent polycarbonate were chosen (LEGO 
design no. 3003; Figure 4.1 a). To seal the bottom side of the bricks, 2×2 flat tiles made 
of opaque ABS were chosen (LEGO design no. 3068). Using a heated metallic wire, a 
shallow hole was made at a specific location on the surface of each tile to act as an 
orientation marker for scanning (Figure 4.1 a). The central cylindrical compartment 
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of the transparent bricks is slightly shorter than the sides of the bricks; to ensure full 
contact of each tile with the central cylindrical compartment of the transparent bricks, 
four layers of transparent tape of size about 6×6 mm2 were attached to the centre of 
each tile (Figure 4.1 a). 
 
Figure 4.1 A simple structural phantom for assessing geometric accuracy in 
preclinical MRI scanners.  
Images show (a) the two different LEGO bricks that make up the phantom, (b) the 
completed phantom, (c) cross sections indicating its internal dimensions (in mm), 
and (d) example MRI images acquired with a rat brain surface RF coil (top, coronal; 
bottom, axial/sagittal). The arrows in (a) indicate (1) the orientation marker and (2) 
transparent tape that ensures full contact between the cylindrical compartment of 
the transparent plastic and the opaque tile. 
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The transparent brick of each phantom was filled by submerging it into distilled water 
doped with Gd 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (Gd-DOTA; 
Dotarem®, Guerbet, Roissy CdG Cedex, France) at a concentration of 3 mmol/L (6 
mL/L). The use of a contrast agent is necessary to shorten both relaxation times in 
order to allow use of a QA pulse sequence with short TR and decrease the overall QA 
duration. The concentration of 3 mmol/L was chosen according to a published table 
(Noebauer-Huhmann et al., 2008) to create a solution with a T2 relaxation time similar 
to that of the healthy striatum in the rat brain at 7 T (Fagan et al., 2008). Gd-based 
contrast agents are often used in MRI phantoms, including a structural preclinical 
phantom developed recently by others (Teh, Maguire, & Schneider, 2016).  
The flat tile was firstly placed over the filled transparent plastic and acetone was 
applied at the joints to temporarily hold them together. Then, a thin layer of epoxy 
resin was applied to permanently join them and seal the phantom.  
4.2.2 Quality assurance criteria 
The constructed phantoms enable assessment of geometric accuracy in preclinical 
MRI scanners via measurement of two criteria:  
1. The internal dimensions across all three orthogonal directions, approximated 
by the distance between opposing edges horizontally or vertically in the 
images (Figure 4.1 c). Measurements in y direction (vertical in axial/sagittal 
image in Figure 4.1 d) are obtained along the sides of the phantom to avoid 
confounding by the tape attached to the centre of the base tile. The overall size 
of the internal phantom area is similar to that of the rat MCA brain territory 
(10-15 mm in any direction). 
2. The volume of the central cylindrical frustum-shaped compartment, 
measured by identifying the relevant region in all slices and summing all of 
its voxels (the central region in images in Figure 4.1 d). This volume is similar 
to that of a medium-sized cortical and subcortical infarct, or a large subcortical 
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infarct in the rat MCAO model (100-200 mm3). 
The internal dimensions of all constructed phantoms were measured before filling 
using callipers to verify inter-phantom precision. To measure the true volume of the 
cylindrical compartment of the phantom, three phantoms were constructed as 
described, but without filling them with liquid solution or attaching them 
permanently. 3-dimensional (3D) CT images of the empty phantoms were obtained 
using a nanoScan® PET/CT scanner (Mediso Ltd., Budapest, Hungary) with an 
isotropic resolution of 34.5 μm (35 kVp beam energy, 1 mA tube current, 450 ms 
exposure time). Using ImageJ (1.50b; Rasband, W.S., National Institutes of Health, 
Bethesda, Maryland, USA, http://imagej.nih.gov/ij/) the CT data were first smoothed 
with a Gaussian filter with an SD of 1 pixel (81.2 μm full width at half maximum 
(FWHM)) and then binarised using an appropriate intensity threshold to produce 
masks of the phantom with exactly the calliper-measured dimensions. The volume of 
the cylindrical compartment in all three phantoms was measured from the 
thresholded CT data and was found to be very precise; the mean value was 
considered as the ground truth (mean ± SD = 153.1 ± 0.4 mm3). CT scanning was 
performed with the assistance of Dr Adriana Tavares (University of Edinburgh). 
4.2.3 MRI scanner and equipment 
All experiments described in this chapter were carried out on an Agilent 7 T 
horizontal bore animal scanner (Agilent Technologies®, Santa Clara, California, USA) 
with a magnet bore with 305 mm inner diameter (ID), located in the Edinburgh 
Preclinical Imaging (EPI) facility at the University of Edinburgh. An actively shielded 
gradient insert with a maximum gradient strength of 400 mT/m and ID of 120 mm 
was used. All MRI scanning described in this chapter was performed using either a 
72 mm ID volume coil for RF transmission and reception, or this volume coil for 
transmission and a rat head two-channel phased array surface coil for reception 
(RAPID Biomedical GmbH, Rimpar, Germany). The software used for data 
acquisition was VnmrJ® (3.2, Agilent). All equipment used is shown in Figure 4.2. 
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Figure 4.2 The preclinical MRI scanner and equipment used for phantom 
imaging. 
Images show (a) the 7 T Agilent scanner, (b) the VnmrJ software for data 
acquisition, (c) the volume coil for signal transmission/reception, (d) the rat head 
surface coil for signal reception, (e) the cradle for rat imaging with arrows indicating 
the ear bar holders, and (f) the surface coil placed on the cradle. The volume coil is 
placed in the centre of the scanner and then the cradle with the surface coil is 
inserted in the volume coil, so that the phantom is positioned at the isocentre of the 
scanner. If the volume coil is used for both signal transmission and reception, the 
cradle is inserted in the volume coil without the surface coil. 
For scanning, the phantom is placed in the rat cradle with the opaque tile at the 
bottom and is kept in place using stereotaxic ear bars, similar to the procedure 
followed for rat brain imaging (Figure 4.2 e). For phantom alignment and positioning 
close to the surface coil, additional LEGO bricks are placed beneath the phantom, 
while masking tape is also used for further immobilisation. If the surface coil is used 
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for signal reception, it is placed on top of the phantom and the assembled cradle is 
positioned at the scanner’s isocentre within the volume coil.  
4.2.4 T2 relaxometry 
To measure the T2 relaxation time of the phantoms’ solution, the volume coil was used 
for signal transmission and reception and a MSME sequence was used for capturing 
T2 relaxation (mems protocol in VnmrJ; parameters in Table 4.1). T2 relaxation follows 
an exponential decay curve over time (Figure 2.2 e); this is described by the following 
equation: 
𝑆 = 𝑆0𝑒
−𝑇𝐸/𝑇2 + 𝑆𝑜𝑓𝑓𝑠𝑒𝑡                                                       (4.1) 
where 𝑆 is the signal corresponding to the relaxing 𝑀𝑥𝑦, 𝑆0 is the maximum signal 
corresponding to 𝑀0 and 𝑆𝑜𝑓𝑓𝑠𝑒𝑡 is an offset factor taking into account any potential 
instrumental imperfections. The MSME sequence generates an image for each TE, the 
signal in which is proportional to 𝑀𝑥𝑦 over time. MATLAB® (2015a; The MathWorks® 
Inc., Natick, Massachusetts, USA) was used to take measurements of the mean  








FOV indicates field of view; MSME, multi-slice multi-echo; NSA, number of sample averages; 
TE, echo time; TR, repetition time. 
*Twenty echo times with an echo spacing of 10 ms were used. 
†No inter-slice gap was used. 
Parameter Value 
Type of sequence MSME 
TR (ms) 1500 
TE* (ms) 10-200 
NSA 1 
FOV (mm×mm) 19.2×19.2 
Matrix size (pixels×pixels) 64×64 
Slice thickness† (mm) 2 
Number of slices 5 
Scan duration (min:sec) 1:36 
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intensity, 𝑆, within a circular region of interest (ROI) with 3 mm diameter at the centre 
of the phantom in all 20 images of the middle slice. Intensity measurements were then 
plotted against TE and equation 4.1 was fitted to the points to estimate the T2 
relaxation time using MATLAB’s Curve Fitting Tool. 
4.2.5 Quality assurance scanning protocol 
Reviewed literature in Chapter 3 revealed that rats are mostly used in experimental 
studies of stroke, with conventional SE and FSE being the most prevalent pulse 
sequences for 2-dimensional (2D) T2WI for the assessment of infarct size. Based on 
these observations, a protocol was devised for the assessment of geometric accuracy 
in preclinical scanners. FSE was chosen over SE for its multifold improvement in 
speed, and sequence parameters were chosen based on parameters for rat T2WI, as 
shown in Table 3.1; parameters were adjusted to reach a compromise between image 
quality and speed of acquisition for imaging with either of the volume or the surface 
coil (fsems protocol in VnmrJ; parameters in Table 4.2).  
For full assessment of geometric accuracy in a preclinical scanner, the phantom is 
scanned using this sequence and the preferred RF coil/s six times, once in each 
primary imaging plane (axial, coronal and sagittal) and all repeated with flipped 
frequency and phase encoding directions in the imaging plane to record any influence 
of spatial encoding. Acquired images are analysed to measure the two QA criteria 
and compare them with the ground truth values; the internal dimensions of the 
phantom are measured in all six scans and the volume of the phantom’s central 
compartment in the axial scan alone, which represents the coronal plane used in 
rodent brain imaging (the x-y plane in Figure 2.3; in phantom scanning the human 
convention is often used, hence this plane is the axial plane). 
 
  
4.3  Automated Image Analysis Tool 67 








A FSE sequence uses 180° refocussing RF pulses after the initial 90° excitation with a number 
equal to ETL, to produce a series of echoes and acquire multiple lines of k-space within each 
TR. ETL indicates echo train length; FOV, field of view; FSE, fast spin echo; NSA, number of 
sample averages; rBW, receiver bandwidth; TEeff, effective echo time (TE corresponding to 
the echo when the central k-space lines determining the image contrast are acquired); TR, 
repetition time. 
*No inter-slice gap was used. 
4.3 Automated Image Analysis Tool 
2D MRI data have a limited resolution, which could impact manual measurement of 
the two QA criteria and cause errors in comparisons between scanners where subtle 
differences in geometric accuracy are present; it is therefore important to acquire 
reliable and reproducible measurements in order to detect true differences between 
scanners. For the analysis of phantom data acquired in this chapter and the 
multicentre study presented in Chapter 6, a simple and fast automated tool was 





Type of sequence FSE 
TR (ms) 1600 
TEeff (ms) 20 
NSA 2 
ETL 4 
rBW (kHz) 100 
FOV (mm×mm) 19.2×19.2 
Matrix size (pixels×pixels) 256×256 
Slice thickness* (mm) 1 
Number of slices 17 
Scan duration (min:sec) 3:28 
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4.3.1 Analysis pipeline 
An analysis pipeline was devised, utilising simple methods for the detection of the 
region representing the phantom in scans and the measurement of its internal 
dimensions or the volume of its central cylindrical compartment (Figure 4.3). Most 
analysis steps were used empirically and were adjusted until acceptable results were 
obtained. The main task of the analysis pipeline is to create accurate binary masks 
(black and white images) of the phantom; for this, three different methods have been 
implemented and compared, as described in the next section. 
Initially, the intensity of the scan is normalised to the range 0 to 1. If the phantom is 
misaligned in the imaging plane, plain binarisation is performed to measure the 
alignment angle based on the slope of the phantom sides and identify the imaging 
plane based on the horizontal and vertical length of the phantom. The slices are then 
aligned and rotated respectively, to ensure equivalent analysis. The boundary of the 
phantom is determined with a segmentation process utilising a range of 
morphological steps (blue boxes in Figure 4.3). The process used for measuring the 
dimensions of the phantom involves scaling of the images using bicubic interpolation 
to perform subpixel analysis, if required; the precision of measurement improves 
proportionally to the scaling factor, but the tool’s computational efficiency decreases.  
The segmentation process for measuring the phantom’s dimensions returns a binary 
mask of the phantom’s boundary alone. The distance between opposing edges across 
four different locations in each direction is computed (horizontal and vertical), by 
identifying the pixel coordinates of opposing edges. For volume estimation, a filled 
version of the boundary mask is returned and the central compartment is identified 
to count included voxels. Both processes are guided by the location of the centroid 
(centre of mass of the binary object) of the whole phantom. 
The analysis pipeline described above is repeated in all slices of the 2D scan that show 
the phantom’s central cylindrical compartment, as determined automatically during 
the initial binarisation. The final dimension in each direction is the mode value of all  
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Figure 4.3 Automated pipeline for the analysis of phantom data. 
This is a simplified diagram showing the major processing steps used to analyse 
the phantom data automatically and measure its internal dimensions and the volume 
of its cylindrical compartment (an axial/sagittal scan is shown for illustration). Three 
different methods were applied and compared in the blue boxes, each utilising a 
series of morphological processing steps; threshold selection in the top blue box 
forms the basis of one of these methods. Only axial/sagittal scans are rotated to 
ensure equivalent analysis. 
measurements (often 20-30 per direction); the mode is used to discard any abnormal 
measurements attributed to the phantom’s orientation marker or other artefacts in the 
images. The final volume is estimated by the sum of all detected voxels. 
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4.3.2 Segmentation methods 
Various methods exist for segmenting objects in greyscale images. Since MRI images 
have background noise that is described by a known (Rician) distribution 
(Gudbjartsson & Patz, 1995) and phantom images are usually characterised by a high 
SNR throughout, three basic methods for segmentation were considered; these were 
implemented in MATLAB and were accompanied by standard morphological 
processing steps using dedicated MATLAB functions to accurately define the 
phantom (blue boxes in Figure 4.3). The three approaches were eventually compared 
to select the best method. 
4.3.2.1 Simple thresholding 
This is the simplest method implemented. The intensity histogram of the whole 
normalised scan is examined to find the first peak corresponding to background noise 
(Figure 4.3). The threshold, 𝑇, is then defined as 
𝑇 = 5 𝐼𝑝𝑒𝑎𝑘                                                                   (4.2) 
where 𝐼𝑝𝑒𝑎𝑘 is the intensity corresponding to the histogram peak; this threshold was 
found to best describe the distribution of background noise in scans acquired using 
either the volume coil alone or the volume-surface coil pair. Any voxels with an 
intensity higher than 𝑇 are assumed to represent the phantom. Prior to and post 
application of the threshold, other processing steps are taken to refine the 
segmentation process, as described below. 
Each rotated slice (Figure 4.3) is firstly smoothed using a small 2D Gaussian filter of 
size 3×3 and an SD of 1 pixel (FWHM = 2.35 pixels) to slightly reduce noise without 
distorting the phantom’s features significantly. Then, the estimated threshold is 
applied to create a binary mask of the phantom. Large unwanted objects around the 
periphery of the image as well as other spurious pixels are removed to retain only the 
phantom mask. To measure the dimensions of the phantom, the mask is first dilated 
and eroded using a horizontal (3 pixels long) and a vertical (5 pixels long) linear 
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structuring element to flatten its boundary, and then the internal pixels of the mask 
are discarded to preserve only the boundary pixels. To measure the volume of the 
cylindrical compartment of the phantom, this region is first identified and retained 
based on the position of the mask’s centroid and then its boundary is flattened as 
described. 
4.3.2.2 k-means clustering 
k-means is an iterative partitioning method that assigns a sample of objects into k 
mutually exclusive clusters (Lloyd, 1982), according to the following procedure: 
1. Choose k initial centroids. 
2. Calculate the distance of each object from each centroid and assign it to the 
cluster with the nearest centroid. 
3. Compute the mean in each cluster to obtain k new centroids. 
4. Iterate over steps 2-3 until the sum of distances within each cluster cannot be 
reduced further. 
The result is the creation of clusters the objects in which are as close as possible 
around their centroid. In image segmentation, each pixel is an object, centroids 
correspond to intensities and partitioning is based on calculating the intensity 
difference between each pixel and each centroid. Here, MATLAB’s kmeans function 
with default parameters was used to perform k-means clustering and group the pixels 
in the images to clusters representing the phantom and the background. The function 
accepts as inputs the image and k and employs a heuristic approach to find the initial 
centroids. It returns a vector containing the index of the cluster to which each pixel 
belongs to, but the indices are not sorted according to intensity. 
k-means clustering with two and three clusters was tested; larger values of k make 
segmentation computationally expensive and the likelihood to produce errors (empty 
clusters) increases. Code was written to sort the vector with the cluster indices 
according to the intensity of corresponding pixels; for k = 2 the cluster with the higher 
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intensity represents the phantom and for k = 3 the two clusters with the higher 
intensity represent the phantom. The same pre- and post-processing morphological 
operations as in simple thresholding are used for k-means clustering as well. k-means 
with k = 3 but no additional processing steps was also used for binarisation in the 
main analysis pipeline, as indicated in Figure 4.3. 
4.3.2.3 Canny edge detection 
Edge detection is an image analysis method that identifies locations in an image 
where there are sharp changes in intensity (the intensity differs significantly between 
adjacent pixels). Most edge detection algorithms depict edges by simply estimating 
the first or second order derivative of the image to produce its gradient version. 
However, Canny (1986) devised a multistage approach that detects as many local 
maxima as possible while being less prone to errors due to noise: 
1. Apply a Gaussian filter to smooth the image and remove noise. 
2. Estimate the intensity gradient of the image by calculating local intensity 
differences (edges) in four directions. 
3. Apply thinning to remove spurious results. 
4. Apply a high and a low threshold to categorise remaining edges to one strong 
and two weak groups. 
5. Preserve the strong edges and the weak edges from the middle group that are 
connected to the former.  
In MATLAB, edge function is used, which accepts a two-element vector with the 
thresholds and the SD of the Gaussian filter, and returns a binary mask with the 
detected edges. The values of the input parameters are arbitrarily chosen based on 
the size and quality of the input image and the salience of features that need to be 
detected. If the thresholds are not given as a function input, edge automatically 
chooses and outputs two rough values, which can then be manually tuned to improve 
edge detection accuracy.  
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A default value of 2 is used by edge function for the SD of the Gaussian filter; this 
leads to false negatives if the image is small or its noise level is low, and to false 
positives in the contrary situation. To automatically estimate an appropriate value, a 
method that takes into account the signal characteristics and the size of the phantom 
images was determined. The histogram of the normalised scan is first examined to 
estimate a threshold using equation 4.2 and compute the mean intensity of all voxels 
with an intensity higher than the threshold, 𝐼𝑝ℎ𝑎𝑛𝑡𝑜𝑚, and the SD of the remaining 





                                              (4.3) 
The height of the image is determined in pixels (256 for the QA protocol). The square 
root in the denominator is a measure of SNR; the effect of it is subtler than the size of 
the image, hence the square root is estimated. The factor 𝑓𝑆𝐷 is used to refine the 
formula to produce appropriate estimates of 𝑆𝐷𝐶𝑎𝑛𝑛𝑦 (normally within 1 to 3).  
To reduce detection errors in the developed Canny edge detection pipeline for 
measuring the volume of the cylindrical compartment of the phantom, an iterated 
procedure is used to modify 𝑆𝐷𝐶𝑎𝑛𝑛𝑦 until the segmented region in each slice satisfies 
a criterion of shape. Initially, each slice is analysed with the parameters defined above 
to create a binary mask of the detected edges. Large unwanted objects around the 
periphery of the image are then removed. The remaining edges should be mostly of 
the phantom; these are filled to obtain the full region of the phantom, the boundary 
of which is flattened by dilation and erosion (as described in Section 4.3.2.1). The 
cylindrical compartment is then identified and retained based on the position of the 





                                                                    (4.4) 
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where 𝐴 is the area of the compartment given by the number of included pixels, 𝑃 is 
its perimeter estimated using standard MATLAB functions and 𝜋 = 3.14159. 𝑆𝐹 is 
called ‘isoperimetric quotient’ and increases as the circularity of the shape increases 
(Kremer & Weisstein, 2016); for example, it equals 0.79 for a square and 1 for a circle 
(maximum possible value). As the cylindrical compartment of the phantom appears 
as a rectangle in axial scans, a value of 𝑆𝐹 = 0.4 was deemed the minimum 
appropriate; while 𝑆𝐹 is less than 0.4, 𝑆𝐷𝐶𝑎𝑛𝑛𝑦 is increased by 0.1 and the procedure 
is repeated until convergence. 
To measure the internal dimensions of the phantom, 𝑆𝐷𝐶𝑎𝑛𝑛𝑦 in equation 4.3 is 
modified to take into account the new size of the images following scaling: 
𝑆𝐷̅̅̅̅ 𝐶𝑎𝑛𝑛𝑦 = 𝑆𝐷𝐶𝑎𝑛𝑛𝑦
scaling factor
2
                                               (4.5) 
This procedure is not iterated as it is less prone to errors than the volume 
measurement procedure; Canny edge detection with the thresholds and 𝑆𝐷𝐶𝑎𝑛𝑛𝑦 is 
applied and the produced binary mask is post-processed to remove spurious pixels 
and preserve only those at the boundary of the phantom. 
To determine thresholds that result in detection of the boundary of the phantom 
while the majority of unwanted edges are excluded, the values produced by 
MATLAB were multiplied by a factor 𝑓𝑇 ranging from 1 to 3 with a step of 0.5 while 
the value of 30 was set for 𝑓𝑆𝐷. 𝑓𝑇 was then kept stable at the determined value and 
𝑓𝑆𝐷 was altered between 10 and 50 with a step of 10 to choose the optimal value. 
4.3.3 Graphical user interface 
Figure 4.4 shows a screenshot of the PhantomAnalysisGUI graphical user interface 
(GUI) developed in MATLAB for assessing the phantom scans interactively and 
comparing the segmentation methods described earlier. Canny edge detection is set 
as the default and related parameters are automatically estimated as soon as a scan is 
loaded, including voxel size and the slices to be analysed. A scaling factor of 5 is the 
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default for performing subpixel measurements of the phantom’s dimensions. All 
these parameters are shown in the Inputs panel of the GUI and can be adjusted by the 
user on demand.  
By clicking the buttons in the Analysis panel, the tool measures and outputs on the 
GUI the dimensions and the volume of the central compartment, and in MATLAB’s 
Command Window the measurements for each slice. The detected boundary of the 
phantom is shown in the Output Data figure; the user chooses between overlaid edges 
or masks for display from a drop-down list. Example pictures showing the analysis 
procedure and the final masks for all analysed slices are saved in the image’s folder 
by checking the Save images? box in the Analysis panel. 
 
Figure 4.4 A graphical user interface for the analysis of phantom data. 
The tool shows the input slices and their histogram on the left, the analysed images 
on the middle and the panels used for controlling and carrying out the analysis on 
the right. The red lines over the analysed image represent the detected boundary 
of the phantom and the small green cross marks indicate opposing points on the 
boundary where the dimensions of the phantom are measured. 
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The tool with all associated code, instructions for its use and the validation dataset 
described below are freely available for download from GitHub 
(https://github.com/Edinburgh-Imaging/PreclinicalMRIPhantomAnalysis). 
4.3.4 Validation dataset 
To examine the accuracy of segmentation, 60 phantom scans were created by 
simulating realistic variation due to protocol differences and system errors at 
different sites. Actual phantom scans in all imaging planes were initially acquired 
using the QA protocol described earlier; six scans were taken with the volume coil 
alone and six scans with the volume-surface coil pair. Using custom-made MATLAB 
functions, each of these 12 scans was randomly scaled within ± 5% of the original FOV 
(19.2×19.2 mm2), translated in-plane within ± 10% of the FOV in either direction, and 
its SNR was altered by either adding Rician noise or smoothing with median filters 
of size 1-3 pixels. Noise in magnetic resonance images is governed by the Rice 











)                                                      (4.6) 
where 𝑥 is the measured pixel intensity, 𝜈 is called the non-centrality parameter 
(corresponds to the intensity in the absence of noise), 𝜎 the scale parameter 
(corresponds to the SD of the distribution) and 𝐼0 the modified Bessel function of the 
first kind with zero order. 𝑝(𝑥) depends on the values of 𝜈 and 𝜎; the ratio 𝜈/𝜎 is a 
measure of SNR. Figure 4.5 shows an actual MRI noise distribution measured in the 
unmodified axial scan acquired using the surface coil, and 𝑝(𝑥) for 𝜎 = 1 and various 
values of 𝜈, generated using a random noise generator developed in MATLAB by Bar-
Guy (2005). The shape of the Rice distribution with 𝜈 = 2 and 𝜎 = 1 matched better 
the actual noise distribution and was chosen for simulations.  
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Figure 4.5 The Rician noise in MRI images. 
The background noise in the phantom images is characterised by a distribution 
similar to the Rice probability density function with 𝜈 = 2 and 𝜎 = 1; this 𝜎 was used 
for generating all the distributions shown in colour. The histograms for all 
distributions are based on data with 252416 voxels and were plotted using 100 bins. 
A noise image was generated for each slice of the phantom scan with the same size 
using Bar-Guy’s generator. All noise images for each scan were then multiplied with 
a randomly estimated factor between 0 and 200 to simulate noise of differing 
magnitude (200 was chosen for 16-bit phantom images with a maximum of 65536 
levels of intensity). The mean intensity of each noise image was subtracted from the 
corresponding phantom slice and the noise image was added to the new phantom 
slice, in order to preserve the overall mean intensity.  
Five scans were created using each original scan, for a total of 60 scans. Simulated 
scans were analysed using the developed GUI to measure the dimensions of the 
phantom in all 60 scans and the volume of the phantom’s cylindrical compartment in 
the 10 scans in the axial plane. The default scaling factor of 5 was used for subpixel 
measurements of dimensions. 
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4.3.5 Statistical analysis 
The simulated scans were analysed manually twice by myself and once by Ross 
Lennen (University of Edinburgh) to examine intra-rater reliability and inter-rater 
reproducibility; Ross Lennen was blinded to the results of my analysis. Each rater had 
at least 3 years of image analysis experience at the time of analysis. The second 
analysis by myself was performed one month after the first analysis to avoid any 
learning effects. ImageJ was used with the straight line tool for measuring dimensions 
(0.01 mm precision) and the freehand selections tool for measuring the volume. 
The accuracy of the developed automated tool for estimating both QA criteria was 
assessed by comparison against the measurements of my first manual analysis, which 
were considered as the ground truth. The agreement between intra- and inter-rater 
measurements, or ground truth measurements and each of the three segmentation 
methods was examined using Bland-Altman analysis (Bland & Altman, 1986). This 
method requires plotting of the difference between corresponding measurements 
against their mean; the compared methods agree if the mean of the differences (which 
represents accuracy) lies close to the ideal mean, zero, as judged based on its 95% CI. 
Bland-Altman analysis is superior to simple correlation analysis for comparing the 
performance of a new method against a gold standard, since correlation measures the 
strength of their relation and not the degree of absolute agreement as the former 
method does (Bland & Altman, 1986). 
To evaluate the spatial overlap between manually defined volumes or manually 
versus automatically segmented volumes, the Dice coefficient (DC) was estimated 
(Dice, 1945). This metric is very popular for the validation of image segmentation 
algorithms, as it takes into account the similarity between the compared regions in 
terms of both shape and location in the image, instead of just their size. DC is given 
by 
𝐷𝐶 =  
2|𝑉𝑎 ∩ 𝑉𝑏|
|𝑉𝑎| + |𝑉𝑏|
                                                                (4.7) 
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where 𝑉𝑎 and 𝑉𝑏 are the two compared volumes; the intersection |𝑉𝑎 ∩ 𝑉𝑏| is the 
number of common voxels and the sum in the denominator is the total number of 
voxels. A value of 0 indicates no overlap and a value of 1 indicates perfect similarity 
between volumes; a good correlation between volumes is often considered to be one 
with 𝐷𝐶 > 0.7. Due to the small number of images used for volume estimation (10), 
DC values were summarised using boxplots showing median values and ranges. 
Custom-written code in MATLAB was used to perform comparisons of binary masks 
for estimating DC. The time required for estimating both QA criteria in each of the 10 
simulated axial scans was measured using a MATLAB function running the 
automated routines over all images and a stopwatch for the manual analysis; a 
standard Intel® Core 2 Quad Q9650 processor (Intel Corp., Santa Clara, California, 
USA) running at 3 GHz with 4 GB of random-access memory on a Windows® 7 
Enterprise machine (Microsoft Corp., Redmond, Washington, USA) was used.  
In SPSS® (22.0, IBM Corp., Armonk, New York, USA), the difference in analysis time 
was examined using repeated measures analysis of variance (ANOVA) with a 
Greenhouse–Geisser correction to account for the violated sphericity (Mauchly's test; 
Table C.2 in Appendix C) and Bonferroni’s post hoc tests to correct for multiple 
comparisons (repeated-measure factor is the analysis method). Distributions of 
measured times were normally distributed, as determined by the Shapiro–Wilk test 
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4.4 Results 
4.4.1 Phantom’s T2 relaxation time 
Figure 4.6 shows the mean intensity within a circle of diameter 3 mm at the centre of 
the phantom, plotted against TE in images acquired using the volume coil and the 
pulse sequence in Table 4.1. By fitting equation 4.1 to the points, the T2 relaxation time 
of the phantom’s liquid solution was estimated to be 53.56 ms, with an excellent 
goodness of fit (?̅?2 = 0.994). 
 
Figure 4.6 Measurement of phantom’s T2 relaxation time. 
The mean intensity was measured within a circle of diameter 3 mm in all images 
acquired with varying TEs (red circle in insert). The T2 exponential decay curve (blue 
line) was fitted on intensity versus TE points to measure the T2 relaxation time: 𝑆 =
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4.4.2 Intra- and inter-rater agreement 
As shown by Bland-Altman plots in Figure 4.7, the intra-rater reliability in the manual 
measurement of the phantom’s dimensions and the volume of its cylindrical 
compartment in the 60 simulated scans is excellent, with the mean difference in all 
plots lying very close to zero.  
 
Figure 4.7 Bland-Altman plots assessing intra-rater agreement. 
The plots show the measurements in (a) x direction, (b) y direction and (c) z 
direction, and (d) the volume measurements. For estimating the differences, the 
measurements of the first analysis were subtracted from the corresponding 
measurements of the second analysis. The solid blue line in each plot indicates the 
mean difference and the dashed blue lines its 95% CI. 
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Inter-rater reproducibility is also excellent (Figure 4.8). The mean differences in 
measurements of the phantom’s dimensions and volume are small and similar to 
those in corresponding comparisons in the intra-rater reliability assessment. 
However, there is a small increase in the dispersion of differences. 
 
Figure 4.8 Bland-Altman plots assessing inter-rater agreement. 
The plots show the measurements in (a) x direction, (b) y direction and (c) z 
direction, and (d) the volume measurements. For estimating the differences, the 
measurements of the first analysis by the first rater were subtracted from the 
corresponding measurements by the second rater. The solid blue line in each plot 
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The volume of the phantom’s cylindrical compartment has a near perfect similarity 
between analyses, as assessed by DC (intra-rater: median = 0.993, interquartile range 
(IQR) = 0.991–0.993; inter-rater: median = 0.984, IQR = 0.981–0.988). The first set of 
measurements by myself are, therefore, reliable and reproducible and are used for 
assessing the performance of the automated methods. 
4.4.3 Performance of automated analysis tool 
4.4.3.1 Selection of Canny edge detection parameters 
Before the three developed methods for automated analysis of phantom data are 
compared, the performance of Canny edge detection was optimised by selecting 
appropriate factors for automatic selection of the two thresholds, 𝑓𝑇, and the SD of 
the Gaussian filter, 𝑓𝑆𝐷 (Section 4.3.2.3). Figures 4.9 and 4.10 show Bland-Altman plots 
assessing the agreement between this method and manual analysis for different 
values of 𝑓𝑇. It is evident that the default thresholds estimated by the MATLAB’s edge 
function (for 𝑓𝑇 = 1) sometimes lead to detection of unwanted edges outside the 
phantom and overestimation of its dimensions (Figure 4.9 a-b). The accuracy of the 
method is almost identical for 𝑓𝑇 values between 1.5 and 3 (Figure 4.9 d-o). The 
iterated procedure for estimating the volume of the phantom’s cylindrical 
compartment was not influenced noticeably by the choice of thresholds, and 
differences with corresponding manual measurements had a mean close to zero 
(Figure 4.10). 𝑓𝑇 = 2.5 was chosen for subsequent analyses, due to the high overall 
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Figure 4.9 Bland-Altman plots assessing the performance of Canny edge 
detection for measuring the phantom’s dimensions for various thresholds. 
Five values of factor 𝑓𝑇 were tested: (a-c) 1, (d-f) 1.5, (g-i) 2, (j-l) 2.5, and (m-o) 3. 
Plots in the left column (a, d, g, j, m) show measurements in x direction, in the central 
column (b, e, h, k, n) in y direction, and in the right column (c, f, i, l, o) in z direction. 
The solid blue line in each plot indicates the mean difference and the dashed blue 
lines its 95% CI. 
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Figure 4.10 Bland-Altman plots assessing the performance of Canny edge 
detection for measuring the volume of the phantom’s cylindrical compartment for 
various thresholds. 
Five values of factor 𝑓𝑇 were tested: (a) 1, (b) 1.5, (c) 2, (d) 2.5, and (e) 3. The solid 
blue line in each plot indicates the mean difference and the dashed blue lines its 
95% CI. 
Setting 𝑓𝑇 to 2.5, the factor for automatic adjustment of the SD of the Gaussian filter 
(𝑓𝑆𝐷 in equation 4.3) was varied between 10 and 50; results are shown in figures 4.11 
and 4.12. In contrast with 𝑓𝑇, 𝑓𝑆𝐷 affects mostly the measurement of volume, with 
small values (large Gaussian filters) causing selection of fewer voxels than manual 
analysis and large values (small Gaussian filters) causing selection of more voxels 
(Figure 4.12 a, e). 𝑓𝑆𝐷 = 30 was the optimal and was chosen for this method. 
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Figure 4.11 Bland-Altman plots assessing the performance of Canny edge 
detection for measuring the phantom’s dimensions for various Gaussian filters. 
Five values of factor 𝑓𝑆𝐷 were tested: (a-c) 10, (d-f) 20, (g-i) 30, (j-l) 40, and (m-o) 
50. Plots in the left column (a, d, g, j, m) show measurements in x direction, in the 
central column (b, e, h, k, n) in y direction, and in the right column (c, f, i, l, o) in z 
direction. The solid blue line in each plot indicates the mean difference and the 
dashed blue lines its 95% CI. 
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Figure 4.12 Bland-Altman plots assessing the performance of Canny edge 
detection for measuring the volume of the phantom’s cylindrical compartment for 
various Gaussian filters. 
Five values of factor 𝑓𝑆𝐷 were tested: (a) 10, (b) 20, (c) 30, (d) 40, and (e) 50. The 
solid blue line in each plot indicates the mean difference and the dashed blue lines 
its 95% CI. 
In agreement with previous observations, DC for the automatically segmented 
volumes remained stable for different values of 𝑓𝑇, but varied significantly for 
different values of 𝑓𝑆𝐷 (Figure 4.13). The highest median DC is 0.982 (IQR = 0.975–
0.983) for the chosen values 𝑓𝑇 = 2.5 and 𝑓𝑆𝐷 = 30, denoting almost perfect similarity 
with manually defined volumes. 
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Figure 4.13 Dice coefficient for various Canny thresholds and Gaussian filters. 
Five values for each of factors (a) 𝑓𝑇 and (b) 𝑓𝑆𝐷 were tested, as indicated, while 
𝑓𝑆𝐷 = 30 and 𝑓𝑇 = 2.5 respectively. The thick blue line of each boxplot indicates the 
median Dice coefficient (value given above). 
4.4.3.2 Comparison of segmentation methods 
Figures 4.14 and 4.15 compare the performance of all segmentation methods 
developed for the analysis of phantom data. Automated analysis by simple 
thresholding is the worst performing method, with the variability in measurements 
for both QA criteria being large, despite a small mean difference between automated 
and manual measurements of phantom’s dimensions (Figure 4.14 a-c; Figure 4.15 a). 
k-means with k = 2 provides accurate estimates of phantom’s dimensions, but the 
volume is underestimated by -9.4 mm3 on average (Figure 4.14 d-f; Figure 4.15 b). In 
contrast, k-means with k = 3 usually overestimates the size of the phantom in all 
directions, but provides fairly accurate estimates of volume (0.6 mm3 mean volume 
difference; Figure 4.14 g-i; Figure 4.15 c). Overall, Canny’s method is the best, with 
measurements for both QA criteria being accurate and the dispersion of their 
differences with manual measurements being small (-0.2 mm3 mean volume 
difference; Figure 4.14 j-l; Figure 4.15 d).  
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Figure 4.14 Bland-Altman plots comparing different methods for measuring the 
phantom’s dimensions. 
Four methods were compared: (a-c) simple thresholding, (d-f) k-means clustering 
with k = 2, (g-i) k-means clustering with k = 3, and (j-l) Canny edge detection. Plots 
in the left column (a, d, g, j) show measurements in x direction, in the central column 
(b, e, h, k) in y direction, and in the right column (c, f, i, l) in z direction. The solid 
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Figure 4.15 Bland-Altman plots comparing different methods for measuring the 
volume of the phantom’s cylindrical compartment. 
Four methods were compared: (a) simple thresholding, (b) k-means clustering with 
k = 2, (c) k-means clustering with k = 3, and (d) Canny edge detection. The solid 
blue line in each plot indicates the mean difference and the dashed blue lines its 
95% CI. 
Repeated measures ANOVA revealed that the analysis time differed significantly 
between all methods (F(1.711, 15.399) = 3092.230, p < 0.001), as well as in all pairwise 
comparisons performed with post hoc tests using the Bonferroni correction (p < 0.001; 
Figure 4.16 b). All automated methods are faster than manual analysis. Expectedly, 
despite being the most computationally efficient method, simple thresholding 
produces more variable DC estimates than the rest of the methods (Figure 4.16 a). The 
median DC is very high for k-means with k = 3 and Canny edge detection, but Canny’s 
method is significantly faster; it requires just 5.3 seconds on average for each axial 
scan to measure both QA criteria (56.4 times faster than manual analysis), in contrast 
with 37.6 seconds spent by k-means with k = 3. Overall, the performance of the
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Figure 4.16 Dice coefficient and analysis time for different phantom data analysis 
methods. 
The plots show (a) the Dice coefficient for methods tested against manual analysis 
and (b) the time required for full analysis of each axial scan by all methods. The 
thick blue line of each boxplot indicates the median estimate (value given above). 
Analysis time is significantly different between all methods in analysis of variance 
pairwise comparisons (p < 0.001). 
automated Canny method is similar to that of the second manual rater, as evaluated 
against the ground truth estimates by the first rater, but has the additional benefit of 
being perfectly reproducible. 
4.5 Discussion 
This chapter describes the procedure followed for the construction of several identical 
sMRI phantoms and the development of an automated image analysis tool for 
assessing geometric accuracy in preclinical scanners. The phantom was scanned using 
both volume and surface RF coils with a simple QA protocol, in order to validate the 
accuracy of the automated tool. The produced images have high resolution and great 
quality, suggesting that the phantom materials and QA protocol are suitable for the 
aforementioned purpose. 
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LEGO bricks were used successfully for the development of clinical MRI phantoms 
previously (Caramanos et al., 2010). In the context of multicentre studies in rat models 
of stroke, the chosen bricks are ideal for a number of reasons: (1) the sizes of the whole 
phantom and its cylindrical compartment are similar to those of the part of the rat 
brain often imaged in stroke and a large subcortical infarct respectively; (2) their 
cuboid shape allows reproducible positioning in the scanners and reliable 
measurement of dimensions, in contrast with spherical or cylindrical phantoms; (3) 
they are manufactured by injection moulding with superior precision (20 μm) than 
most alternative approaches, such as 3D printing (Quercioli et al., 1998); (4) they are 
made of plastics with great dimensional stability and MRI compatibility (Osswald & 
Menges, 2010; Shackelford et al., 2015; Wapler et al., 2014); and (5) they are very cheap 
and widely available. It should be noted, however, that the small size of the phantom 
precludes monitoring of geometric accuracy in studies assessing morphological 
outcomes larger than those in models of neurological diseases in rodents. 
Furthermore, while the phantom has similarities with a rat brain in terms of overall 
size and T2 relaxation, the volume of its cylindrical compartment does not mimic the 
shape of an infarct or the contrast in intensities between injured and healthy tissue. 
Even so, the phantom constitutes a useful method for examining the influence of 
scanning parameters and identifying sources of geometric variability in small animal 
MRI. Methods for creating small phantoms with exact lesion characteristics are 
currently not available. 
The need for routine QA assurance in preclinical MRI has only recently been 
recognised; others proposed phantom designs to facilitate cancer studies (Lee, 
Fullerton, Baiu, Lescrenier, & Goins, 2011) or perform 3D geometric distortion 
correction (O'Callaghan et al., 2014; Teh et al., 2016; Yoshimaru, Totenhagen, 
Alexander, & Trouard, 2014). These phantoms could not be used in the studies 
described in this thesis, as their size hinders use with various types of imaging coils 
at different centres, most are constructed with lower precision or require more 
complex procedures for construction and post-processing of acquired data, and are 
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not as cost-effective.  
It is widely accepted that manual analysis is time-consuming, laborious and depends 
on many factors, ranging from the experience of the rater to the display and room 
lighting settings used; these may compromise the intra-rater reliability and inter-rater 
reproducibility. QA of clinical MRI scanners with standardised phantoms has been 
the norm for decades, but only recently the assessment of data has shifted from 
manual to automated (Davids et al., 2014; Panych et al., 2015). Following this path, an 
automated tool was also developed for the analysis of phantom data acquired in this 
thesis to improve the reliability and reproducibility of QA and enable valid 
comparisons between different scanners. A few common methods were implemented 
and compared, and Canny edge detection was found to be superior; this is used in 
the multicentre study presented in Chapter 6. The superiority of this method can be 
attributed to the following two reasons: Firstly, the presence of global intensity 
inhomogeneities (bias field) governs the detection of edges in simple thresholding 
and k-means clustering, which rely on assumptions of intensity homogeneity. In the 
images acquired using the surface RF coil, segmentation using these two methods 
could cause the inclusion of more pixels in the part of the image that lies closer to the 
coil, as compared to the rest of the image. Secondly, the distribution of the signal 
coming from the phantom’s liquid solution may lie very close to that of background 
noise, or even overlap with it. This problem can become apparent in the low SNR 
images taken using the volume coil, which can affect the selection of an appropriate 
threshold or cause clustering errors. That being said, Canny’s method depends on 
more input parameters than the other two methods (two intensity thresholds and the 
SD of the Gaussian filter); methods for estimating these automatically have been 
devised, and were found to perform very well in all scenarios. The robustness of the 
developed analysis pipeline is showcased by the often identical results for various 
values for these parameters above or below the optimal. 
The FSE pulse sequence was used for acquiring images with volume and surface RF 
coils; as indicated by the systematic review presented in the previous chapter, these 
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are widely used for MRI in experimental stroke for the assessment of infarct size 
(Milidonis, Marshall, Macleod, & Sena, 2015). Despite that sequence parameters were 
chosen based on those used in T2WI in rat models of stroke (Table 3.1), some were 
adjusted to produce images with good overall quality in a short period of time for the 
purpose of QA, and may not be appropriate for use in experimental in vivo imaging. 
For example, a short TR was used to increase the speed of acquisition and a small 
FOV was used to improve the resolution and therefore the precision of 
measurements; this TR would not be sufficient for nuclei in the brain to fully relax for 
the acquisition of the next line of data, and a small FOV could introduce significant 
aliasing artefacts in, at least, rat brain imaging.  
Fast, accurate and reliable methods for the assessment of geometric accuracy in 
preclinical MRI scanners in the context of multicentre studies in rat models of stroke 
were developed. These are used in Chapter 6 to carry out a multicentre assessment of 







Development of a Semi-Automated 
Infarct Segmentation Tool 
Reliable assessment of the effect of MRI variability on infarct volume quantification 
requires an accurate and reproducible measurement method. In this chapter, a simple 
threshold-based semi-automated method for the analysis of rodent brain 2D T2WI 
data and the measurement of infarct volume is proposed. Its accuracy and 
reproducibility is assessed by comparison against measurements of gold standard 
manual analysis and a common volumetric technique, stereological point counting. 
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5.1 Introduction 
Rodents are the most widely used animals in experimental stroke and infarct volume 
is the primary outcome measured (Howells et al., 2010; Macrae, 2011). Infarct volume 
exhibits high inter-animal heterogeneity in the majority of rodent MCAO models (Liu 
et al., 2009), which, as shown earlier, may be magnified by an excess of sources of 
errors related to the outcome assessment method and particularly MRI. Chapter 4 
suggested an MRI QA protocol to reduce the variability and improve the accuracy of 
measured morphological outcomes, but still the most significant contribution to 
heterogeneity often comes from post-processing methods used for the analysis of 
acquired images. The consistency in measurements within groups of animals can be 
improved by increasing the number of animals used or excluding outliers (Dirnagl, 
2006), but using a more accurate and reproducible method of measurement may have 
a similar effect. A decreased measurement variability can help increase the statistical 
power of the study, improve the generalisability of findings and reduce the waste of 
animals in studies where large cohorts are needed, such as multicentre studies. In 
addition, automating the method as much as possible can further reduce the burden 
to the assessors and the overall duration of the study. 
As revealed by the systematic review presented in Chapter 3, manual planimetric 
analysis is often employed for estimating infarct size on 2D T2WI data. Semi-
automated methods including basic thresholding are also used, but these are 
currently applied on quantitative T2 maps or intensity-homogeneous images acquired 
using volume RF coils. Reasons behind this may vary, as described below. Firstly, 
qualitative MRI data often suffer from severe bias field effects that preclude the use 
of automated software that rely on the assumption of global intensity homogeneity, 
particularly when surface RF coils are used. Secondly, infarcts usually have complex 
shapes and indistinct boundaries, resulting in ROIs with inhomogeneous contrast 
that are difficult to define automatically. Thirdly, infarcts in the subacute and chronic 
phases of stroke are enlarged due to the presence of vasogenic oedema, which results 
in a shift of the midline between the brain hemispheres and other abnormalities in the 
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brain, such as cerebral microbleeds and enlargement of ventricles in some MCAO 
models that may confound unsupervised analysis techniques. Therefore, manual 
planimetric analysis of 2D T2WI data is still considered as the gold standard 
approach; it requires the rater to manually outline the boundary of the infarct area in 
each slice, making the procedure extremely labour intensive, time-consuming and 
subjective, as it depends on the experience and personal judgement of the rater, 
amongst other.  
Expectedly, there is an absence of dedicated tools for automated or semi-automated 
analysis of such data in rodent models of stroke. As a result, data acquired in 
preclinical centres are often analysed manually by corresponding researchers. 
Numerous studies describe dedicated infarct segmentation tools for use on clinical 
brain MRI data (Bauer, Gratz, Gralla, Reyes, & Wiest, 2014; Filippi et al., 2014), but a 
few have created basic computerised methods for estimating infarct size from 
histologically stained rodent brain slices (Regan, Detwiler, Huang, Lynch, & Regan, 
2007; Swanson et al., 1990). Herein, an attempt is made to define an analysis pipeline 
for the analysis of qualitative T2WI data for the measurement of infarct size, aiming 
to improve the repeatability, reproducibility and speed of analysis. Most steps of this 
pipeline are performed by a dedicated MATLAB tool, allowing automated 
segmentation of the infarct and subsequent manual editing of the selected regions in 
each slice to further improve segmentation accuracy. The tool was validated against 
gold standard full manual analysis of a standard set of rat brain T2WI data acquired 
as part of an MCAO experiment. The tool was also compared with stereological point 
counting, a method previously used for the analysis of multi-slice data in clinical 
studies with reported high accuracy and reproducibility (Acer, Sahin, Usanmaz, 
Tatoğlu, & Irmak, 2008; Saunders et al., 1995; Thrippleton et al., 2014). Intra- and inter-
rater agreement in the measurement of infarct volume was evaluated for all three 
methods. 
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5.2 Methods 
5.2.1 Analysis pipeline 
A clear definition of the infarct as observed in qualitative 2D T2WI data in standard 
MCAO models is not available, and manual analysis is performed on subjective terms 
across centres. Here, a pipeline for the semi-automated analysis of such data was 
devised based on the following four observations: 
1. The infarct can be defined based on the intensity of healthy tissue in the 
corresponding contralateral hemisphere, as proposed by articles 
systematically evaluated in Chapter 3 (Jiang et al., 2006; Modo, Beech, Meade, 
Williams, & Price, 2009; Veldhuis et al., 2003). 
2. The infarct extends across a single brain hemisphere (ipsilateral hemisphere) 
within the territory supplied by the corresponding MCA. 
3. The infarct initiates at the occluded origin of the artery and extends outwards 
to encompass surrounding regions, therefore no healthy tissue is enclosed by 
infarcted tissue. 
4. More than one infarcted regions may be visible in a single MRI slice through 
the brain, but all regions are connected across slices into a single blob (Bauer 
et al., 2014). 
The semi-automated analysis pipeline is shown in Figure 5.1; most analysis steps 
were used empirically and were optimised for use on coronal scans (indicated in 
Figure 2.3), which is the imaging plane primarily used in rodent models of stroke 
according to the systematic review presented in Chapter 3. The steps within the blue 
box in Figure 5.1 are performed using a custom-made dedicated MATLAB tool.  
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Figure 5.1 Semi-automated pipeline for the measurement of infarct size. 
This is a simplified diagram showing the major processing steps used to analyse 
the rodent brain data and measure infarct volume in the ipsilateral hemisphere; 
analysis is performed in coronal T2WI scans. The analysis steps within the blue box 
are incorporated in a custom-made MATLAB tool, with those on the right indicating 
manual input. 
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The first and most critical step is the correction of bias field in the images; this can be 
very challenging in stroke images as the intensity is expectedly not homogeneous 
across the brain (the lesion is brighter than healthy tissue in T2WI). Bias field 
correction was performed using the N4 algorithm (Tustison & Gee, 2010) in 3D Slicer 
(4.4.0; http://www.slicer.org). The corrected images are loaded in the developed 
MATLAB tool along with masks of the corresponding ipsilateral hemisphere. Their 
intensity is first normalised to the range 0 to 1 and the normalised images are passed 
in two different branches of the analysis pipeline. In one branch (right column in 
Figure 5.1) their intensity is automatically adjusted by scaling it to the intensity range 
in the middle slice; these images are used in steps requiring manual input. In the other 
branch (middle column in Figure 5.1) the tool smooths the images using a Gaussian 
filter to remove noise. Then, MATLAB’s polygon tool is used to manually select a 
large region in the healthy contralateral hemisphere without ventricles or MRI 
artefacts. The mean and SD of the intensity in this region, 𝐼𝑐𝑜𝑛𝑡𝑟𝑎 and 𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑎 
respectively, are used to calculate an intensity threshold using the formula 
𝑇𝐼 = 𝐼𝑐𝑜𝑛𝑡𝑟𝑎 + 𝑓𝑇𝐼  𝑆𝐷𝑐𝑜𝑛𝑡𝑟𝑎                                                      (5.1) 
𝑇𝐼 is applied on the smoothed slices to obtain a binary mask of the infarct; voxels with 
an intensity higher than 𝑇𝐼 are classified as infarct. 𝑇𝐼 depends on a factor 𝑓𝑇𝐼 , as used 
previously by Veldhuis et al. (2003), Jiang et al. (2006) and Modo et al. (2009). The 
produced binary masks are intersected with corresponding masks of the ipsilateral 
hemisphere to identify common pixels that lie within the hemisphere. Basic 
morphological operations in MATLAB are applied to refine the masks automatically, 
including filling of holes, closing of local regions using a disk-shaped structuring 
element and removing of small spurious regions. These processes are performed on 
each slice of the 2D scan where the infarct is present; slices are specified by the user. 
Eventually, the largest connected object across slices is detected and preserved.  
Following initial selection of the infarct, the regions can be manually edited using the 
MATLAB tool to refine the boundary of the infarct. MATLAB’s freehand tool was 
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incorporated to allow selection of regions to be added or removed. When adding 
regions, the new infarct masks are intersected again with corresponding masks of the 
ipsilateral hemisphere. The final infarct volume is estimated by the sum of all voxels 
included in the selected regions. 
To optimise the performance of the analysis pipeline, a standard MRI dataset (Section 
5.2.3) was analysed repeatedly by altering parameter values of all crucial analysis 
steps, as shown in Table 5.1. Manual editing of the infarct regions was skipped (last 
step in Figure 5.1), in order to optimise the automated part of the pipeline alone. 
Initially, the performance of bias field correction when different regions are taken into 
account was examined. Binary masks of the regions listed in Table 5.1 were fed to the 
N4 algorithm, except when the whole image was taken into account (no masks 
required). After the optimal mask for bias field correction was determined, the size of 
the Gaussian smoothing filter, the radius of the disk-shaped structuring element for 
morphological closing and, finally, the factor 𝑓𝑇𝐼  determining the intensity threshold 
in equation 5.1 were altered in order; the optimal value for each processing step was 
set for optimisation of the rest.  
Table 5.1 Optimising the performance of the infarct segmentation tool. 
Analysis of a standard MRI dataset was repeated by using different parameters for each of 
the four processing steps to select the optimal, starting from the step on the left while using 
the parameters in bold for the other steps. SD indicates standard deviation in pixel values (an 






Radius of structuring 
element for closing 
(pixels) 
Intensity 
threshold factor 𝒇𝑻𝑰  
No masks No smoothing No closing 1.0 
Ipsilateral hemisphere 3×3, SD = 1 1 1.2 
Contralateral hemisphere 3×3, SD = 2 2 1.4 
Brain 5×5, SD = 1 3 1.6 
 5×5, SD = 2 4 1.8 
 7×7, SD = 1 5 2.0 
 7×7, SD = 2  2.2 
   2.4 
   2.6 
   2.8 
   3.0 
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5.2.2 Graphical user interface 
Figure 5.2 shows a screenshot of the RodentAnalysisGUI developed in MATLAB for 
assessing coronal rodent brain scans interactively and measuring infarct volume. The 
GUI incorporates all processing steps within the blue box in Figure 5.1. Using the 
buttons in the Inputs panel on the right of the GUI, a brain scan and corresponding 
masks of the ipsilateral hemisphere are loaded. The voxel size is read from the raw 
data, but this and the number of slices where the infarct is present can be adjusted in 
the Inputs panel by the user. The intensity threshold can also be adjusted in this panel 
by setting factors that alter the contribution of either term in equation 5.1.  
The user loads or roughly draws a region in the middle slice in the healthy 
contralateral hemisphere that is used to estimate the intensity threshold (as shown in 
the middle panel in Figure 5.2 a). By clicking the Measure volume button in the 
Analysis panel, the tool measures and outputs on the GUI the infarct volume, and in 
MATLAB’s Command Window the measurements for each slice. By clicking the Edit 
button, the panel in the middle of the GUI changes into an edit mode, which can be 
used to manually refine the boundary of the infarct (Figure 5.2 c). The identified 
infarct is shown in the Output Data figure; the user chooses between overlaid edges 
or masks for display from a drop-down list. The final infarct masks for all analysed 
slices are saved in the image’s folder by checking the Save masks? box in the Analysis 
panel. The GUI also allows manual editing of pre-saved masks by clicking the Load 
to edit button in the Analysis panel. 
The tool with all associated code, instructions for its use and an example scan from 
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Figure 5.2 A graphical user interface for the measurement of infarct size. 
On the left of (a) the input slices and their histogram are shown, while on the right 
the panels used for controlling and carrying out the analysis are shown. On the 
middle of the tool the user can (a) select a region in the healthy contralateral 
hemisphere for estimating the threshold, (b) view the segmentation results and (c) 
manually edit the segmented regions. The red lines over the image in (b, c) 
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5.2.3 Validation dataset 
To examine the accuracy of segmentation, coronal brain T2-weighted scans of 21 
different Sprague-Dawley rats were analysed using the procedure described above. 
This dataset was acquired as part of a study assessing the influence of gender on the 
evolution of ischaemic injury and penumbra (Baskerville, Macrae, Holmes, & 
McCabe, 2016). The rats were subjected to permanent MCAO using the intraluminal 
filament suture model described in Section 2.1.3. A 7 T scanner was used to perform 
T2WI at 24 hours after occlusion of the artery to visualise the extent of the infarct.  
Scans were analysed manually using the freehand selection tool in ImageJ to trace the 
infarct, the ipsilateral and contralateral hemispheres and create corresponding masks. 
Custom-written code in MATLAB was used to create an image sequence containing 
the masks of each hemisphere, or combine the masks for each slice to create a 
sequence with masks of the whole brain. These were used to test the performance of 
bias field correction. Masks of the ipsilateral hemisphere were used along with the 
corrected T2WI data to measure infarct volume with the developed MATLAB tool 
and optimise its performance, as described in Section 5.2.1. 
5.2.4 Comparison with stereological point counting 
While the accuracy of the developed methodology can be evaluated by comparison 
against gold standard manual analysis, the often poor reproducibility and speed of 
the latter may constitute inappropriate benchmarks. Therefore, an additional method 
for volume measurement with reported excellent reproducibility and efficiency in a 
range of clinical applications was used, and specifically stereological point counting 
(Acer et al., 2008; Saunders et al., 1995; Thrippleton et al., 2014). This is a method 
similar to manual planimetric analysis, but reduces analysis time by subsampling the 
data in all or fewer equidistant slices. 
Point counting was performed on the uncorrected raw brain images of the Sprague-
Dawley rats using the dedicated Stereology module in Analyze software (11.0; Mayo 
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Clinic, Rochester, Minnesota, USA). A randomly positioned and oriented grid of 
points is superimposed over the slices by setting the required slice gap and spacing 
between adjacent points. Points that lie over the ROI are selected using the cursor 
(Figure 5.3). In this study, a grid with a unique position and orientation for each 
animal was used, superimposed on all slices. Further strict criteria to reduce sampling 
bias were set: points that were exactly at the top-right boundary of the ROI were 
included but points at the bottom-left boundary were excluded. Similar to manual 
analysis, the volume of the ROI is calculated using the following formula: 
𝑉 = 𝑡𝑑2 ∑ 𝑝𝑖
𝑛
𝑖=1
                                                                (5.2) 
where 𝑡 is the slice thickness, 𝑑 is the distance between adjacent points (grid spacing), 
𝑝𝑖 is the number of points selected in each slice, 𝑖, and 𝑛 is the total number of slices 
used (Garcia-Finana, Cruz-Orive, Mackay, Pakkenberg, & Roberts, 2003; Thrippleton 
et al., 2014).  
 
Figure 5.3 Measurement of infarct volume using stereological point counting.  
These eight coronal slices across the brain of a rat (caudal to rostral from top left to 
bottom right), show a randomly positioned and oriented grid of points (red). The 
user-selected green points represent the infarct. The spacing between adjacent 
points is 1.27 mm. 
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According to Keller and Roberts (2009), the grid should be dense enough to permit a 
reliable and precise volume estimation without compromising efficiency; at least 200 
points on average must fall within the ROI to achieve a coefficient of error (CE) lower 
than 5.0%. To verify this, the CE was estimated in Microsoft Excel using the following 
formula: 










             (5.3) 
where  
𝛼(𝑞) =
Γ(2𝑞 + 2) ζ(2𝑞 + 2) cos(𝜋𝑞)
(2𝜋)2𝑞+2(1 − 22𝑞−1)
                                           (5.4) 
𝐶𝑘 = ∑ 𝑝𝑖𝑝𝑖+𝑘
𝑛−𝑘
𝑖=1
,       𝑘 = 0, 1, … , 𝑛 − 1                                          (5.5) 
?̂? = 0.0724 
𝑃
√𝐴
 √𝑛 ∑ 𝑝𝑖
𝑛
𝑖=1
                                                     (5.6) 
𝑃 √𝐴⁄  in equation 5.6 is a shape factor, determined by the area, 𝐴, and the perimeter, 
𝑃, of the ROI over a few representative slices; it equals 3.54 for a circle and increases 
for more irregular shapes. Γ is the gamma function and ζ the Riemann zeta function 
estimated using MATLAB’s gamma and zeta functions respectively; 𝜋 = 3.14159. 𝑞 
takes values between 0 and 1, with smaller values denoting more irregular objects; 
for 𝑛 ≥ 5, it is estimated using the formula: 




3(𝐶0 − ?̂?) − 4𝐶2 + 𝐶4




}                          (5.7) 
The first term in the square root of equation 5.3 is the contribution of the variability 
between slices and the second term is the contribution of the variability due to point 
counting within slices (Garcia-Finana et al., 2003). 
The validation dataset was analysed using point counting to calculate the volume of 
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the infarct, the ipsilateral and contralateral hemisphere. Based on the mean volume 
of each structure estimated by manual tracing in ImageJ, ideal grid sizes providing 
on average at least 200 points over each structure were determined. Manually traced 
regions in slices from five randomly selected animals were used to estimate mean 
values for 𝐴 and 𝑃 and then the shape factor in equation 5.6 for each structure. 
Random selection was performed using the RANDBETWEEN function in Microsoft 
Excel. 
5.2.5 Measurement of corrected infarct volume 
The volumes of the two brain hemispheres are necessary to account for the space-
occupying effect of vasogenic oedema and brain swelling when calculating infarct 
volume, which is significant at the time point when the rat dataset was acquired (24 
hours following MCAO). According to Swanson et al. (1990), the volume of the 
vasogenic oedema in the ipsilateral hemisphere is equal to the difference in the 
volumes of the two brain hemispheres; the infarct volume is then corrected using the 
following formula: 
𝑉𝐼 = 𝑉𝐼𝑢 + 𝑉𝐶𝐻 − 𝑉𝐼𝐻                                                          (5.8) 
where 𝑉𝐼𝑢 is the uncorrected infarct volume (measured directly using each method), 
𝑉𝐼𝐻 the volume of the ipsilateral hemisphere and 𝑉𝐶𝐻 the volume of the contralateral 
hemisphere. However, this formula does not take into account the fact that the 
healthy contralateral hemisphere is compressed by the oedema to the same extent as 
the ipsilateral hemisphere is extended, whereas the infarct is not compressed. Gerriets 




                                                               (5.9) 
The corrected infarct volume, 𝑉𝐼𝑐, is then 
𝑉𝐼𝑐 = 𝑉𝐼 𝐶𝐹                                                                  (5.10) 
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As mentioned previously, the validation dataset was analysed by myself to measure 
𝑉𝐼𝑢, 𝑉𝐼𝐻 and 𝑉𝐶𝐻 using manual tracing in ImageJ and stereological point counting in 
Analyze. Semi-automated segmentation in MATLAB was used to measure 𝑉𝐼𝑢 alone; 
manual measurements of 𝑉𝐼𝐻 and 𝑉𝐶𝐻 were used to correct these 𝑉𝐼𝑢measurements for 
brain swelling. 𝑉𝐼𝐻 and 𝑉𝐶𝐻 were measured on slices including infarcted tissue. 
Analysis was guided by a commonly used brain atlas (Paxinos & Watson, 1997), while 
training in infarct identification was provided by an experienced neuroscientist (Dr 
Chris McCabe, University of Glasgow).  
5.2.6 Statistical analysis 
Similar to the methodology described in Section 4.3.5, the processing steps of the 
semi-automated segmentation method (Table 5.1) were optimised based on DC 
estimated using equation 4.7, which assesses the spatial overlap between manually 
and semi-automatically defined regions (Dice, 1945). To estimate the optimal 
intensity threshold factor 𝑓𝑇𝐼  in equation 5.1, a piecewise cubic polynomial 
(smoothing spline curve) was fitted to the mean DC estimates using the MATLAB’s 
Curve Fitting Tool with default parameters; the optimal 𝑓𝑇𝐼 corresponding to the 
maximum DC value on the curve was identified using the feval function in 
MATLAB. 
The accuracy of the optimised semi-automated tool and point counting was assessed 
by comparison against manual measurements in images from all 21 animals 
performed by myself, which were considered as the ground truth. The agreement 
between groups of measurements was examined using Bland-Altman analysis (Bland 
& Altman, 1986), as described in Section 4.3.5. DC was used to compare the 
performance of the optimised semi-automated method against manual analysis; 
stereological point counting does not produce masks that can be compared using DC. 
The time required for delineating the infarct in each of the 21 animals using each 
method was measured using a stopwatch. SPSS was used to compare measured 
times, 𝑉𝐼𝑢 and 𝑉𝐼𝑐 between methods using repeated measures ANOVA with a 
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Greenhouse–Geisser correction where sphericity was violated (Mauchly's test; Table 
C.2) and Bonferroni’s post hoc tests to correct for multiple comparisons (repeated-
measure factor is the analysis method). Distributions of measurements were normally 
distributed, as determined by the Shapiro–Wilk test for normality (Table C.1). A p-
value less than 0.05 was considered statistically significant. 
Finally, ten animals were randomly selected using the RANDBETWEEN function in 
Microsoft Excel to examine intra-rater reliability and inter-rater reproducibility of all 
three methods in the measurement of infarct volume. For this reason, data were 
analysed twice by myself and once by Ross Lennen (University of Edinburgh); the 
latter was blinded to the results of my analysis. For repeated point counting by either 
rater, the grids used in the first analysis by myself were reused, so that any potential 
variability in measurements can be attributed to the raters and not to grid differences 
(Thrippleton et al., 2014). For each rater, repeated analyses by various methods were 
performed with an interval of at least two weeks to avoid any learning effects. Each 
rater had at least 3 years of image analysis experience at the time of analysis. The 
agreement between groups of measurements and delineated infarct regions was 
examined using Bland-Altman analysis and DC; since the same grid was used for 
each animal for point counting, DC was estimated by identifying common points.  
Due to the small number of images used in intra- and inter-rater analyses (10), DC 
values were summarised using boxplots showing median values and ranges. For all 
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5.3 Results 
5.3.1 Selection of parameters for semi-automated 
segmentation 
The semi-automated segmentation tool was optimised before comparison with 
manual analysis and stereological point counting, by repeated analysis of the data 
using the parameters in Table 5.1. Initially, different methods for correcting the bias 
field were examined by feeding masks to the N4 algorithm in 3D Slicer to guide the 
correction; each mask led to noticeably different results (Figure 5.4). If no mask is 
given (default method) the correction fails to detect the true bias field in the images 
produced primarily by the surface RF receive coil. Masks that excluded the areas 
surrounding the brain led to detection of more slowly varying bias fields across the 
FOV, with correction based on the healthy contralateral hemisphere providing the 
best estimate of the expected bias field in the images. 
 
Figure 5.4 Comparison of bias field correction methods.  
The images show (a) a corrected slice through the middle of the brain (uncropped 
matrix) and (b) corresponding bias fields estimated in 3D Slicer when various masks 
are used, as indicated at the top. The bias field when masks of the contralateral 
hemisphere are used is similar to the expected radial intensity gradient produced by 
the surface coil that sits at the top of the rat’s head. h. indicates hemisphere 
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Figure 5.5 shows how significant the bias field correction is to the semi-automated 
analysis pipeline (Figure 5.5 a). The spatial overlap between manually defined and 
semi-automatically segmented infarct volumes, as determined with the DC, was poor 
when images were corrected based on the whole FOV (mean ± SD = 0.085 ± 0.057), the 
ipsilateral hemisphere (mean ± SD = 0.020 ± 0.045) and the whole brain (mean ± SD = 
0.135 ± 0.089). DC was highest for the contralateral hemisphere (mean ± SD = 0.868 ± 
0.051); data for all subsequent analyses using the semi-automated method were 
corrected based on masks of this hemisphere. 
The accuracy of segmentation was not influenced in a similarly great extent by other 
analysis steps (Figure 5.5 b-d). Identified infarct regions were mostly identical for 
various sizes of the Gaussian filter used for smoothing the images and various radii 
of the disk-shaped structuring element used for morphologically closing the binary 
infarct mask. For smoothing, the minimum DC was obtained when bias field 
corrected images were not smoothed (mean ± SD = 0.861 ± 0.058) and the maximum 
for the small Gaussian filter of size 3×3 pixels and an SD of 1 pixel (FWHM = 2.35 
pixels; DC: mean ± SD = 0.867 ± 0.052); the latter was used for subsequent analyses. 
For morphological closing, the minimum DC was obtained for a radius of the 
structuring element of 5 pixels (mean ± SD = 0.857 ± 0.056) and the maximum for no 
closing (mean ± SD = 0.867 ± 0.052); the latter was set as the default in the MATLAB 
tool. 
The second most influential analysis step is the intensity threshold used for the initial 
selection of the infarct; the factor 𝑓𝑇𝐼  determining its value (equation 5.1) was altered 
between 1.0 and 3.0 after all other steps were optimised. Then, a curve was fitted to 
the mean DC estimates to determine the optimal 𝑓𝑇𝐼 that corresponded to the peak of 
the curve (maximum DC = 0.868; Figure 5.5 d); this was found to be 𝑓𝑇𝐼 = 2.1 and was 
set as the default in the developed MATLAB GUI. The fitted curve had an excellent 
goodness of fit (?̅?2 = 0.999). 
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Figure 5.5 Dice coefficient for various parameters in the semi-automated analysis 
pipeline. 
Different (a) masks to correct images for bias field, (b) sizes of Gaussian smoothing 
filter, (c) radii of structuring element for morphological closing, and (d) intensity 
threshold factors were used. The four analysis steps were optimised in the order 
shown, starting with default parameters: size of the Gaussian filter: 3×3, SD = 1; 
radius of structuring element for closing: 1; intensity threshold factor: 2. The thick 
blue line for each group of measurements indicates the mean Dice coefficient; for 
(d), a curve was fitted to the data to accurately define the optimal threshold factor. 
SD indicates standard deviation. 
Figure 5.6 shows the detected infarct without any manual editing in a coronal slice 
through the middle of the brain of a representative animal, for various parameters of 
the four analysis steps. Bias field correction using different masks results in highly 
heterogeneous infarcts, with the algorithm often failing to select any voxels when the 
ipsilateral hemisphere is used (Figure 5.6 a). Increasing the size of the Gaussian filter 
or the intensity threshold leads to selection of fewer voxels (Figure 5.6 b, d), whereas 
increasing the radius of the structuring element for morphological closing causes
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Figure 5.6 Infarct for various parameters in the semi-automated analysis pipeline. 
The detected boundary of the infarct before any manual editing is shown on the 
same coronal slice through the middle of the brain of a rat (red). Different (a) masks 
to correct images for bias field, (b) sizes of the Gaussian smoothing filter (in pixels), 
(c) radii of the structuring element for morphological closing (in pixels), and (d) 
intensity threshold factors were used. Bias field correction using masks of the 
ipsilateral hemisphere led to complete miss of the infarct in this animal. h. indicates 
hemisphere; SD, standard deviation. 
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5.3.2 Selection of parameters for stereological point 
counting 
For stereological point counting, the shape factor (𝑃 √𝐴⁄  in equation 5.6) for the 
infarct, the ipsilateral and contralateral brain hemispheres was determined as 4.35, 
3.89 and 4.15 respectively, indicating that the infarct is more irregularly shaped than 
the hemispheres. Using the manually determined mean volume of each structure, the 
optimal grid spacing (d in equation 5.2) was determined to be 1.27 mm, 1.86 mm and 
1.66 mm respectively (or 13, 19 and 17 pixels respectively for the dataset used). Grids 
generated using this spacing provided on average 227.14, 213.19 and 214.24 points 
within the whole volume of each structure respectively. The mean CE (equation 5.3) 
was estimated as 2.0%, 3.1% and 3.4% for these structures respectively, well below 
the maximum CE of 5.0% for reliable point counting. 
5.3.3 Comparison of methods 
Figure 5.7 assesses the agreement between the two methods and gold standard 
manual tracing for the measurement of infarct volume. Stereological point counting 
was found to be more accurate than semi-automated segmentation and with a lower 
dispersion of differences (mean difference is -0.2 mm3 and 6.7 mm3 respectively).  
Nevertheless, the DC was high for semi-automated segmentation, even before 
manual editing of the detected infarct using the developed tool (pre-editing: mean ± 
SD = 0.868 ± 0.052; post-editing: mean ± SD = 0.931 ± 0.022; Figure 5.8 a). The time 
required for analysis of each scan differed significantly between methods, as revealed 
by a repeated measures ANOVA test (F(2, 40) = 257.166, p < 0.001; Figure 5.8 b). 
Pairwise comparisons performed with post hoc tests using the Bonferroni correction 
also indicate that semi-automated analysis including manual editing is significantly 
faster than manual tracing and point counting (mean ± SD is 3.68 ± 0.88, 10.54 ± 1.58 
and 4.76 ± 0.88 minutes respectively; p < 0.001 for all pairwise comparisons).  
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Figure 5.7 Bland-Altman plots comparing methods for measuring infarct volume. 
The plots assess the agreement between manual tracing and (a) stereological point 
counting or (b) semi-automated threshold-based segmentation. The solid blue line 
in each plot indicates the mean difference and the dashed blue lines its 95% CI. 
Absolute 𝑉𝐼𝑢 and 𝑉𝐼𝑐 suggest that the lower accuracy and higher dispersion of 
measurements of the semi-automated tool compared with point counting did not 
affect its correlation with either of the other two methods (Figure 5.8 c, d). Repeated 
measures ANOVA showed that both 𝑉𝐼𝑢 and 𝑉𝐼𝑐 did not differ significantly between 
methods (F(1.514, 30.283) = 2.415, p = 0.118 and F(2, 40) = 2.175, p = 0.127 respectively, 
with a Greenhouse–Geisser correction for the former; Table C.2). As shown in Figure 
5.8, the distributions of infarct volumes determined by each method were similar (for 
manual tracing, point counting and semi-automated analysis: uncorrected: mean ± 
SD is 274.8 ± 74.0 mm3, 274.6 ± 76.7 mm3 and 281.5 ± 84.4 mm3 respectively; corrected: 




116 5.3  Results  
 
Figure 5.8 Dice coefficient, analysis time and infarct volume for all methods. 
The plots show (a) the Dice coefficient comparing infarct volumes defined by manual 
tracing and the semi-automated method (pre- and post-manual editing), (b) the time 
required for full analysis of each scan, (c) the uncorrected infarct volume and (d) the 
infarct volume corrected for brain swelling. The Dice coefficient comparing point 
counting and manual analysis cannot be estimated. The thick blue line for each 
group of measurements indicates the mean value. Analysis time is significantly 
different between all methods in analysis of variance pairwise comparisons                                               
(p < 0.001). 
Figure 5.9 shows the infarct regions detected by the optimised semi-automated tool 
in a representative scan with a low DC and a representative scan with a high DC 
before manual editing. Selected regions tend to include false positives in slices at the 
caudal or rostral end of the MCA territory where the true infarct area is often small 
(Figure 5.9 a), and may also include the hyperintense ventricles where they are 
adjacent to the lesion (Figure 5.9 c); these slices often require manual editing. 
However, semi-automated segmentation can assist in the identification of potentially  
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Figure 5.9 Infarct in two rats identified by semi-automated segmentation. 
These four coronal slices (caudal to rostral from left to right) show the infarct 
boundary for (a, b) an animal for which segmentation before manual editing had a 
low Dice coefficient and (c, d) an animal for which segmentation before manual 
editing had a high Dice coefficient. The ground truth manually traced infarct is shown 
in green (identical in a, b and in c, d), while the segmented infarct boundary is shown 
in red (a, c) before manual editing and (b, d) after manual editing. Semi-automated 
segmentation can assist in the identification of infarct areas that manual analysis 
fails to identify (arrow in b), but sometimes includes areas than are not infarct (for 
example, the ventricles indicated by the arrows in c). Semi-automated segmentation 
had a Dice coefficient of 0.775 and 0.936 before manual editing (a and c 
respectively), and 0.915 and 0.949 after manual editing (b and d respectively). 
infarcted tissue (Figure 5.9 b).   
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5.3.4 Intra- and inter-rater agreement 
Ten of the 21 scans were randomly selected to perform repeated analyses using all 
three methods to assess their intra-rater reliability and inter-rater reproducibility. 
Bland-Altman plots in Figure 5.10 show that the dispersion of differences between 
corresponding measurements in inter-rater analyses is higher than intra-rater 
analyses for all three methods, but the mean difference is smaller for manual tracing 
and point counting in inter-rater analyses. Manual tracing is the most reproducible 
method between different raters (mean difference is 0.5 mm3; Figure 5.10 b), while the 
other two methods were equally reproducible (mean difference is 3.6 mm3 for point 
counting and 2.8 mm3 for semi-automated analysis; Figure 5.10 d, f). Semi-automated 
segmentation has the best reliability among all methods (mean difference is -0.6 mm3; 
Figure 5.10 e).  
Infarct regions defined by repeated analyses by the same or different raters have a 
high similarity overall, as indicated by DC in Figure 5.11. Expectedly, DC is higher 
for intra-rater analysis than for inter-rater analysis using either method. The same 
rater produced the most homologous infarcts using the semi-automated method 
(median = 0.988, IQR = 0.979–0.990) and the least homologous infarcts using manual 
analysis (median = 0.970, IQR = 0.959–0.975), despite the low variability in infarct 
volume differences for the latter (Figure 5.10 a). Median DC estimates for intra- and 
inter-rater analyses using stereological point counting are the most comparable 
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Figure 5.10 Bland-Altman plots assessing intra- and inter-rater agreement. 
Repeated analysis (a, c, e) by the same rater or (b, d, f) by two different raters is 
assessed for (a, b) gold standard manual tracing, (c, d) stereological point counting 
and (e, f) semi-automated threshold-based segmentation for measuring infarct 
volume. For estimating the differences, the measurements of the first analysis by 
the first rater were subtracted from the corresponding measurements of the second 
analysis or the second rater. The solid blue line in each plot indicates the mean 
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Figure 5.11 Dice coefficient comparing repeated analyses. 
The plots show the Dice coefficient for infarct volumes defined in (a) intra-rater and 
(b) inter-rater analyses using each method. The thick blue line of each boxplot 
indicates the median Dice coefficient (value given above). 
5.4 Discussion 
This chapter describes the procedure followed for the development of a semi-
automated method for measuring infarct volume on 2D T2-weighted images in rodent 
models of stroke. Its accuracy, reproducibility and speed was evaluated by analysis 
of a dataset of rat images acquired as part of a recent study assessing the influence of 
gender on the evolution of ischaemic injury and penumbra (Baskerville et al., 2016); 
measured infarct volumes were compared against those determined using gold 
standard manual planimetric analysis of the same data. Infarct volumes between the 
two methods did not differ significantly, but the developed method was found to be 
significantly faster and produced volumes in repeated analyses that had a greater 
similarity. The semi-automated method was further compared with point counting, 
a stereological technique often employed for the measurement of volumes in clinical 
studies (Acer et al., 2008; Saunders et al., 1995; Thrippleton et al., 2014). While 
stereological point counting is an accurate method when using a dense grid of points, 
semi-automated analysis is faster and more repeatable. 
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The pipeline for semi-automated analysis was devised based on observations made 
in previous studies, brain anatomy and stroke pathophysiology. Initially, widely used 
academic tools are employed to trace the brain hemispheres and correct the raw data 
for bias field. Then, a dedicated MATLAB GUI is used to apply an intensity threshold 
to binarise the images and define the boundary of the infarct using simple 
morphological operations. The infarct was defined as the areas in the ipsilateral 
hemisphere where the intensity is higher than the mean plus 2.1 SDs of the intensity 
in healthy tissue in the contralateral hemisphere sampled in the middle coronal slice. 
No study has ever applied a thresholding technique in qualitative T2WI acquired 
using surface RF coils before, which is currently a commonly used imaging protocol. 
A similar infarct definition was used in previous studies in rat models of stroke in 
intensity normalised images acquired using either quantitative T2WI or volume RF 
coils (Jiang et al., 2006; Veldhuis et al., 2003), but no study provided further details 
regarding the image analysis procedure. While the tool developed here performs an 
initial identification of the infarct with good accuracy (DC is larger than the normally 
accepted minimum of 0.7), optional manual editing of the identified infarct regions 
can be performed using the same tool to further improve measurement accuracy. The 
tool fills a gap in current preclinical stroke practice and can be used to assist manual 
segmentation of the infarct by detecting areas where necrotic tissue is present but is 
too dim to be traced by the human eye in common intensity heterogeneous images. 
Its performance is not affected by the severity of stroke, the extent and consequences 
of vasogenic oedema, the shape of the infarct or the alignment and positioning of the 
brain in the image that may confound unsupervised analysis techniques. It has a high 
intra-rater reliability, suggesting that its use in a multicentre study employing 
centralised data analysis could reduce the variability and improve the consistency of 
measurements, allowing the execution of more reliable comparisons between cohorts. 
Despite these advantages, the proposed method requires use of various software for 
pre-processing the images, which could increase analysis burden and time in the long 
run, though not in a larger extent than full manual analysis. The N4 algorithm in 3D 
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Slicer software was employed to correct the images for bias field and homogenise the 
intensity across the brain (Tustison & Gee, 2010). The algorithm models the bias field 
by performing curve fitting in the log space and was successfully applied in a recent 
study to correct sMRI data of rats and mice (Oguz, Zhang, Rumple, & Sonka, 2014). 
A few MATLAB tools for performing bias field correction are available (Kroon D-J, 
2009; Salvado, 2006), but are not optimised for use on stroke images and perform 
poorly for the data used in this study. Furthermore, the rat images were pre-
processed to manually draw the brain hemispheres in ImageJ; masks of the 
contralateral hemisphere are used to perform bias field correction, whereas masks of 
the ipsilateral hemisphere are used to guide intensity thresholding to detect the 
infarct. Recently, various methods for automatic rodent brain segmentation in MRI 
data were proposed (Chou, Wu, Bai Bingren, Qiu, & Chuang, 2011; Oguz et al., 2014; 
Zhang et al., 2009). None of these techniques can segment each hemisphere 
separately, which is important in stroke not only for the aforementioned reasons, but 
also for correcting potential infarct volume overestimations due to brain swelling, or 
normalising measurements to 𝑉𝐼𝐻 or 𝑉𝐶𝐻. In addition, these algorithms were validated 
on high resolution 3D brain images of healthy animals. Brains of ischaemic animals 
are characterised by asymmetrical anatomy and intensity; this factor alone could be 
sufficient to cause serious performance issues to these tools. The technique by Chou 
et al. (2011) was also applied on a 2D MRI dataset, but processing time ranged from 
32 to 39 minutes per animal; this is longer than the time spent for manual tracing in 
this study. Due to time constraints, new methods for automatic identification of each 
brain hemisphere and bias field correction were not implemented in the developed 
MATLAB tool. Future work could focus on the development of a brain hemisphere 
segmentation method that utilises computer vision algorithms to adapt to the shape 
and appearance of the boundary of each hemisphere, without relying explicitly on 
assumptions of global intensity homogeneity (Babalola, Cootes, Twining, Petrovic, & 
Taylor, 2008; Wells, Grimson, Kikinis, & Jolesz, 1996). Then, a bias field correction 
step guided by the voxels in the segmented contralateral hemisphere should follow. 
In contrast with the lesioned ipsilateral hemisphere, the contralateral hemisphere 
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leads to a relatively precise estimate of the bias field, suggesting that the T2 relaxation 
time and thus the signal across it is relatively homogeneous (Figure 5.12). A tool with 
this capacity will eliminate the need for manual pre- and post-processing of data for 
intensity normalisation and calculation of 𝑉𝐼𝑐 respectively, improving its efficiency 
and bringing it a step closer to routine preclinical utility. 
This is the first study employing stereological point counting for the measurement of 
the volume of the infarct and each brain hemisphere in a rodent model of stroke; 
shape factors for each ROI, as well as optimal grid sizes ensuring the presence of at 
least 200 points on average within each ROI for low measurement error (CE < 5.0%) 
were determined for the intraluminal filament suture model in Sprague-Dawley rats 
scanned at 24 hours after stroke. While the size of each brain hemisphere in rats or 
mice is similar for most stroke models at this time point, infarct size could differ 
significantly and point counting parameters should be adjusted for its measurement 
in individual studies based on the expected infarct size.  
 
Figure 5.12 T2 relaxation map in the rat brain following stroke. 
These eight coronal slices (caudal to rostral from top left to bottom right) are of rat 
that was subjected to the same stroke model as the rats in this study and was 
scanned using quantitative T2-weighted imaging. The T2 relaxation time is relatively 
uniform within the healthy contralateral hemisphere across slices (right side of 
brain), apart from the cerebrospinal fluid that has a slower relaxation rate. Provided 
by and used with permission from Dr Tracy Farr (University of Nottingham).  
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A well optimised point counting procedure has high accuracy and reproducibility in 
repeated analyses, as shown here, but it also has a particular limitation that might 
discourage its use in most modern experiments: it does not provide masks of the 
measured ROIs that are necessary for various post-processing analyses, such as 
assessment of its shape and appearance across animals, or template formation using 
registration methods. On the other hand, manually traced ROIs in ImageJ can easily 
be transformed into corresponding masks, while the developed MATLAB tool can 
save the masks automatically on demand. 
A fast, accurate and reliable method for assisted manual analysis of 2D T2WI data in 
rodent models of stroke and measurement of infarct volume was developed. The 
improved repeatability of this method over gold standard manual analysis holds 
promise for the implementation of a standardised data analysis protocol in future 
large multicentre studies. The tool will have a central role in the multicentre 
simulation study presented in the following chapter, aiming to compare infarct 
volume and infarct-based study effects from a large number of simulated MRI scans 








Between- and Within-Scanner 
Variability 
Using the structural MRI phantoms and the image analysis tool described in Chapter 
4 a multicentre QA study is carried out, assessing geometric accuracy in six different 
preclinical MRI scanners across Europe as used for the assessment of infarct size in 
rat models of stroke. Longitudinal imaging over a period of six months is performed 
to examine the daily, weekly and monthly within-scanner variability in geometric 
accuracy. Then, T2-weighted scans simulating the scaling errors in each scanner and 
the voxel size of the imaging protocol used at each centre are generated. The scans 
are analysed using the semi-automated tool presented in Chapter 5 to determine the 
impact of MRI variability on the measurement of infarct volume and related statistical 
group comparisons.  
Parts of this chapter have been published or presented as: 
Milidonis, X., Lennen, R. J., Jansen, M. A., Mueller, S., Boehm-Sturm, P., Holmes, W. M., . . . 
Marshall, I. (2016). Multicenter Evaluation of Geometric Accuracy of MRI Protocols Used in 
Experimental Stroke. PLOS ONE, 11(9), e0162545. doi:10.1371/journal.pone.0162545 
Milidonis, X., Lennen, R. J., Sena, E. S., Macleod, M. R., & Marshall, I. (2015). Accuracy of 
geometric measurements in high-resolution MRI scanners: between- and within-system 
evaluation. Presented at the 21st Annual Scientific Meeting of the British Chapter of the International 
Society for Magnetic Resonance in Medicine (ISMRM). London, UK. 
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6.1 Introduction 
Currently, studies in animal models of stroke are performed at a single centre, use 
sample sizes that are too small to allow valid statistical comparisons between animal 
groups and have poor generalisability (Dirnagl, 2006; Landis et al., 2012). Multicentre 
studies can be the way forward, as data from multiple cohorts at participating centres 
are pooled to improve statistical power, which can be useful for the investigation of 
subgroups or detection of subtle effects (Bath et al., 2009; Dirnagl et al., 2013). Of great 
interest in animal models of stroke is sMRI for longitudinal in vivo measurement of 
various morphological outcomes and most importantly infarct size, the primary 
outcome used for the assessment of treatment effects (Macrae, 2011). However, 
combining sMRI data in multicentre studies can be problematic, as differences in the 
performance of scanners can introduce systematic variation in measurements and 
obscure the effects of interest. Furthermore, alterations in the performance of 
individual scanners over time, either due to normal drift or hardware and software 
upgrades, can affect the comparability of longitudinal measurements even within the 
same cohort. Of all possible confounders in the assessment of morphological 
outcomes, the geometric accuracy of the MRI scanner is probably the most important; 
this must be monitored and improved at regular intervals across centres in order to 
minimise errors and ensure correspondence between measurements. 
Before undertaking large multicentre stroke studies involving sMRI, it is important 
to investigate whether the variability between and within scanners is small enough 
to allow pooling of data; if not, strategies to address this variability must be 
determined. Until now, the accuracy and reproducibility of sMRI in different 
preclinical scanners has not been evaluated, despite an extensive assessment of 
clinical scanners in multicentre studies over the years. Those studies found that 
geometric accuracy is influenced by magnetic field inhomogeneity, gradient 
nonlinearity and positioning within the scanner (Jovicich et al., 2006), hardware and 
imaging protocols (Chen et al., 2014; Kruggel, Turner, Muftuler, & The Alzheimer's 
Disease Neuroimaging Initiative, 2010), and system upgrade or normal drift (Takao, 
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Hayashi, & Ohtomo, 2011; Takao et al., 2013). Meanwhile, others compared scanners 
using QA approaches involving standardised phantoms that limit the variance 
associated with inter-individual differences; they found that many scanners failed to 
pass QA criteria essential to geometric accuracy, such as spatial resolution and slice 
thickness, with results being dependent on the type of sequence used (Ewers et al., 
2006; Ihalainen et al., 2011). Recently, possibly the first multicentre preclinical stroke 
trial was performed and its findings hint that treatment effects based on MRI lesion 
volume may vary significantly between centres, but no examination of the role of 
MRI-related factors was carried out (Maysami et al., 2015).  
This chapter presents the first multicentre study assessing the impact of MRI 
heterogeneity on geometric accuracy of different preclinical MRI systems, as used 
routinely in experimental stroke. The aim of the study was to observe the variability 
in stroke imaging for the assessment of infarct size and not perform an absolute 
comparison of identical systems and imaging protocols; study procedures mimicked 
those normally followed in such in vivo experiments. However, since lesion 
progression in stroke is a constantly evolving process (Karki et al., 2010; Wegener et 
al., 2006), a QA approach was chosen instead of an in vivo experiment, utilising the 
phantoms and image analysis tool described in Chapter 4. The phantoms were 
scanned using a standardised sequence and other centre-specific sequences to 
determine the potential benefit of standardised over heterogeneous imaging. 
Moreover, within-scanner stability was evaluated at a single centre over a period of 
six months, covering time points often used in longitudinal stroke studies to monitor 
lesion evolution. Further examination of both between- and within-scanner imaging 
data allowed identification of scanning parameters that mostly contributed to 
variability in geometric accuracy. Finally, synthetic scans were generated by 
transforming a standard in vivo dataset; this simulated simultaneous scanning of the 
same animals at the six participating centres and allowed between-scanner 
comparison under various pre-specified scenarios. This led to evaluation of the 
impact of MRI variability on infarct size and related study effects across centres. 
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6.2 Methods 
6.2.1 Between-scanner variability 
In this multicentre study, the scanner used in experiments presented in Chapter 4 and 
five additional preclinical MRI scanners were evaluated; all were located in six 
different centres across Europe (centres or scanners labelled ‘A’, ‘B’, ‘C’, ‘D’, ‘E’ and 
‘F’; Table 6.1). For comparison, the location of each centre ‘B’–‘F’ is concealed 
throughout this chapter. All scanners had a magnetic field strength of 7 T and all 
except ‘A’ are routinely used for the assessment of infarct size in rat models of stroke 
by Multi-PART collaborators.  
Each of the constructed identical phantoms described in Chapter 4 was sent to each 
participating centre. To ensure correspondence in imaging across centres, a scanning 
form with detailed instructions for phantom placement, slice positioning, scanning 
and preparation of data, as well as exemplar images, was pre-prepared and sent along 
with the phantom (see Appendix D); forms were filled in by participating centres and 
were sent back along with the acquired data. Each centre was asked to use the 
standard coil set-up for rat brain imaging; all used a volume coil for RF transmission 
and a surface coil for RF reception, the details of which are given in Table 6.1. Centre 
‘E’ used a mouse head surface coil due to unavailability of the rat head surface coil at 
the time of imaging. Following the standard rodent neuroimaging procedure and as 
shown previously (Figure 4.2), the phantom was attached to the surface coil and the 
latter was placed on the animal cradle. The whole assembly was then positioned in 
the scanner so that the phantom was at the isocentre of the magnet. Before the start 
of the study, all six scanners were undergoing only annual preventive maintenance 
by external service engineers and none were calibrated for geometric accuracy using 
this or any other phantom by study participants. Furthermore, none of the systems 
employed a method for automatic gradient nonlinearity distortion correction. 
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Table 6.1 Details of scanners and imaging coils. 
ID indicates inner diameter; RF, radiofrequency. Scanner ‘A’ is that used in Chapter 4. 
Each centre scanned the phantom using the optimised standardised QA sequence, as 
described in Chapter 4 (labelled ‘a’; Table 6.2) and the centre’s favourite in vivo 
sequence for the assessment of infarct size in the rat model of stroke (labelled ‘b’, ‘c’, 
‘d’, ‘e’ and ‘f’; Table 6.2), with the exception of scanner ‘A’ which was assessed using 
sequence ‘a’ alone, since no stroke experiments were performed in this centre prior to 
this study. All stroke sequences ‘b’–‘f’ were basic structural T2-weighted sequences, 
as shown in Table 6.2. Each sequence was used to acquire six scans in various imaging 
planes, as described by the QA protocol in Chapter 4 (Section 4.2.5). Phantoms were 
imaged before any other experiment on the day of scanning to ensure similar 
operating temperatures of the systems.  
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Table 6.2 Parameters of standardised and stroke pulse sequences. 
Sequence ‘a’ is the standardised quality assurance sequence used in Chapter 4. In vivo T2-
weighted sequences ‘b’–‘f’ are used at corresponding centres ‘B’–‘F’ (Table 6.1) for assessing 
infarct size in rat models of stroke. ETL indicates echo train length; FOV, field of view; FSE, 
fast spin echo; MSME, multi-slice multi-echo; NSA, number of sample averages; N/A, not 
applicable; RARE, rapid acquisition with relaxation enhancement (the name of FSE sequence 
in Bruker systems); rBW, receiver bandwidth; TEeff, effective echo time; TR, repetition time. 
*Applies to all sequences except ‘c’, for which 16 TEs with an echo spacing of 11 ms were 
used. 
†None of the sequences used an inter-slice gap. 
6.2.2 Within-scanner variability 
6.2.2.1 Gradient calibration 
Based on the internal dimensions of the phantom, as measured in images taken using 
sequence ‘a’ in the between-scanner variability study, the three gradient coils of 
scanner ‘A’ were calibrated by altering the strengths of the three gradient coils until 
scaling errors in each orthogonal direction were nulled. This procedure is performed 
using the Digital eddy current compensation tool (DeccTool) in the scanner’s software 
VnmrJ 3.2, the GUI of which is shown in Figure 6.1 (Agilent Technologies, 2011). 
Parameters a b c d e f 
Type of sequence FSE RARE MSME RARE RARE RARE 
TR (ms) 1600 5000 3375 2742 3000 3500 
TEeff* (ms) 20 47 11-176 33 24 33 
NSA 2 2 1 4 1 4 
ETL 4 8 N/A 8 4 8 
rBW (kHz) 100.0 50.0 59.5 47.0 50.0 32.9 
FOV (mm×mm) 19.2×19.2 25.0×25.0 19.2×19.2 40.0×40.0 25.0×25.0 25.6×25.6 
Matrix size 
(pixels×pixels) 
256×256 256×256 256×256 256×256 256×256 256×256 
Slice thickness† 
(mm) 
1 0.75 1 1 0.6 0.5 
Number of slices 17 17 17 25 12 31 
Voxel size (×10-3 
mm3) 
5.6 7.2 5.6 24.4 5.7 5.0 
Scan duration 
(min:sec) 
3:28 5:20 10:48 5:28 3:12 7:28 
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Figure 6.1 The digital eddy current compensation tool in VnmrJ software. 
The strength of each gradient coil depends on the ECC+Grad (%) scaling factor in 
the Scale panel, estimated by VnmrJ by providing the true and measured dimension 
of the phantom in the corresponding direction. 
Basic gradient calibration of the other scanners can be performed using similar 
procedures, but assessment of within-scanner variability was restricted to 
Edinburgh’s own scanner ‘A’ for logistical reasons. 
6.2.2.2 Imaging 
Starting immediately after calibration of all three gradient coils, scanning was 
performed at daily, weekly and monthly intervals, with five time points per interval; 
this corresponds to imaging over a total time period of about six months. The QA 
protocol involving centre’s ‘A’ equipment (Table 6.1) and the standardised sequence 
‘a’ (Table 6.2) was used to acquire six scans per time point, as described earlier. The 
phantom was kept in the scanner room during the whole imaging experiment to 
ensure temperature stability. Each scanning session including phantom positioning 
lasted between 1–1.5 hours. 
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6.2.3 Post hoc imaging 
Post hoc imaging was performed with the calibrated scanner ‘A’ to examine the 
influence of possible confounders, as described below. 
6.2.3.1 Comparison of imaging coils 
The loop coil in a mouse head surface coil has a smaller diameter than that of a rat 
head surface coil, which makes it sensitive over a smaller ROI. As centre ‘E’ used a 
mouse head surface coil for RF reception instead of a rat head surface coil, imaging 
was performed to determine its impact on geometric accuracy that could possibly 
affect between-scanner comparisons of QA criteria. A rat head and a mouse head two-
channel phased array surface coil that are used routinely in centre ‘A’ for rodent brain 
imaging, were used in conjunction with a volume RF transmit coil (centre ‘A’ in Table 
6.1) to scan the phantom consecutively. Sequence ‘a’ was used to acquire the six scans 
for each coil, as described before. 
6.2.3.2 Influence of magnetic susceptibility 
Geometric distortion in images can be affected significantly by magnetic 
susceptibility artefacts that produce local field inhomogeneities; these depend not 
only on the difference in magnetic susceptibility between adjacent imaged structures, 
but can be amplified by increasing TE or decreasing receiver BW (rBW) (McRobbie et 
al., 2006; Schenck, 1996). In vivo stroke sequences ‘b’–‘f’ had a longer TE and a 
narrower rBW than the standardised sequence ‘a’ (Table 6.2), therefore susceptibility 
effects in those sequences may be prevailing. To further examine these effects using 
scanner ‘A’, consecutive phantom scanning using three different sequences was 
performed: sequence ‘a’ and sequence ‘b’ as described in Table 6.2, and a modified 
version of ‘b’ (here labelled ‘bmodified’); the latter sequence theoretically amplifies 
magnetic susceptibility effects by using a large effective TE (93 ms) and a narrow rBW 
(40.3 kHz), the narrowest allowed by the scanner’s software given this value of TEeff. 
Other parameters of ‘bmodified’ matched the parameters of ‘b’ in Table 6.2.  
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6.2.4 Simulations 
6.2.4.1 Reference data 
The scans used previously for the validation of the semi-automated infarct 
segmentation tool were as the reference data for in vivo simulation. In short, these are 
coronal brain T2-weighted scans of 21 different Sprague-Dawley rats (males: 𝑛 = 10, 
300–350 g; females: 𝑛 = 11, 250–280 g), acquired 24 hours after MCAO using scanner 
‘B’ and imaging protocol ‘b’ described in Tables 6.1 and 6.2 respectively. They were 
recently used to assess the influence of gender on the evolution of ischaemic injury 
and penumbra (Baskerville et al., 2016).  
6.2.4.2 Scaling using 3D affine geometric transformations 
The freehand selection tool in ImageJ was used to manually trace the contralateral 
hemisphere in the reference scans and custom-made MATLAB functions were used 
to create corresponding binary masks. The scans and the masks were fed to the N4 
algorithm in 3D Slicer (Tustison & Gee, 2010) to correct the bias field in the scans. 
For data simulation, it was assumed that at small distances from the isocentre of each 
preclinical MRI scanner (covering the brain of a rodent), the predominant type of 
geometric distortion is linear scaling in each orthogonal direction due to improper 
calibration of gradient coils’ strengths, and that any global nonlinearities due to 
magnetic field inhomogeneity or local nonlinearities due to magnetic susceptibility 
artefacts in the brain are minute and similar between scanners (as suggested by 
phantom imaging); any nonlinearities due to either reason may already have been 
present in the reference scans. A function was written in MATLAB to linearly scale 
the bias field corrected scans in each direction by applying a 3D affine geometric 
transformation, represented by the following transformation matrix: 
𝐴𝑠 = [
𝑠𝑥 0 0 0
0 𝑠𝑦 0 0
0 0 𝑠𝑧 0
0 0 0 1
]                                                           (6.1) 
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where 𝑠𝑥, 𝑠𝑦 and 𝑠𝑧 are the scaling factors in x, y and z direction, respectively, in 
multiples of the image size (for example, for 𝑠𝑥 = 2 the image size is doubled in x 
direction). All zero elements denote that no translation, rotation and shearing is 
performed, whereas the element of 1 at the bottom right corner is necessary for 
normalisation of the matrix in homogeneous coordinates. MATLAB’s affine3d 
function is used to create the transformation matrix and imwarp function is used to 
apply the transformation to an image. Bicubic interpolation was chosen for 
generating the new images. 
The centre of the produced multi-slice scan is the same as that of the reference scan, 
which simulates identical positioning of each animal in the scanners. However, 
depending on the scaling factors, the outermost pixels or slices in the produced scan 
that are located outside of the boundaries of the reference scan may be interpolated 
only partially. This is crucial for the subsequent semi-automated threshold-based 
analysis of the data, as higher or lower pixel intensities within the infarct at these 
locations could lead to segmentation failure. To avoid this, the developed MATLAB 
function estimates the median intensity in the middle slice of the reference scan and 
passes it to imwarp function to ‘fill’ the outermost pixels or slices in the generated 
scan; this value was found to be similar to the mean intensity in the healthy 
contralateral hemisphere in these reference scans and the transformation preserves 
the intensity homogeneity within the brain across slices.  
Figure 6.2 shows an example scan scaled with 𝑠𝑥 = 1, 𝑠𝑦 = 1 and 𝑠𝑧 = 1.1 (simulates 
a scaling error of 10.0% in z direction). This scaling corresponds to 17.6 new slices 
based on the 16 slices in the reference scan; instead, imwarp generates 18 slices, the 
first and last of which are interpolated partially using the reference data and partially 
by filling with a specified intensity. The default filling intensity is zero, producing 
abnormally low pixel intensities in the first end last slices, and slightly higher pixel 
intensities in the second and penultimate slices compared to the rest of the slices 
(Figure 6.2 b); this is due to the bicubic interpolation method used in the 
transformation. Filling with an intensity similar to that in the healthy contralateral 
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brain hemisphere ensures a homogeneous intensity in the brain across slices, the 
profile of which is similar to that in the original scan (Figure 6.2 a, c). The intensity of 
any infarcted areas in the outermost pixels or slices is reduced accordingly, 
simulating representative contributions of PVE for each combination of scaling 
factors used. 
 
Figure 6.2 Scaling scans across the slice direction.  
The three first and three last slices (caudal to rostral from left to right) in (a) an 
example bias field corrected reference scan are shown, as well as the scan scaled 
by filling outermost slices with (b) the default zero intensity and (c) the median 
intensity measured in the middle slice. The intensity in all images was scaled to the 
same range for comparison. Plot (d) shows the mean intensity across slices for all 
three scans, measured within a circle of diameter 3 mm in the cerebral cortex of the 
healthy contralateral hemisphere at a similar location in corresponding slices (for 
example, the red circle in the first slice in (a)). The slice number for the reference 
scan was scaled to the range 1–18 for direct comparison with the scaled scans. 
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Following transformation, the new scans are cropped by the developed MATLAB 
function to the required in-plane matrix size, which is 256×256 for all simulated 
imaging protocols (Table 6.2). If the new scans have a smaller matrix size, new rows 
and/or columns of pixels are added accordingly in each side to keep the brain centred 
in the FOV; the intensity chosen for these pixels is the minimum intensity in the 
reference scan. SNR differences were not modelled as the SNR in scans acquired using 
scanner ‘B’ and protocol ‘b’ is lower than that expected in scans from other centres (as 
suggested by phantom imaging), and the value in the uncorrected for bias field 
reference scans was found to be mean ± SD = 26.4 ± 3.8, based on 5 randomly selected 
scans (3 mm diameter circular ROI in infarct at the subcortex area; 19.2×2 mm2 
rectangular ROI in artefact-free background); SNR higher than 20 offers little 
advantage to image analysis (McRobbie et al., 2006). For the MSME sequence ‘c’ 
(Table 6.2), it was not possible to simulate quantitative T2 maps and was assumed that 
the extent of the infarct in such images is identical to that on qualitative bias field 
corrected images; scans for this sequence were created using the method described 
above. 
6.2.4.3 Estimation of scaling factors 
The scaling factors in the transformation matrix (equation 6.1) are estimated by a 
series of calculations devised to combine the contribution of: 
1. the linear scaling errors in scanner ‘B’ estimated using protocol ‘b’ (the scanner 
and protocol used to acquire the reference scans; Tables 6.1 and 6.2 
respectively), and 
2. the linear scaling errors in each other centre, and/or 
3. the differences in voxel size between protocol ‘b’ and the rest of the protocols.  
The reference scans must first be corrected for the presence of linear scaling errors in 
scanner ‘B’; the percentage correction error in each direction is estimated using the 
formula 
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% correction error𝑥,𝑦,𝑧 =
100 − (100 + ?̅?𝑥,𝑦,𝑧)
100 + ?̅?𝑥,𝑦,𝑧
100%                           (6.2) 
where ?̅?𝑥,𝑦,𝑧 is the median linear scaling error across each direction in scanner ‘B’, as 
measured in phantom scans. In x or y direction, the percentage difference between 
the pixel size for sequence ‘b’, 𝑑𝑥,𝑦𝑏 , and the required pixel size for each other 
sequence, 𝑑𝑥,𝑦, is estimated as 
% difference𝑥,𝑦 =
𝑑𝑥,𝑦𝑏 − 𝑑𝑥,𝑦 
𝑑𝑥,𝑦
100%                                          (6.3) 
The same percentage difference can be computed by using the FOV in each direction 
instead, as the matrix size is identical for all simulated scans. A similar formula is 
used to estimate the percentage difference between the two corresponding slice 
thicknesses in z direction, 𝑡𝑏 and 𝑡: 
% difference𝑧 =
𝑡𝑏 − 𝑡 
𝑡
100%                                                   (6.4) 
The percentage correction errors and differences estimated using equations 6.2–6.4, 
as well as the median scaling errors in each scanner, are used to estimate three 
normalised scaling factors for each direction in each scanner as follows:  
scaling factor𝑖 =
100 + % error or difference𝑖
100
                                 (6.5) 
where 𝑖 indicates each of the three contributing components listed above (1 to 3). The 
three scaling factors are multiplied to estimate a pooled estimate for each orthogonal 
direction in each scanner: 
𝑠𝑥,𝑦,𝑧  = ∏ scaling factor𝑖
3
𝑖=1
                                                   (6.6) 
𝑠𝑥, 𝑠𝑦 and 𝑠𝑧 are used by the developed MATLAB function to perform scaling in all 
three directions using the transformation matrix defined previously (equation 6.1). 
The new pixel size, FOV and slice thickness can be estimated by dividing the relevant 
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parameter in sequence ‘b’ with the corresponding scaling factor. An example 
calculation of the pooled scaling factors in each direction for a simulated dataset is 
shown in Table 6.3. These factors were used to transform the reference dataset and 
simulate 21 scans for system ‘A’ and the standardised sequence ‘a’ (Tables 6.1 and 6.2 
respectively), based on corresponding median linear scaling errors and voxel size 
differences between this sequence and sequence ‘b’.  
The scaled FOV and slice thickness based on the factors accounting for pixel and slice 
thickness differences are indeed those for sequence ‘a’ (19.2×19.2 mm2 and 1 mm 
respectively); these are used for calculating infarct volume in this example dataset. 
The final pooled FOV and slice thickness represent the expected ones in the simulated 
scans, which are smaller than those specified by sequence ‘a’ due to the contribution 
of the positive linear scaling errors in this system. This hints that the brain and the 
infarct across all directions in the simulated scans will be larger than those in scans 
with the same voxel size but without the effect of linear scaling errors. 
Table 6.3 Estimating pooled scaling factors for data simulation. 
Correction errors are estimated using the errors in scanner ‘B’ for sequence ‘b’ (Figure 6.4 b). 
In this example, the linear scaling errors are the median errors in system ‘A’ for sequence ‘a’, 
as shown later in Figure 6.4 a. Pixel sizes and slice thicknesses to estimate percentage 
differences are listed in Table 6.2. The pooled scaling factors 𝑠𝑥, 𝑠𝑦 and 𝑠𝑧 are shown in bold; 
these were used to back calculate the corresponding pooled percentage error. The pooled 









New FOV or slice 
thickness (mm) 
x Scanner ‘B’/sequence ‘b’ correction -0.70 0.99 25.18 
 Linear scaling error 4.47 1.04 23.93 
 Pixel size difference 30.21 1.30 19.20 
 Pooled estimate 35.08 1.35 18.51 
y Scanner ‘B’/sequence ‘b’ correction -1.45 0.99 25.37 
 Linear scaling error 4.82 1.05 23.85 
 Pixel size difference 30.21 1.30 19.20 
 Pooled estimate 34.51 1.34 18.59 
z Scanner ‘B’/sequence ‘b’ correction -0.93 0.99 0.76 
 Linear scaling error 4.47 1.04 0.72 
 Slice thickness difference -25.00 0.75 1.00 
 Pooled estimate -22.37 0.78 0.97 
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The procedure described above was repeated 18 times to simulate datasets of 21 scans 
and compare infarct volume measurements between all six preclinical centres (Table 
6.1) for the following three cases: 
1. Scanners are not calibrated and sequences ‘a’–‘f’ are used at corresponding 
centres (both the linear scaling errors measured using each sequence and the 
differences in voxel size are simulated).  
2. Scanners are not calibrated and the standardised sequence ‘a’ is used (only the 
linear scaling errors measured using sequence ‘a’ are simulated). 
3. Scanners are calibrated and sequences ‘a’–‘f’ are used at corresponding centres 
(only the differences in voxel size are simulated). 
The factors shown in Table 6.3 for correcting the images for scaling in scanner ‘B’ and 
sequence ‘b’ were common in all simulations. The reference and all simulated datasets 
are freely available for download (http://dx.doi.org/10.7488/ds/1496). 
6.2.5 Image analysis 
6.2.5.1 Measurement of quality assurance criteria 
In accordance with the stroke imaging protocol used in centre ‘C’, multi-echo images 
acquired using stroke sequence ‘c’ were pre-processed to create quantitative T2 
relaxation maps. For this purpose, MRI Processor plugin in ImageJ with default 
parameters was used; the plugin estimates T2 relaxation using equation 4.1 in a voxel-
wise fashion, based on the list of TE values of the MSME sequence given in Table 6.2 
(Prodanov & Verstreken, 2012). Background noise in the generated maps was brighter 
than the phantom’s liquid solution, therefore the intensity in the maps was inverted 
so that the contrast between the phantom and background was matched with that of 
images from all other centres and sequences.  
According to the QA protocol and using the automated tool described in Chapter 4, 
the internal dimensions of the phantom were measured in scans in all imaging planes 
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and the volume of the phantom’s cylindrical compartment was measured in axial 
scans. To examine the impact of SNR on volumetric accuracy in the between-scanner 
variability study, its value was measured in the axial scans acquired with the 




                                                        (6.7) 
where 𝐼𝑝ℎ𝑎𝑛𝑡𝑜𝑚 is the mean intensity within a circular ROI measured at the centre of 
the phantom in the middle slice (3 mm diameter) and 𝑆𝐷𝑛𝑜𝑖𝑠𝑒 the SD of the 
background noise measured in an artefact-free rectangular ROI in the same slice 
(19.2×2 mm2). The 0.655 factor is used to take into account the Rician distribution of 
the noise, which takes only positive values in these magnitude images which reduce 
the true SD.  
6.2.5.2 Deformation mapping 
To aid the interpretation of geometric errors in this multicentre study, the middle 
slices through the centre of the phantom in axial and coronal MRI scans were used to 
create 2D deformation maps quantifying the distance each pixel in the MRI images 
must move in order to recover the shape of the phantom in CT images or in baseline 
MRI scans; the latter was used for within-scanner variability images only. For this 
purpose, registration methods were used, as shown in Figure 6.3. 
The binary 3D CT masks of the phantom, created as described previously in Chapter 
4 (Section 4.2.2), were pre-processed to create the template images for registration. 
Initially, a sufficient number of the 34.5 μm thick slices around the centre of the 
phantom were selected to match the slice thickness in sequences ‘a’–‘f’, either in the 
axial or the coronal plane; for example the middle 29 slices of the 3D CT scan were 
selected to create the template image for MRI sequences ‘a’, ‘c’ and ‘d’ that used 1 mm 
thick slices. The intensity of the slices was averaged in the slice direction to obtain a 
single greyscale image for each plane, which was then resized to match the in-plane 
resolution of the standardised sequence ‘a’ using bicubic interpolation (matrix size 
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Figure 6.3 Generating 2D geometric deformation maps. 
Binary 3-dimensional (3D) computed tomography (CT) masks are processed to 
create template images showing the true shape of the phantom, while MRI images 
are processed to match the intensity profile and homogeneity of the CT templates. 
MRI images (source images) are then registered to the CT templates (target 
images) using rigid and non-rigid transformations in order (blue box), which deform 
them until the true shape of the phantom is recovered. For the within-scanner 
variability study, the baseline MRI images taken post-gradient calibration were used 
as target images for registration. A prior transformation was applied to the original 
MRI image in the figure for demonstration. 
256×256 pixels2 and FOV 19.2×19.2 mm2). Low Rician noise was added to the averaged 
images as described before (Section 4.3.4) to obtain the final CT templates. The MRI 
slices were pre-processed for correcting for bias field using the N4 algorithm 
(Tustison & Gee, 2010) in 3D Slicer. Then, the intensity of MRI slices was normalised 
to that in the CT templates by multiplication. Images acquired using stroke sequences 
were resized to match the in-plane resolution of the CT templates using bicubic 
interpolation. For the within-scanner variability study, the baseline MRI images 
acquired soon after gradient calibration were used as template images instead of CT 
images, to observe changes in geometric distortion from baseline; these images were 
bias field corrected, while follow-up images were corrected and normalised, as 
described above. All pre-processing steps except bias field correction were carried out 
in ImageJ and MATLAB. 
2D deformation maps were created using freely available plugins in ImageJ. A rigid 
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transformation (global translation and rotation) with the StackReg plugin was used to 
align MRI images over corresponding template images (Thevenaz, Ruttimann, & 
Unser, 1998). Then, a non-rigid b-splines transformation (local composite reshaping) 
with the bUnwarpJ plugin was used to precisely match the aligned MRI images over 
the templates (Arganda-Carreras et al., 2006). This tool produces a text file containing 
the new horizontal and vertical coordinates of each pixel of the MRI image; each value 
is the sum of the original coordinate and the horizontal or vertical displacement 
induced on that pixel. Code was written in MATLAB to read the coordinates in the 
text file and compute the pixel-wise Euclidean distance, 𝑑(𝑥, 𝑦), according to 
𝑑(𝑥, 𝑦) = √(xdim(𝑥𝑛𝑒𝑤 − 𝑥𝑜𝑙𝑑))
2
+ (ydim(𝑦𝑛𝑒𝑤 − 𝑦𝑜𝑙𝑑))
2
                    (6.8) 
where 𝑥𝑜𝑙𝑑 and 𝑦𝑜𝑙𝑑 are the original pixel coordinates (0 to 255), 𝑥𝑛𝑒𝑤 and 𝑦𝑛𝑒𝑤 the 
new pixel coordinates, and xdim and ydim the size of the pixel in each direction (75 
μm for sequence ‘a’). The MATLAB code also generates colour maps with 𝑑(𝑥, 𝑦) 
values to visualise geometric distortion. Daily, weekly and monthly pixel-wise mean 
and SD maps were created to combine the deformation maps in the longitudinal 
study. 
6.2.5.3 Measurement of infarct volume in simulated data 
The freehand selection tool in ImageJ was used to manually trace the ipsilateral and 
contralateral brain hemispheres in all generated scans, and then the developed semi-
automated threshold-based MATLAB tool was used to segment the infarct (Section 
5.2.2). Analysis was performed by myself, whose repeatability in the use of the tool 
was found to be excellent (Figures 5.10 and 5.11).  Scans within each dataset were 
analysed randomly, starting with the dataset with the lowest in-plane resolution for 
cases 1 and 3 where different sequences are simulated (Nieuwstadt et al., 2015). 
Random selection was performed using the RANDBETWEEN function in Microsoft 
Excel, while image analysis was guided by a commonly used brain atlas (Paxinos & 
Watson, 1997). For each dataset, the volume of each ROI was estimated by 
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multiplying the number of selected voxels with the corresponding voxel size for each 
simulated sequence, as given in Table 6.2.  
6.2.6 Statistical analysis 
Measurements of phantom dimensions and volumes were compared with 
corresponding ground truth values (Section 4.2.2) to estimate percentage linear 




100%                                            (6.9) 
From each set of six scans, 12 measurements in total were obtained for the phantom 
dimensions, corresponding to four measurements per orthogonal direction; errors 
were summarised using median values and ranges where appropriate. To identify 
imaging parameters that might have an impact on volumetric accuracy, the measured 
volumetric errors in the between-scanner variability study were compared with 
corresponding errors predicted by linear scaling errors alone. For this purpose, the 
median scaling errors across each direction, ?̅?𝑥, ?̅?𝑦 and ?̅?𝑧, were used to estimate the 
predicted volumetric errors, according to 
% predicted errorv =
(?̅?𝑥 + 100)(?̅?𝑦 + 100)(?̅?𝑧 + 100)
10000
− 100%                (6.10) 
The distributions of linear scaling errors across the two encoding directions in the 
within-scanner variability study were assessed for normality using the Shapiro–Wilk 
test; measurements were not normally distributed (Table C.1), therefore a 
nonparametric Mann–Whitney U test was used to examine their difference. Statistical 
comparisons between centres, sequences or time points were not performed due to 
the small number of measurements for each. 
In the simulation study, 𝑉𝐼𝐻 and 𝑉𝐶𝐻 were used to correct infarct volume for vasogenic 
oedema using equation 5.10 and estimate 𝑉𝐼𝑐. 𝑉𝐼𝑐 was also expressed as the percentage 
of 𝑉𝐼𝐻, 𝑉𝐶𝐻 or the volume of the whole brain (𝑉𝐼𝐻 + 𝑉𝐶𝐻); these are relative measures 
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of infarct size that are often reported and statistically compared between groups in 
published articles (Table B.3). Hemispheric and whole brain volumes for oedema 
correction and estimation of relative infarct volume were estimated either based on 
all acquired slices through the MCA territory, or only the slices which included 
infarcted tissue to determine the impact of each approach. 
To examine the overall comparability of imaging across centres for each of the three 
simulated cases, measurements were compared between centres using repeated 
measures ANOVA with a Greenhouse–Geisser correction where sphericity was 
violated (Mauchly's test; Table C.2) and Bonferroni’s post hoc tests to correct for 
multiple comparisons (repeated-measure factor is the centre/scanner). The ANOVA 
output included 𝜂2 (partial eta squared), which is an effect size indicating the 
proportion of variance in measurements explained by variation between scanners. 
Distributions of measurements for all simulated datasets were normally distributed, 
as determined by the Shapiro–Wilk test for normality (Table C.1), thus were 
summarised using the mean value. 
Using the measurements in the two animal groups (male and female rats), statistical 
comparisons were performed to determine the impact of MRI variability in infarct 
volume-based study effects across centres. The two groups in each simulated dataset 
were compared using an exact two-tailed Mann–Whitney U test to account for their 
small size, and were summarised using the median and its 95% CI estimated using 
10000 bootstrap samples. The percentage median difference in infarct volume 
between groups was also estimated using the formula 
% median difference =
medianm − medianf 
1
2⁄ (medianm + medianf)
100%                       (6.11) 
where medianm and medianf are the median infarct volumes in male and female rats 
in each dataset respectively.  
All statistical tests were performed in SPSS. A p-value less than 0.05 was considered 
statistically significant. 
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6.3 Results 
6.3.1 Between-scanner variability 
Geometric errors in scanners are shown in Figure 6.4. The majority of linear scaling 
errors were positive; the median error was negative only in z direction in scanner ‘D’ 
when the stroke sequence was used. Overall, geometric accuracy in stroke sequences 
was not worse than the accuracy in the standardised sequence, but measurements 
with the former were more dispersed in the majority of scanners. In systems ‘B’–‘F’, 
median errors per direction were within 0.03% to 1.84% for the standardised sequence 
(Figure 6.4 a) and within -0.27% to 2.19% for the stroke sequences (Figure 6.4 b). 
Scanner ‘A’ was assessed using the standardised sequence ‘a’ alone and was found 
that it overestimated the phantom’s dimensions by a median error of 4.47% across x 
and z directions and 4.82% across y direction. In all systems except ‘A’, a consistent 
difference in scaling errors between frequency and phase encoding directions was not 
observed; errors in scanner ‘A’ were larger in frequency encoding in all three 
directions, but the number of measurements was too small to verify this statistically. 
Correspondingly, volumetric errors were positive for both standardised and stroke 
sequences in all scanners. With the standardised sequence, system ‘A’ overestimated 
the volume by 18.73%, while the error ranged from 5.71% to 11.67% in the rest of the 
scanners (values for ‘B’ and ‘F’ respectively; Figure 6.4 c). Stroke sequences had a 
better overall volumetric accuracy compared to the standardised sequence (median 
error 6.19% versus 9.02% in all scanners ‘B’–’F’), but errors were dispersed between 
3.96% and 12.51% (values for ‘E’ and ‘C’ respectively; Figure 6.4 c). Measured 
volumes were higher than corresponding predicted volumes for all systems and 
sequences, with percentage differences between the two estimates ranging from 
2.19% to 10.10% for the standardised sequence (scanners ‘B’ and ‘F’ respectively) and 
2.49% to 10.53% for stroke sequences (scanners ‘E’ and ‘D’ respectively; Figure 6.4 c). 
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Figure 6.4 Between-scanner variability in scaling and volumetric error. 
Geometric accuracy in six different scanners was evaluated by measuring 
percentage linear scaling errors across the three orthogonal directions with (a) the 
standardised sequence ‘a’ in all scanners and (b) the stroke sequences ‘b’–‘f’ in 
corresponding scanners ‘B’–‘F’, with median values shown by the thick black lines. 
Plot (c) shows the percentage volumetric error with values predicted by the median 
scaling errors indicated by the dashed lines. Scaling errors were measured in scans 
in all imaging planes and volumetric errors in the axial scans alone. 
The difference between measured and predicted volumetric errors suggests that 
factors other than simple linear scaling errors may contribute to volumetric accuracy; 
Figure 6.5 shows a positive association between this error difference and SNR or slice 
thickness. For example, when the standardised sequence is used the difference is 
small for scanner ‘B’ and high for scanner ‘F’, images of which had the highest and 
lowest SNR respectively. Considering the different stroke sequences alone, a large  
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Figure 6.5 Influence of SNR and slice thickness in volumetric errors. 
Plots of the difference in measured and predicted volumetric error against (a) signal-
to-noise ratio (SNR) and (b) slice thickness are shown. Errors were measured in 
axial scans acquired with (a) the standardised sequence and (b) the stroke 
sequences in six and five centres respectively, indicated next to each point. Points 
are too few to reliably determine the type of association between variables. 
slice thickness led to an increased difference between measured and predicted 
volumes (sequences ‘c’ and ‘d’ with a thickness of 1 mm). 
Figure 6.6 shows sample axial and coronal images through the centre of the phantom 
acquired at all centres using the standardised and stroke sequences. Images are 
characterised by various forms of bias field produced by RF inhomogeneity (for 
example, two-channel versus four-channel phased array surface coil in centres ‘A’ 
and ‘B’ respectively), Gibbs ringing artefact across phase encoding (most prevalent in 
images from centre ‘D’) and some geometric distortion. To visualise the geometric 
distortions more clearly, MRI images were used to create colour maps showing the 
Euclidean displacement per pixel to deform MRI images to match corresponding CT 
images of the phantom (Figure 6.7). Both raw images and deformation maps show 
two different patterns of geometric distortion in participating scanners; images from 
scanner ‘A’ are expanded in an isotropic way, whereas images from the rest of the 
scanners are characterised by minor nonlinearities that lie across phase encoding (a 
line across this direction would appear bent). Distortion effects were not only more 
prevalent but were also more variable in scans acquired using stroke sequences, in 
agreement with linear scaling and volumetric errors in Figure 6.4. 
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Figure 6.6 Sample images acquired using six different MRI scanners.  
These are slices through the centre of the phantom in (a, c) the axial (x-y) and (b, 
d) the coronal (x-z) plane acquired using (a, b) the standardised and (c, d) the stroke 
sequences. ‘A’–‘F’ at the top of the figure indicate the scanner; ‘A’ was evaluated 
only with the standardised sequence ‘a’. Phase encoding is in the horizontal 
direction (x) in both planes. Images taken using the stroke sequences for scanners 
‘B’, ‘D’, ‘E’, and ‘F’ were scaled to match the in-plane resolution of the standardised 
sequence for direct comparison. Corresponding colour maps visualising the 
deformation required to recover the true shape of the phantom are shown in Figure 
6.7. 
Considering only the area covered by the phantom, the Euclidean displacement 
induced to MRI images to match corresponding CT images using non-rigid 
registration ranged from 0 to 0.45 mm; the maximum value was observed in the axial 
image taken using scanner ‘A’. In images acquired in centres ‘B’–‘F’, the maximum 
displacement was 0.22 mm with the standardised sequence and 0.38 mm with stroke 
sequences, both in the coronal plane (scanners ‘E’ and ‘F’ respectively; Figure 6.7 b, 
d). 
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Figure 6.7 Deformation in images acquired with six different MRI scanners.  
The 2D maps show the in-plane Euclidean displacement applied to (a, c) axial (x-y) 
and (b, d) coronal (x-z) MRI images acquired using (a, b) the standardised and (c, 
d) the stroke sequences, to recover the true shape of the phantom in template CT 
scans. ‘A’–‘F’ at the top of the figure indicate the scanner; ‘A’ was evaluated only 
with the standardised sequence ‘a’. Phase encoding is in the horizontal direction (x) 
in both planes. Corresponding MRI images are shown in Figure 6.6. 
6.3.2 Within-scanner variability 
The gradient coils in system ‘A’ that performed poorly were calibrated based on 
measurements shown in Figure 6.4; then, drifts in its performance were recorded 
longitudinally over six months. Figure 6.8 shows plots of linear scaling and 
volumetric errors in this system. At baseline, median scaling errors were reduced to 
-0.33%, -0.50% and 0.25% in x, y and z direction respectively (‘d0’ time point in Figure 
6.8 a). These figures did not change significantly during the subsequent longitudinal 
assessment, with median errors remaining within ± 1.00% in all three directions over 
time. The apparent size of the phantom in the MRI images fluctuated similarly during 
daily, weekly and monthly imaging, with the exception of a small but apparent drift 
in the performance of the y gradient from the second to the last month (median -0.41% 
to -0.86% at ‘m2’ to ‘m6’ time points respectively; Figure 6.8 a).  
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Figure 6.8 Within-scanner variability in scaling and volumetric error.  
Scanner ‘A’ and the standardised sequence ‘a’ were used to acquire images after 
gradient calibration and measure (a) percentage linear scaling errors across the 
three orthogonal directions and (b) percentage volumetric errors. Scaling errors 
were measured in scans in all imaging planes and volumetric errors in axial scans 
alone. The coloured lines in (a) follow the median values at each time point. d 
indicates day; w, week; m, month. ‘d0’ is the baseline time point immediately after 
calibration. 
The volume of the phantom’s cylindrical compartment was overestimated at all time 
points (Figure 6.8 b). Across the three time intervals, volumetric error varied 
differently, but the overall variability across the whole six-month period was very 
small compared to between-scanner variability (median = 7.33%, IQR = 0.43%).  
Considering all data in the within-scanner variability study, it was found that linear 
scaling errors across the frequency encoding direction were significantly larger than 
errors across phase encoding in scanner ‘A’ (frequency: median = 0.12%, IQR = 0.35%; 
phase: median = -0.63%, IQR = 0.67%; Mann–Whitney U test: U = 136, p < 0.001). 
Images acquired during the three time intervals were used to create colour maps 
showing the Euclidean displacement per pixel that deforms the phantom in these 
images to match the phantom in the baseline images (‘d0’ time point in Figure 6.8); 
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pixel-wise mean and SD maps were created using the maps in each time interval 
(Figure 6.9). In agreement with previous observations, the mean displacement was 
very small in each time interval, with maximum displacement over the phantom area 
being 0.06 mm, 0.07 mm and 0.11 mm in daily, weekly and monthly scans 
respectively. However, SD deformation maps revealed an increasing variance in 
geometric accuracy from short-term to long-term imaging, particularly in y direction 
(Figure 6.9 c), in agreement with the heterogeneity observed in linear scaling errors 
across the same direction (Figure 6.8 a). 
 
Figure 6.9 Deformation in repeated MRI.  
The 2D maps show the pixel-wise (a, b) mean and (c, d) SD of the in-plane 
Euclidean displacement applied to (a, c) axial (x-y) and (b, d) coronal (x-z) MRI 
images acquired over time to recover the shape of the phantom in baseline scans 
(‘d0’ time point in Figure 6.8). As indicated at the top of the figure, images acquired 
‘daily’ (four scans), ‘weekly’ (five scans) and ‘monthly’ (five scans) were used to 
create these maps. The colour bar of the mean displacement was scaled to that in 
Figure 6.7. Phase encoding is in the horizontal direction (x) in both planes.  
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6.3.3 Post hoc imaging 
6.3.3.1 Comparison of imaging coils 
In this multicentre study, centre ‘E’ used a mouse head surface coil for imaging, which 
expectedly produced images with a more severe bias field compared to other 
scanners that used rat head surface coils, at least along the y direction (Figure 6.6). To 
determine whether this effect could have affected measurements of QA criteria, both 
types of surface coils were used to scan the phantom in centre ‘A’ consecutively. 
Median scaling errors for the rat head surface coil were -0.10%, -0.86% and 0.25% 
along the x, y and z direction respectively; similarly, for the mouse head surface coil 
they were -0.10%, -0.95% and 0.25% respectively. Volumetric errors were 8.15% and 
7.40% for the rat and mouse head surface coil respectively. Figure 6.10 shows sample 
images and corresponding deformation maps indicating that there is only a small 
difference in distortion effects produced by the rat and mouse head surface coils, with 
maximum displacement being 0.08 mm and 0.09 mm in images acquired with each, 
respectively. These observations suggest that these coils can be used interchangeably.  
 
Figure 6.10 Effect of imaging coil on geometric distortion.  
The figure shows sample slices through the phantom in (a) the axial (x-y) and (b) 
coronal (x-z) planes acquired using two different surface RF coils in centre ‘A’, as 
indicated at the top. Corresponding 2D deformation maps showing the displacement 
needed to recover the true shape of the phantom in template CT scans are given in 
(c) the axial and (d) the coronal plane. The colour bar of the displacement was 
scaled to that in Figure 6.7. Phase encoding is in the horizontal direction (x) in both 
planes. 
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6.3.3.2 Influence of magnetic susceptibility 
Sequences ‘a’, ‘b’ (Table 6.2) and a modified version of the latter (‘bmodified’) which 
theoretically amplifies magnetic susceptibility effects were used to scan the phantom 
in centre ‘A’ consecutively and determine whether nonlinearity effects similar to 
those in systems ‘B’–‘F’ (Figure 6.7) can be observed in ‘A’ as well. Sample images 
and corresponding deformation maps are given in Figure 6.11. 
 
Figure 6.11 Magnetic susceptibility effects on geometric distortion.  
The figure shows sample slices through the phantom in (a) the axial (x-y) and (b) 
coronal (x-z) planes acquired using three different sequences in centre ‘A’, as 
indicated at the top. Corresponding 2D deformation maps showing the displacement 
needed to recover the true shape of the phantom in template CT scans are given in 
(c) the axial and (d) the coronal plane. The colour bar of the displacement was 
scaled to that in Figure 6.7. Phase encoding is in the horizontal direction (x) in both 
planes. Images taken using sequences ‘b’ and ‘bmodified’ were scaled to match the in-
plane resolution of the standardised sequence ‘a’ for direct comparison. These MRI 
images have improved intensity uniformity compared to images from the same 
scanner shown in Figures 6.6 and 6.10 as they were taken following maintenance 
of the system and imaging coils. 
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Apart from some minute geometric variation that could arise from the difference in 
noise levels in acquired images, neither ‘b’ nor ‘bmodified’ produced nonlinearities in 
this system similar to those in scanners ‘B’–‘F’; overall distortion was similar to that 
in images taken using the standardised sequence ‘a’. The maximum displacement 
was 0.08 mm, 0.08 mm and 0.09 mm in maps for sequence ‘a’, ‘b’ and ‘bmodified’ 
respectively. 
6.3.4 Simulations 
6.3.4.1 Scaling factors 
Table 6.4 lists all the pooled scaling factors used for data simulation. As shown in the 
table, the reference scans acquired using the uncalibrated scanner ‘B’ and sequence 
‘b’ were used in the first simulation case. For the second case, scaling factors across 
scanners were similar, as the standardised sequence ‘a’ was modelled for each system 
(Figure 6.4 a). Factors across scanners differed significantly in cases 1 and 3 due to the 
use of sequences with differing voxel size. Datasets for scanners ‘A’ and ‘C’ in case 3 
were identical due to the use of sequences with the same voxel size. 
Table 6.4 Pooled scaling factors for simulating datasets. 
These factors are used to simulate scans for cases where (1) scanners are not calibrated and 
sequences ‘a’–‘f’ are used at corresponding centres, (2) scanners are not calibrated and the 
standardised sequence ‘a’ is used, and (3) scanners are calibrated and sequences ‘a’–‘f’ are 





A B C D E F 
1 x 1.35 1.00 1.30 0.62 1.00 0.97 
 y 1.34 1.00 1.29 0.62 0.99 0.96 
 z 0.78 1.00 0.76 0.74 1.24 1.51 
2 x 1.35 1.30 1.30 1.29 1.32 1.30 
 y 1.34 1.30 1.28 1.30 1.30 1.29 
 z 0.78 0.75 0.76 0.74 0.75 0.75 
3 x 1.29 0.99 1.29 0.62 0.99 0.97 
 y 1.28 0.99 1.28 0.62 0.99 0.96 
 z 0.74 0.99 0.74 0.74 1.24 1.49 
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An example reference scan and corresponding produced scans for cases 2 and 3 for 
scanner ‘A’ are shown in Figure 6.12. The brain and infarct appear slightly larger in 
the scan incorporating the large scaling errors in the uncalibrated system ‘A’, 
compared to those in the scan that does not simulate scaling errors (Figure 6.12 b and 
c respectively); at the same time, scans are comprised by 13 and 12 slices respectively, 
leading to marked difference in the number of voxels within the infarct. 
 
Figure 6.12 Reference and scaled datasets. 
The brain and infarct in all slices (caudal to rostral from left to right) in (a) an example 
bias field corrected reference scan are shown, as well as in corresponding scaled 
scans simulating (b) errors in the uncalibrated scanner ‘A’ while the standardised 
sequence ‘a’ is used, and (c) no errors in the calibrated scanner ‘A’ while the 
standardised sequence ‘a’ is used. The produced true field of view in each scan is 
shown on the left. The infarct defined using the semi-automated tool is shown in 
red. 
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6.3.4.2 Infarct volume between scanners 
Table 6.5 shows the results of repeated measures ANOVA between scanners when 
infarct volume is expressed as an absolute or relative estimate for all three simulation 
cases. Infarct volume was corrected using 𝑉𝐼𝐻 and 𝑉𝐶𝐻 (equation 5.10), calculated 
according to two different approaches reported in literature: using all slices covering 
the MCA territory (standardised across animals), or only the slices including the 
infarct (differing across animals). Then, 𝑉𝐼𝑐 was expressed as the percentage of 𝑉𝐼𝐻, 
𝑉𝐶𝐻 or the volume of the whole brain. The results of pairwise comparisons using 
Bonferroni’s post hoc tests are given in Table C.3 and are indicated in Figures 6.13 
and 6.14. 
Infarct volume measures differ significantly between scanners, even when the same 
sequence with uncalibrated scanners (case 2) or different sequences with perfectly 
calibrated scanners are used (case 3); the only exception was for 𝑉𝐼𝑐 expressed as a 
percentage of 𝑉𝐶𝐻 measured in slices including the infarct for case 3 (p = 0.059). 
Between-scanner variability was often lower for case 3 compared to the other two in 
all comparisons, and post hoc tests sometimes failed to detect any significant 
difference between scanners even when ANOVA did (Figures 6.13 and 6.14). Despite 
a better concordance between scanners when the infarct volume was corrected for 
ipsilateral swelling and expressed as a relative estimate based on MRI slices including 
the infarct (p-values ranged from 0.003 to 0.059), the proportion of variance in 
measurements explained by variation between scanners was small (𝜂2 ranged from 
0.12 to 0.16). In contrast, variation between scanners explained a significant portion 
of the overall measurement variance when infarct volume was corrected and 
expressed as a relative estimate based on all slices (𝜂2 ranged from 0.42 to 0.67). The 
use of uncalibrated scanners was the main contributor to the overall measurement 
variance (cases 1 and 2). No significant differences existed between scanners ‘A’ and 
‘C’ in case 3 (using the same voxel size) for any of the examined infarct volume 
measures.  
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Table 6.5 Repeated measures analyses of variance between scanners. 
Case refers to simulations of scans when (1) scanners are not calibrated and sequences ‘a’–
‘f’ are used at corresponding centres, (2) scanners are not calibrated and the standardised 
sequence ‘a’ is used, and (3) scanners are calibrated and sequences ‘a’–‘f’ are used at 
corresponding centres. Where df = 5, sphericity was assumed, otherwise the Greenhouse–
Geisser correction was applied. p-values less than 0.01 are shown in bold and above 0.05 in 
italic. Results of corresponding pairwise comparisons using Bonferroni’s post hoc tests are 
given in Table C.3 and are indicated in Figures 6.13 and 6.14. 𝜂2 (partial eta squared) is the 
effect size indicating the proportion of variance in measurements explained by variation 




Case df F 𝜼𝟐 p-value 
Uncorrected, in mm3 1 1.97 129.83 0.87 < 0.001 
 2 1.75 120.26 0.86 < 0.001 
 3 3.37 3.71 0.16 0.012 
Corrected based on all slices 
      in mm3 1 2.77 52.79 0.72 < 0.001 
      2 2.17 59.77 0.75 < 0.001 
 3 2.89 12.50 0.38 < 0.001 
      as % of brain 1 5.00 15.30 0.43 < 0.001 
      2 2.45 40.40 0.67 < 0.001 
 3 2.83 17.11 0.46 < 0.001 
      as % of ipsilateral 1 5.00 14.59 0.42 < 0.001 
      hemisphere 2 2.47 39.73 0.66 < 0.001 
 3 2.64 16.99 0.46 < 0.001 
      as % of contralateral 1 5.00 16.15 0.45 < 0.001 
      hemisphere 2 2.41 41.08 0.67 < 0.001 
      3 3.01 16.82 0.46 < 0.001 
Corrected based on slices including the infarct 
      in mm3 1 2.80 60.71 0.75 < 0.001 
      2 2.47 69.17 0.78 < 0.001 
 3 2.55 9.95 0.33 < 0.001 
      as % of brain 1 5.00 3.79 0.16 0.004 
      2 2.24 3.54 0.15 0.033 
 3 2.62 3.28 0.14 0.033 
      as % of ipsilateral 1 5.00 3.88 0.16 0.003 
      hemisphere 2 2.25 3.56 0.15 0.032 
 3 2.53 3.76 0.16 0.022 
      as % of contralateral 1 5.00 3.67 0.15 0.004 
      hemisphere 2 2.24 3.50 0.15 0.034 
      3 2.74 2.71 0.12 0.059 
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Figure 6.13 Infarct volume corrected based on all slices and expressed as an 
absolute or relative estimate. 
Measurements for all three cases for scanners ‘A’–‘F’ as (a) an absolute 
uncorrected and (b) an absolute corrected infarct volume are shown, as well as the 
latter expressed as (c) the percentage of the brain, (d) the ipsilateral and (e) the 
contralateral hemisphere (h.). The thick blue line for each group of measurements 
indicates the mean value. Scanners with which there are significant pairwise 
differences are indicated above each distribution; red labels indicate p < 0.01. 
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Figure 6.14 Infarct volume corrected based on slices including the infarct and 
expressed as an absolute or relative estimate. 
Measurements for all three cases for scanners ‘A’–‘F’ as (a) an absolute 
uncorrected and (b) an absolute corrected infarct volume are shown, as well as the 
latter expressed as (c) the percentage of the brain, (d) the ipsilateral and (e) the 
contralateral hemisphere (h.). The thick blue line for each group of measurements 
indicates the mean value. Scanners with which there are significant pairwise 
differences are indicated above each distribution; red labels indicate p < 0.01. 
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6.3.4.3 Group comparisons 
Two of the male rats died before completion of the experiment and in one female rat 
MCAO was incomplete; these were excluded from group comparisons in the original 
study and from this study as well. Tables 6.6 and 6.7 show the results of infarct 
volume comparison between the remaining eight male and 10 female rats; Table 6.6 
lists the percentage median differences between groups and Table 6.7 lists the 
corresponding p-values from exact two-tailed Mann–Whitney U tests performed for 
each simulated dataset. 
The group percentage median difference for absolute 𝑉𝐼𝑢 was within 26.68–31.93% 
across scanners for all examined cases; the range was smaller for calibrated systems 
using different sequences (case 3; 2.73%). For absolute volumes corrected using either 
method, the range of percentage median differences was similar to that for the 
absolute 𝑉𝐼𝑢. Comparing groups using relative estimates of infarct volume increased 
the variability between scanners. Relative estimates of infarct volume corrected based 
on all slices varied similarly when expressed as a percentage of the brain or either 
hemisphere, with the overall variability being within 21.81–34.11%. Expectedly, 
relative estimates of infarct volume corrected based on a different number of slices 
per animal varied in a greater extent, specifically for cases 1 and 2 for all types of 
relative measures (Table 6.6). Furthermore, the percentage median differences for 
these measures was much smaller than for the absolute 𝑉𝐼𝑢 (overall range is 5.84–
21.05%). When volumes were corrected based on all slices, variability was smaller 
between uncalibrated systems using a standardised sequence (case 2), but when 
volumes were corrected based on slices including the infarct, variability was smaller 
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Table 6.6 Percentage median differences in infarct volume between male and female rats. 
All values are percentages (%) except for ‘Case’. Eight male and 10 female rats comprise the 
compared groups. Case refers to simulations of scans when (1) scanners are not calibrated 
and sequences ‘a’–‘f’ are used at corresponding centres, (2) scanners are not calibrated and 
the standardised sequence ‘a’ is used, and (3) scanners are calibrated and sequences ‘a’–‘f’ 
are used at corresponding centres. The range of the percentage median difference across 





Case A B C D E F Range 
Uncorrected, in mm3 1 31.43 28.45 29.67 27.65 28.35 28.71 3.78 
 2 31.93 31.87 31.04 31.33 30.97 28.17 3.76 
 3 29.14 28.10 28.68 27.16 29.41 26.68 2.73 
Corrected based on all slices 
      in mm3 1 35.39 34.50 30.20 29.86 34.33 28.94 6.44 
      2 35.25 35.31 33.57 35.40 32.53 30.26 5.14 
 3 29.51 32.07 29.39 27.46 33.29 28.70 5.83 
      as % of brain 1 31.47 30.56 25.58 25.82 30.33 24.89 6.58 
      2 29.97 31.29 29.57 31.48 28.49 27.16 4.32 
 3 26.30 27.97 26.57 23.31 29.27 24.76 5.96 
      as % of ipsilateral 1 28.83 28.81 23.72 24.00 28.47 23.56 5.27 
      hemisphere 2 27.36 28.58 26.98 29.73 25.84 24.96 4.77 
 3 25.05 25.51 25.32 21.81 27.45 22.82 5.64 
      as % of contralateral 1 33.68 32.73 27.88 28.07 32.62 27.31 6.37 
      hemisphere 2 33.66 34.11 31.80 33.64 31.00 29.87 4.23 
      3 28.41 30.31 28.74 25.70 31.54 27.44 5.84 
Corrected based on slices including the infarct 
      in mm3 1 32.51 30.40 28.00 26.97 30.49 26.77 5.74 
      2 29.66 31.66 30.70 29.59 29.35 27.31 4.35 
 3 26.44 27.43 25.43 25.14 29.24 27.58 4.10 
      as % of brain 1 16.65 14.46 13.85 9.29 7.24 11.45 9.41 
      2 11.32 16.24 18.07 8.33 16.37 7.06 11.01 
 3 9.52 12.12 12.49 8.73 10.32 13.40 4.67 
      as % of ipsilateral 1 15.30 14.60 12.06 7.46 6.14 10.39 9.16 
      hemisphere 2 11.20 14.74 15.65 6.95 14.94 5.84 9.81 
 3 9.10 11.00 9.64 7.69 8.70 12.57 4.88 
      as % of contralateral 1 19.50 15.36 16.43 10.73 9.93 12.90 9.58 
      hemisphere 2 13.71 18.09 21.05 10.83 18.11 9.18 11.87 
      3 12.14 13.93 16.03 13.15 12.49 16.41 4.28 
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In concordance with percentage median differences, statistical comparisons between 
infarct volume measurements in male and female rats show that the method used for 
correcting for brain swelling and expressing the volume as a relative estimate leads 
to large deviations in p-values (Table 6.7).  
The p-value for absolute 𝑉𝐼𝑢 was within 0.008–0.021 across scanners for all examined 
cases. In contrast with percentage median differences, the range was smaller for 
uncalibrated systems using the standardised sequence ‘a’ (case 2; 0.007). For absolute 
volumes corrected using either method, the range of p-values was similar to that for 
the absolute 𝑉𝐼𝑢 (all below 0.027). For some scanners, group differences were highly 
significant (p < 0.01); this was often the case for scanner ‘D’.  
Similarly to percentage median differences, comparing groups using relative 
estimates increased the variability between scanners. p-values for relative estimates 
of infarct volume corrected based on all slices were below 0.083 for all types of relative 
estimates and cases (overall range is 0.012–0.083). Relative estimates of infarct volume 
corrected based on a different number of slices per animal varied in a greater extent, 
with all p-values being larger than the maximum measured for the absolute 𝑉𝐼𝑢 
(overall range is 0.034–0.460). For the majority of infarct volume measures shown in 
Table 6.7, between-scanner variability in p-values was smaller when the standardised 
sequence ‘a’ was used (case 2). Group comparisons led to almost identical results for 
scanners ‘A’ and ‘C’ in case 3 for any of the examined infarct volume measures. 
Figures 6.15 and 6.16 present plots of infarct volume in the two animal groups drawn 
from corresponding distributions of measurements shown in Figures 6.13 and 6.14 
respectively; bootstrap estimates of the 95% CIs of each median value and results of 
group comparisons according to Table 6.7 are also indicated. Results obtained by 
Mann–Whitney U tests agreed with CIs; overlapping of the latter normally suggests 
that no significant difference exists between groups. 
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Table 6.7 Mann–Whitney U tests comparing infarct volume between male and female rats. 
All values are p-values except for ‘Case’. Corresponding U statistics are given in Table C.4.  
Eight male and 10 female rats comprise the compared groups. Case refers to simulations of 
scans when (1) scanners are not calibrated and sequences ‘a’–‘f’ are used at corresponding 
centres, (2) scanners are not calibrated and the standardised sequence ‘a’ is used, and (3) 
scanners are calibrated and sequences ‘a’–‘f’ are used at corresponding centres. p-values less 
than 0.01 are shown in bold and above 0.05 in italic. The range of p-values across scanners 




Case A B C D E F Range 
Uncorrected, in mm3 1 0.016 0.009 0.021 0.012 0.016 0.021 0.012 
 2 0.012 0.016 0.016 0.009 0.016 0.009 0.007 
 3 0.012 0.021 0.012 0.008 0.012 0.021 0.013 
Corrected based on all slices 
      in mm3 1 0.012 0.006 0.016 0.009 0.016 0.016 0.009 
      2 0.012 0.016 0.012 0.004 0.016 0.004 0.011 
 3 0.016 0.027 0.012 0.009 0.021 0.016 0.018 
      as % of brain 1 0.021 0.012 0.021 0.016 0.027 0.021 0.015 
      2 0.016 0.021 0.021 0.012 0.021 0.012 0.009 
 3 0.021 0.083 0.016 0.016 0.027 0.021 0.068 
      as % of ipsilateral 1 0.021 0.009 0.021 0.016 0.043 0.021 0.035 
      hemisphere 2 0.016 0.021 0.021 0.012 0.021 0.021 0.009 
 3 0.021 0.083 0.016 0.016 0.034 0.027 0.068 
      as % of contralateral 1 0.021 0.016 0.021 0.016 0.027 0.021 0.011 
      hemisphere 2 0.012 0.027 0.021 0.012 0.027 0.016 0.015 
      3 0.016 0.027 0.016 0.016 0.016 0.021 0.011 
Corrected based on slices including the infarct 
      in mm3 1 0.016 0.006 0.016 0.006 0.016 0.004 0.011 
      2 0.016 0.016 0.012 0.006 0.016 0.004 0.011 
 3 0.006 0.021 0.006 0.006 0.012 0.016 0.014 
      as % of brain 1 0.068 0.055 0.101 0.068 0.408 0.043 0.365 
      2 0.101 0.101 0.034 0.083 0.122 0.122 0.088 
 3 0.055 0.146 0.068 0.034 0.237 0.068 0.203 
      as % of ipsilateral 1 0.068 0.068 0.146 0.101 0.460 0.043 0.416 
      hemisphere 2 0.146 0.101 0.043 0.122 0.122 0.146 0.102 
 3 0.055 0.237 0.055 0.043 0.315 0.083 0.272 
      as % of contralateral 1 0.043 0.043 0.101 0.043 0.274 0.043 0.231 
      hemisphere 2 0.083 0.083 0.043 0.083 0.122 0.101 0.079 
      3 0.055 0.101 0.055 0.027 0.173 0.068 0.146 
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Figure 6.15 Infarct volume in male and female rats corrected based on all slices 
and expressed as an absolute or relative estimate. 
Measurements for all three cases for scanners ‘A’–‘F’ as (a) an absolute 
uncorrected and (b) an absolute corrected infarct volume are shown, as well as the 
latter expressed as (c) the percentage of the brain, (d) the ipsilateral and (e) the 
contralateral hemisphere (h.). Each coloured box indicates the median and its 95% 
confidence intervals. Significant difference between groups is indicated above each 
pair (based on Mann–Whitney U test); * indicates p < 0.05; **, p < 0.01.  
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Figure 6.16 Infarct volume in male and female rats corrected based on slices 
including the infarct and expressed as an absolute or relative estimate. 
Measurements for all three cases for scanners ‘A’–‘F’ as (a) an absolute 
uncorrected and (b) an absolute corrected infarct volume are shown, as well as the 
latter expressed as (c) the percentage of the brain, (d) the ipsilateral and (e) the 
contralateral hemisphere (h.). Each coloured box indicates the median and its 95% 
confidence intervals. Significant difference between groups is indicated above each 
pair (based on Mann–Whitney U test); * indicates p < 0.05; **, p < 0.01.  
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6.4 Discussion 
Despite that the use of preclinical MRI systems in experimental research was 
intensified long ago by the need of in vivo assessment of injury over extensive periods 
of time, individual centres still rely on annual maintenance of their systems 
(O'Callaghan et al., 2014), which is performed at different times across centres. At the 
same time, imaging hardware and protocols for in vivo imaging are highly 
heterogeneous, as shown in Chapter 3 (Milidonis et al., 2015). The impact of this 
variability in preclinical stroke studies remained unexplored, but its influence on 
effects derived using MRI lesion volumes can be profound, as recently hinted by 
findings of possibly the first multicentre preclinical stroke trial (Maysami et al., 2015). 
Using the simple QA approach presented in Chapter 4, a multicentre study was 
designed and carried out to specifically determine how imaging performance and 
heterogeneity between and within scanners can influence geometric accuracy when 
MRI is used as in the assessment of infarct size in rodent models of stroke. It was 
found that miscalibrated gradient coils have the most significant impact. To identify 
whether the use of different sequences increases variability compared to the use of an 
identical sequence, each centre’s preferred in vivo sequence was used to scan the 
phantom and QA measurements were compared to those from a standardised 
sequence. Findings suggest that an identical sequence ensures better agreement 
between centres and could thus be more favourable in a multicentre setting. 
Geometric accuracy was assessed by measurement of two QA criteria that were 
described in Chapter 4: linear scaling errors, estimated according to the internal 
dimensions of the phantom measured in scans in all imaging planes, and volumetric 
errors, based on the volume of the central compartment of the phantom measured in 
the axial plane. The axial plane in phantom imaging corresponds to the coronal plane 
in rodent brain MRI often used in experimental studies (x-y plane; Figure 2.3) and the 
phantom’s central cylindrical compartment encompasses marked PVE in this plane 
that is characteristic of lesions in 2D MRI data.  
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Unfortunately, acceptance limits for geometric accuracy in preclinical systems are 
currently not available, but scaling errors in systems ‘B’–’F’ were comparable and 
mostly within the ± 1% limit proposed by the American College of Radiology for 
clinical systems (American College of Radiology, 2015). Scaling errors in system ‘A’ 
were higher and similar in extent to those measured in a scanner from the same 
vendor in a previous study (O'Callaghan et al., 2014). Unexpectedly, a persistent 
difference in measurements between frequency and phase encoding directions in all 
imaging planes was observed in this system with sequence ‘a’, both before and after 
gradient coil calibration. Linewidths from manual global magnetic field shimming 
were well below 100 Hz for all scans and the rBW was 100 kHz; these are often 
sufficient to negate most distortion effects. Yet, the presence of this difference points 
to other sequence limitations and MRI artefacts that are prevalent in either of the two 
in-plane directions, such as ghosting or Gibbs ringing due to Fourier transform 
imperfections in phase encoding. 
In contrast, volumetric errors were positive and inconsistent across centres. This 
emphasises that assessment of volume using 2D sequences can be influenced 
adversely by factors other than linear scaling errors and normal system performance 
drift. Firstly, a large voxel size can blur the boundary of an object due to PVE, leading 
to a seeming boundary outward shift and eventually volume overestimation. This is 
a well-known phenomenon and was observed in previous QA (Khan et al., 2012; Luft, 
Skalej, Welte, Kolb, & Klose, 1996) and in vivo studies (Ren et al., 2004). Stroke 
sequences ‘c’ and ‘d’ had the thickest slices and led to the two largest differences 
between measured and predicted volumes amongst centres. The use of a smaller slice 
thickness and therefore more slices through the volume of interest can reduce this 
artefact, explaining the higher overall measurement accuracy of stroke sequences 
compared to the standardised sequence in systems ‘B’–’F’. Secondly, while a high 
SNR improves image quality and delineation of the ROI, in slices with significant PVE 
the apparent contrast between ROI and background may be enhanced, causing 
inclusion of false positives. Here, data from centre ‘B’ had a noticeably lower SNR 
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compared to data from other centres, leading to small differences between measured 
and predicted volumetric errors. Finally, slice positioning may affect volume 
estimation in a considerable extent, particularly when the ROI is small or the slices 
are very thick, and even small variations can introduce inconsistencies in PVE 
(Ashton et al., 2003) and gradient distortion effects (Jovicich et al., 2006). Phantom 
scanning in this study adhered to detailed instructions for slice positioning, among 
other, and acquired images were comparable; any influence of this factor could have 
only been minimal. These observations suggest that formulae currently used for 
estimating volumes from 2D in vivo sequences data could be modified to account for 
unwanted misestimations (Liu et al., 2009; Rosen & Harry, 1990; Sahin et al., 2003), 
but further studies are needed to determine the best approach in individual study 
designs. 
Using slices through the middle of the phantom, maps depicting the deformation 
applied to the images to match distortion-free CT or baseline images were created, to 
provide aid in the interpretation of geometric errors. The geometric distortion seen in 
these maps is comparable to the expected 3D distortion in the MRI systems due to 
magnetic field inhomogeneity but might not be identical, as they are quantified using 
different methods; a phantom with a large number of equidistant control points (grid 
structure) and 3D registration methods are often required for the latter (O'Callaghan 
et al., 2014; Wang, Strugnell, Cowin, Doddrell, & Slaughter, 2004). The 2D maps 
created here clearly revealed that, further to factors described previously, the 
measurement variability in scanners ‘B’–‘F’ was influenced by subtle spatial 
distortion effects that could have arisen due to a number of possible reasons. Firstly, 
design limitations of gradient coils in high-field systems, such as short bore or short 
gradient rise times that induce eddy currents in nearby conducting materials, can 
produce nonlinearities in the magnetic field (Caramanos et al., 2010; Wang et al., 
2004). The pattern of distortion was similar for systems ‘B’–’F’ that make use of 
gradient coils from the same manufacturer, but could not be observed in system ‘A’ 
in any scan acquired, even after using in vivo sequence ‘b’ and a modified version of 
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it which theoretically amplifies distortion effects. However, the phantom’s size is not 
sufficient to allow deduction of rational acceptance decisions, as manufacturers for 
these coil systems specify the maximum permitted linearity over a much larger 
volume than that of this phantom (in the coils used here this is between ± 4-5% over 
an 80 mm diameter of spherical imaging volume). Secondly, additional local magnetic 
field inhomogeneities may have been produced due to magnetic susceptibility 
differences along the interfaces of the phantom’s contrast solution, plastic and 
surrounding air. As the phantoms’ plastic materials and water are both diamagnetic 
(Wapler et al., 2014) and the characteristic susceptibility effect of opposing regions 
with bright and dark signal was not apparent in the images, it is believed that 
influence of susceptibility along the plastic-solution interface has been insignificant. 
However, the presence of paramagnetic air in close proximity might have been 
influential, which raises further concerns over in vivo imaging across centres, as the 
air-filled sinuses and nasal cavity lie close to the brain and could cause heterogeneous 
susceptibility artefacts. Finally, it must be noted that a narrow rBW may introduce 
positional shifts along the frequency encoding direction as it decreases gradient 
amplitude and enhances susceptibility artefacts. This could partially explain why 
nonlinearities were more enhanced in images taken using the stroke sequences 
utilizing about half of the standardised sequence’s rBW to improve SNR. In general, 
geometric distortion in small animal scanners increases rapidly as the distance 
increases from the magnet’s isocentre, indicating that even relative measures based 
on a small and a larger volume—such as the lesion to brain size ratio—could be 
affected detrimentally. Methods for correcting geometric distortion should be used in 
preclinical MRI as well (Jack et al., 2008; Jovicich et al., 2006; O'Callaghan et al., 2014; 
Teh et al., 2016).  
Despite that imaging performance is undoubtedly a major source of uncertainty in 
measurements, its impact on infarct size and associated statistical group comparisons 
has never been established; such comparisons typically determine the conclusions 
drawn and the success or failure of the study. Using in vivo data simulations, the 
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influence of the two largest sources of variability—scaling errors and voxel size 
differences—was examined. Representative scans for each of the six participating 
centres were generated and analysed by a single rater using the semi-automated tool 
described in Chapter 5, and infarct size was estimated using various approaches 
reported in literature. Simulations debunked the common misconception amongst 
researchers that relative estimates of morphometric outcomes allow efficient 
comparisons between scanners; in the case of infarct volume in experimental stroke 
MRI, at least, measurement variability and related group differences may increase 
due to the interplay of the various ROIs used to estimate these relative measures. 
Comparisons based on a repeated measures design suggested that infarct volume 
differs significantly between scanners when gradient coils are not calibrated and 
different sequences are used, when it is expressed either as an absolute or a relative 
estimate. The concordance between systems improves when they are characterised 
by high geometric accuracy or identical sequences are used. Concordance also 
improves when the infarct volume is corrected for brain swelling based only on slices 
showing the infarct and expressed as a relative estimate, probably because this 
method introduces a level of heterogeneity in measurements that eliminates biases in 
the direction of inter-animal volume differences across scanners, which normally 
determines the result of a repeated measures ANOVA test. The same reason could 
explain the small proportion of variance in these measurements that is explained by 
variation in scanners; variability is mostly within each scanner, attributed to the use 
of a different number of slices per animal when estimating this relative infarct 
volume. Nevertheless, group comparisons reveal that this method is inappropriate 
for correcting infarct volume as it leads to percentage differences that are much 
smaller than those measured in the absolute 𝑉𝐼𝑢; accordingly, p-values from Mann–
Whitney U tests suggest that no significant differences exist between groups, while 
significant differences exist between groups for the absolute 𝑉𝐼𝑢. Between-scanner 
variability in percentage group differences and p-values was smaller when a 
standardised sequence and uncalibrated systems were used, instead of different 
sequences and calibrated systems. Despite this, values differed for each examined 
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case and infarct volume measure, with p-values fluctuating above or below the 
significance level rather unpredictably. Semi-automated analysis is not to blame for 
this variability; measurements in identical datasets (scanners ‘A’ and ‘C’ for case 3) 
were not significantly different for any of the evaluated infarct volume measures, and 
corresponding group comparisons led to equivalent results for these scanners. These 
observations suggest that the only option in a multicentre scenario is the use of highly 
accurate systems and identical imaging protocols, agreeing with previous findings. 
The percentage median differences are of particular importance in preclinical trials, 
as they are estimated in a similar fashion to the ES representing the efficacy of tested 
drugs (equation A.4 in Appendix A). While not common, researchers may choose to 
correct infarct volume for brain swelling by using 𝑉𝐼𝐻 and 𝑉𝐶𝐻 measured only on slices 
where the lesion is visible and then proceed to report it as a relative measure (Lestro 
Henriques et al., 2015). At a first glance, this seems a safe solution to the negating 
effect of formulae used to correct for brain swelling when it occupies a large part of 
the ipsilateral hemisphere (McBride et al., 2015). However, the space-occupying effect 
of oedema may extend beyond the slices where the infarct is visible, as indicated by 
the midline shift in the brain in the slice of the rostral end in Figure 6.12. In the dataset 
used here, for a 30% treatment effect based on the absolute 𝑉𝐼𝑢, the effect can be 15% 
or smaller based on the aforementioned relative estimate. This marked difference in 
ES could be detrimental for meta-analyses’ validity, a primary hypothesis of which is 
the concordance of absolute and relative estimates of MRI infarct volume when 
pooling effects. It could therefore be important for such meta-analyses to first 
determine the presence of a potential bias in treatment effects before proceeding to 
data pooling. In the meantime, strict guidelines for the use of oedema-correcting 
formulae and the estimation of relative infarct volume must be defined for future use; 
ideally, hemispheric volumes based on the whole MCA territory should be used, 
covered by the same number of slices with an identical thickness across centres. Even 
though correction of the smallest infarct in this study did not lead to a negative 
estimate (from 82.8 mm3 to 22.6 mm3 in the reference scan), very small infarcts could 
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be excluded from analyses. 
The transformations used a pooled scaling factor for each orthogonal direction in the 
evaluated MRI systems, combining factors accounting for the linear scaling errors in 
the scanner used to acquire the reference dataset, the linear scaling errors in each 
participating scanner and the required voxel size. It must be noted that scaling each 
reference scan three times using the individual factors could have caused cumulative 
transformation errors, such as significant blurring or production of more or less slices 
than those suggested by the pooled scaling factor and thus misestimations of infarct 
volume. The first task was to correct the reference scans for the linear scaling errors 
in the system that was used to acquire them (‘B’; Table 6.1). Even if errors in this 
system were different at the time of scanning than those used here (Figure 6.4 b), 
statistical comparisons between simulated datasets would not be affected since the 
same correction was applied to all simulations; this could probably hold true even if 
this correction was entirely skipped. Furthermore, one could argue that infarct 
volume for each of the cases examined in this study could be measured by either 
scaling the binary infarct masks for the reference dataset, or multiplying the number 
of voxels in these masks with ‘scaled’ voxel sizes. Either approach would reduce 
analysis time significantly, but would fail to simulate changes in the shape and 
appearance of the infarct, as well as PVEs in the outermost slices. 
A major limitation of the multicentre phantom study is that only 7 T scanners were 
evaluated, while just one of them was an Agilent scanner and longitudinal imaging 
was performed with this system alone. Inclusion of more preclinical systems would 
have provided more conclusive evidence for the role of field strength and vendor in 
geometric accuracy, but could not be achieved here due to logistical considerations. 
Furthermore, small deviations from the scanning protocol may have introduced small 
systematic variation in some of the analyses that could possibly render corresponding 
comparisons less effective. The most apparent deviation from the protocol was the 
use of a mouse head surface coil by one of the centres instead of a rat head surface 
coil, but post hoc imaging showed that this could not affect measurements 
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detrimentally. In any case, such deviations would be representative of the true 
heterogeneity in experimental imaging and the subsequent variation in measured 
biological effects. The limitations of the simulation study vary: Firstly, 2D MRI images 
were used as reference scans, provided by a collaborating institution performing 
stroke experiments routinely. High resolution 3D data with isotropic voxel size 
would have been ideal, because they would minimise interpolation errors in the 
transformation, provide more realistic PVEs in the generated slices and allow 
establishment of ground truth measurements. However, imaging protocols in 
experimental stroke remain 2D sequences with thicknesses that are significantly 
coarser than the in-plane resolution (0.35-3 mm in rat T2WI; Table 3.1).  Furthermore, 
the purpose of the investigation was to compare infarct volumes and related study 
effects between centres, and not determine imaging accuracy by comparison with a 
ground truth. Secondly, the reference images were scaled using linear factors 
estimated by scanning a cuboid MRI phantom with a size similar to that of the rat 
brain. This fails to capture the exact geometric distortion in the FOV. 3D warping 
using deformation maps estimated by scanning dedicated whole coverage geometric 
phantoms at each MRI centre could be more useful but still not ideal, as such 
phantoms cannot model the exact characteristics of the rodent head and therefore the 
deformation maps would not capture associated MRI artefacts. Any potential 
nonlinearities and artefacts already present in the reference scans were transferred to 
the generated ones by the transformations used. Similarly, it was assumed that animal 
placement and orientation in the scanner, slice positioning, tissue contrast in each 
sequence and the method for image analysis were identical for each simulated 
dataset. SNR differences were not simulated as values for each scan and each centre 
were expected to be significantly above 20; any higher SNRs offer little advantage to 
image analysis (McRobbie et al., 2006). Nevertheless, the statistical comparisons 
performed might have even underestimated the true variability in effects between 
centres. Finally, the small size of the dataset used could have had a significant impact 
on statistical comparisons. Unfortunately, incorporating additional data was not 
possible due to the significant heterogeneity between animal studies in terms of 
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overall aims and experimental procedures (Milidonis et al., 2015; Rivers & Wardlaw, 
2005). No such data are publicly available either. This study emphasises the need for 
larger and more effective studies, as well as the establishment of public repositories 
where MRI and other data from animal stroke studies are kept for use in post hoc 
exploratory analyses, such as the one performed here. 
This study uncovers a widespread inconsistency in geometric accuracy of different 
preclinical MRI scanners, raising concerns regarding the comparability of measured 
outcomes across centres. Linear scaling and volumetric errors in scanners are 
overstated when MRI gradient coils are not properly calibrated, but even after 
calibration heterogeneity can be significant due to the use of 2D imaging protocols. 
Statistical comparisons were found to be prone to small differences in scanner errors, 
potentially leading to conflicting conclusions about the examined effect if the exact 
same animals were to be scanned across centres. Scanners of the same manufacturer 
have largely similar performance and imaging using an identical sequence ensures 
better agreement between measurements. While these might not be a concern in 
studies performed locally that estimate effects based on relative measurements and 
comparisons against controls assessed with the same method, multicentre studies 
could combine absolute measurements for one or more cohorts from different centres 
with a highly variable number of animals.  In such studies, the conduct of MRI must 
be optimised by the development of standardised methods for routine scanner QA 
and in vivo imaging, similar in rigor to those utilized in clinical centres (Jack et al., 
2008; Wintermark et al., 2008). Procedures such as those described here must be 
considered the minimum set of QA tests performed. Additional tests may be needed 
if scanners are used routinely for advanced stroke MRI, such as diffusion-weighted 
and functional MRI that place even higher demands on system performance. 
Characterization of the effects of these imaging methods across centres was beyond 
the scope of this study, but should be the focus of future work for the establishment 




Discussion and Conclusions 
This chapter summarises the main contributions of this thesis and describes potential 
implications for experimental focal cerebral ischaemia research. A list of 
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7.1 Contributions 
A known fact since the nineties, the failure in the translation of neuroprotective effects 
from animals to humans led to the development of recommendations to improve the 
quality and reporting of preclinical stroke research (Stroke Therapy Academic 
Industry Roundtable (STAIR), 1999). Later assessment of published records revealed 
that studies failing to report measures to reduce bias—randomisation and blinding—
could falsely inflate estimates of efficacy; this forced an update to these criteria (Fisher 
et al., 2009) and the publication of further recommendations for good laboratory 
practice (Macleod et al., 2009). To complement STAIR criteria, specific instructions for 
the modelling of stroke and the measurement of physiological parameters and other 
outcomes were made available (Liu et al., 2009). Imitating standard recommendations 
for reporting clinical trials (Begg et al., 1996), the ‘Animals in Research: Reporting In 
Vivo Experiments’ (ARRIVE) guidelines were published to serve as the reference in 
preclinical publication practice (Kilkenny, Browne, Cuthill, Emerson, & Altman, 
2010). More recently, generic guidelines for the description of basic information 
regarding the use of various imaging modalities in preclinical research were 
published (Stout et al., 2013). In the meantime, others suggested a more radical 
solution: implementation of multicentre animal stroke trials with the same rigour as 
randomised controlled clinical trials to improve the validity and generalisability of 
experimental findings (Bath et al., 2009; Dirnagl & Fisher, 2012; Dirnagl et al., 2013; 
Howells & Macleod, 2012). Such studies utilising the diagnostic and prognostic 
capacity of MRI could improve the understanding of stroke and help shape the future 
of its treatment.  
While all these recommendations constitute a major step towards the improvement 
of preclinical stroke research, no consideration has been given specifically to the use 
and reporting of MRI in animal stroke studies. This could prove damaging for 
multicentre animal stroke studies. Large clinical imaging collaborations have 
investigated the use of MRI and devised standardised protocols for widespread use 
(Jack et al., 2008; Wintermark et al., 2008), but no preclinical consortium has ever 
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reached this milestone. Nevertheless, MRI is a versatile tool and its applications in 
stroke are ever-expanding, suggesting that definition of a standardised multimodal 
imaging protocol could be a far-fetched goal (Duong, 2012a, 2013; Farr & Wegener, 
2010).  
Instead, this thesis focussed on the most rudimentary application that is often taken 
for granted: the measurement of infarct volume using basic sMRI protocols. A 
coherent and systematic approach was followed to investigate approaches used for 
both image acquisition and analysis, identify factors contributing to variability 
between and within centres, and define strategies for its reduction to facilitate 
multicentre animal stroke studies. Firstly, a systematic review of relevant studies was 
carried out to determine the extent of heterogeneity in MRI acquisition and post-
processing methods for the assessment of lesions. Extracted data were meta-analysed 
to identify the MRI contrast technique providing the most accurate estimate of late 
infarct-volume based treatment effect by comparison with gold standard post-
mortem histological analysis. Secondly, a multicentre study involving six different 
MRI scanners across Europe was designed and carried out, in order to assess 
geometric accuracy in systems when used for stroke imaging. Imaging consisted of 
scanning a dedicated structural phantom using either a standardised sequence or 
centre-specific in vivo sequences used for the measurement of infarct size, and data 
were analysed using an automated tool developed specifically for this purpose. 
Finally, in vivo images in a rat model of stroke were simulated for each scanner by 
modelling the measured geometric errors and the voxel size for corresponding in vivo 
sequences. Infarct volume was measured in each scan using a custom-made 
threshold-based semi-automated tool and statistical tests were performed to 
determine the impact of MRI variability in both infarct volume and related group 
comparisons across centres.   
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7.1.1 Tools 
Assessment of geometric accuracy in different MRI scanners was made possible by 
the use of sMRI phantoms. The phantoms had to be precisely constructed, have an 
overall size similar to that of the rat MCA territory, be longitudinally stable and be 
made with cheap, readily available and MRI-suitable materials. LEGO bricks were 
chosen and used to construct a number of identical phantoms (Chapter 4). Phantoms 
were filled with a Gd-DOTA solution with a T2 relaxation time similar to that of the 
healthy striatum in the rat brain at 7 T (53.56 ms). Using callipers and high resolution 
CT imaging, phantoms were found to be structurally precise and suitable for 
multicentre QA. The internal dimensions and the volume of the central compartment 
of the phantom were used as criteria for geometric accuracy. Acquired phantom data 
had a high quality, which allowed the development of a simple and fully automated 
segmentation tool in MATLAB for their analysis. The main processing step in the 
analysis pipeline is the crude detection of the boundary of the phantom using Canny 
edge detection, which is a computationally light algorithm that performs accurate 
detection of local intensity variations without relying on assumptions of global 
intensity homogeneity (Canny, 1986). Intensity inhomogeneities were found to affect 
other tested algorithms such as basic thresholding and k-means clustering. 
Segmentation is aided by additional morphological processing steps that refine the 
boundary of the phantom. The tool was found to perform full assessment of each scan 
in just 5.3 seconds on average and with very high accuracy as compared to gold 
standard manual analysis (DC: median = 0.982, IQR = 0.975–0.983). 
The work described in this thesis also led to the development of a second tool for the 
detection of the infarct and measurement of its volume on T2WI images in rodent 
models of stroke (Chapter 5). Similar to phantom data, the primary artefact in these 
images is the bias field arising from RF coil sensitivity. However, the abnormal shape 
of the infarct and its poor contrast compared to the surrounding healthy tissue did 
not allow implementation of a similar analysis pipeline. Estimating the bias field 
based on the voxels in the contralateral brain hemisphere proved pivotal and made 
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the use of a threshold-based approach viable. The tool performs binarisation of bias 
field corrected images using a threshold determined by the intensity in the healthy 
contralateral hemisphere of each animal, as used previously in analysis of 
quantitative MRI data (Jiang et al., 2006; Modo et al., 2009; Veldhuis et al., 2003). A 
series of morphological processing steps then refine the infarct boundary. The tool 
offered high segmentation accuracy at this stage (mean ± SD of DC is 0.868 ± 0.052), 
but in many cases the hyperintense ventricles and global intensity variations in the 
slice direction were causing volume overestimations. Therefore, analysis is 
performed with a custom-made MATLAB GUI allowing manual post-processing of 
segmented regions where deemed necessary. The tool is independent of the severity 
of stroke, the extent and consequences of vasogenic oedema, the shape of the infarct 
or the alignment and positioning of the brain in the image that may confound 
unsupervised analysis techniques. Infarcts defined by semi-automated and gold 
standard manual analysis are alike (mean ± SD of DC is 0.931 ± 0.022), but semi-
automated analysis is significantly faster (mean ± SD of analysis time per animal is 
3.68 ± 0.88 and 10.54 ± 1.58 minutes) and more reliable when used by the same rater 
(mean infarct volume difference in repeated analyses is -0.6 and 4.3 mm3). 
Reproducibility in inter-rater analysis using this tool was not as high, despite 
equivalent training of both raters. These observations suggest that the tool could 
permit effective use in centralised data analysis in multicentre studies, which could 
be crucial for the execution of reliable statistical comparisons between cohorts.  
7.1.2 Findings 
Based partially on the aforementioned phantom and tools, studies described in this 
thesis led to important discoveries regarding the use of MRI for the measurement of 
infarct volume across centres; the main findings are summarised below. 
Reporting of methods for lesion size measurement in published articles is lacking. 
The systematic review presented in Chapter 3 revealed that the analysis method used 
for lesion size determination was mentioned for 65% of imaging protocols. Specific 
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lesion boundary criteria were specified for thresholding techniques only, accounting 
for 76% of the reported analysis methods. Methods for correcting infarct volume in 
T2WI due to the space-occupying effect of oedema were used in 25% of relevant 
studies. At the same time, methods to reduce bias and improve the validity of analysis 
were seldom reported; blinded assessment of lesion size was reported in 17% of 
studies and analysis by multiple independent raters in just 2%. In contrast, 
parameters pertinent to MRI hardware and scanning protocols were more often 
reported; yet, no study provided all imaging items considered. 
The conduct of MRI is highly heterogeneous between studies. Systematic review 
findings indicate that various scanners, RF coils and types of pulse sequences are 
used. T2WI was the most commonly reported contrast technique (83% of studies) and 
was performed using SE, FSE, MSME and FLAIR sequences with a range of 
parameters; in rats, for example, slices ranged from six to 35, slice thicknesses from 
0.35 mm to 3 mm, FOV from 22×22 mm2 to 120×120 mm2 and matrix sizes from 64×64 
to 512×512. Lesions were defined in images using manual, semi-automated 
(thresholding) or fully automated methods. Various thresholds of abnormality were 
mentioned for quantitative T2WI, DWI and PWI, but a clear justification was often 
omitted. Lesion size was usually reported as an absolute estimate (58% of studies), 
while other studies chose a variety of relative estimates. 
T2WI is equivalent to gold standard histology for estimating infarct-based ES. 
Meta-analysis of articles using both MRI and post-mortem histology in the same 
animals at corresponding time points suggests that T2WI is strongly associated with 
histology for estimating late infarct-volume based treatment effects (?̅?2 = 0.699, p < 
0.001). In fact, despite that T2WI gives a slightly more conservative estimate of pooled 
efficacy compared to histology (22.2% and 25.5% respectively), CIs are narrower for 
the former, suggesting that this MRI technique may allow improvements in the 
statistical power of a study. On the other hand, DWI is poorly associated with 
histology for the estimation of infarct volume-based treatment effects. 
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Stereological point counting is an accurate and reliable method for measuring 
infarct volume if the grid of points is dense enough. Nevertheless, it does not permit 
generation of masks of the infarct that are necessary in modern morphological studies 
that perform post-processing analyses, such as assessment of its shape and 
appearance across animals or time points, or template formation using registration 
methods. Threshold-based semi-automated analysis using the developed MATLAB 
tool is faster, has a higher reliability when used by the same rater and allows 
extraction of lesion masks (Chapter 5). 
The infarct is represented by tissue in the ipsilateral hemisphere with an intensity 
higher than 2.1 times the mean intensity in healthy tissue in the contralateral 
hemisphere. Automatically segmented infarcts (pre-manual editing) had the highest 
DC for this threshold when compared to manually defined infarcts. The threshold 
can be used for semi-automated localisation of the infarct in qualitative T2WI data 
of—at least—Sprague Dawley rats scanned 24 hours after MCAO. It was similar to 
the threshold used in quantitative T2 maps in previous studies using a different rat 
strain and different time points (Jiang et al., 2006; Li et al., 2009), which implies that it 
could be applicable to a range of study designs. 
Geometric accuracy between preclinical MRI scanners varies. Currently, preclinical 
MRI centres rely on annual maintenance of systems by external service engineers. 
Chapter 6 highlighted the repercussions of this practice; linear scaling errors in each 
orthogonal direction were mostly positive in six different 7 T scanners. Five of the 
evaluated systems were made by Bruker and had smaller errors than the single 
Agilent system used in the study. Nevertheless, images acquired with Bruker systems 
demonstrated prevalent nonlinearities that were not observed in the Agilent system. 
RF coils do not influence geometric accuracy significantly. 
The use of an identical pulse sequence across scanners reduces the variability in 
geometric errors. In systems routinely used in stroke studies, linear scaling errors 
were within 0.03% to 1.84% with a standardised sequence and within -0.27% to 2.19% 
182 7.1  Contributions  
with different in vivo T2WI sequences. Similarly, volumetric error ranged from 5.71% 
to 11.67% and 3.96% to 12.51% respectively. 
Volume estimation using 2D pulse sequences is affected by slice thickness and 
SNR. Linear scaling errors in MRI systems alone are not sufficient to explain 
volumetric errors in phantom images. The error in repeated scanning using the 
calibrated Agilent scanner was persistently high (median = 7.33%, IQR = 0.43%). The 
difference between measured errors and those predicted by linear scaling errors was 
positively associated with slice thickness and SNR. Careful inspection of images 
points out that a thick slice contributes to significant PVE, while a high SNR increases 
the apparent intensity of the ROI in areas where PVE is significant, causing inclusion 
of false positives. 
Longitudinal variability in geometric accuracy over six months is low. Linear 
scaling errors remained within ± 1.00% over six months of repeated phantom 
scanning using the standardised sequence and the calibrated Agilent scanner. The 
coefficient of variation in phantom’s cylindrical volume was 0.40%, which is minute 
compared to that in infarct volume in rodents over much shorter periods (Liu et al., 
2009). The fluctuation in the apparent size of the phantom was similar during daily, 
weekly and monthly imaging.  
Infarct volume differs significantly between the evaluated six MRI scanners. The 
simulation study presented in Chapter 6 suggests that a variability in geometric errors 
or in voxel size of the extent shown by the multicentre phantom study, is sufficient to 
render infarct volumes across centres incomparable. The variance in measurements 
between scanners is attributed mostly to differences in geometric errors.  
Statistical comparisons between groups lead to different conclusions across 
scanners. The variability in group comparisons between scanners decreases when a 
standardised sequence is used. Infarct volumes expressed as relative estimates 
(percentage of brain or hemispheric volume) inflate between-scanner variability. For 
the dataset used in the simulation study, p-values across scanners fluctuated around 
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the significance level of 0.05 for relative infarct volumes, but were always less than 
the significance level for absolute volumes.  
Correcting infarct volume for brain swelling and expressing it as a relative estimate 
based on hemispheric volumes measured only in slices that include the infarct is 
erroneous. The variability in such relative estimates is attributed mostly to within-
scanner variance rather than between-scanner variance. This method leads to smaller 
group percentage median differences than for the absolute 𝑉𝐼𝑢 (values for our dataset 
were within 5.84–21.05% and 26.68–31.93% respectively), while p-values are 
considerably more variable (0.034–0.460 and 0.008–0.021 respectively). Volumes 
corrected for swelling and expressed as an absolute measure based on all acquired 
slices (identical brain region for all animals) have low between-scanner variability in 
percentage median differences and p-values, which are similar to those for the 
absolute 𝑉𝐼𝑢 (27.46–35.40% and 0.004–0.027 respectively).  
7.2 Recommendations  
In alignment with previous knowledge, these findings allow recommendations to be 
made that could provide an optimal environment for multicentre studies in rodent 
models of stroke employing sMRI to measure infarct size, facilitate pooling of 
measurements and improve the statistical power of the study. 
Before embarking on a multicentre study, each centre should test and optimise the 
performance of their system by scanning a structural phantom with size and signal 
characteristics similar to that of the rodent brain. The imaging protocol should consist 
of a single T2WI sequence that is intended for use in the actual in vivo experiment; 
some parameters may be tailored to each centre, as described below. Despite that 
radiologists tend to acquire and analyse 2D data with high in-plane resolution, PVE 
and therefore measurement errors can be minimised by using a more isotropic voxel 
size; this should be standardised. With current hardware and software capabilities, a 
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FSE sequence such as ‘f’ in Table 6.2 could be close to the ideal; this made use of the 
thinnest slices among protocols examined in the multicentre QA study and obtained 
data with great quality and reduced volumetric errors. This, however, necessitates 
investment in a phased array RF receive coil that allows improvement in SNR when 
small NSAs are used. A SNR of at least 20 is required (McRobbie et al., 2006) and the 
duration of a scan should normally not exceed 10 minutes. At least one scan in each 
of the three primary imaging planes should be acquired to measure the phantom’s 
dimensions in each orthogonal direction and identify any bias in encoding direction. 
Phantom data should be analysed locally using an automated tool to ensure 
consistency across centres and measurements should be used to perform basic 
calibration of all three gradient coils. The phantom, QA protocol and data analysis 
tool presented in Chapter 4 could be used effectively for this purpose; minor 
modifications of the tool’s source code can allow analysis of images of any cuboid 
phantom. If the phantom allows assessment of volumetric accuracy, such as the one 
used here, phantom data from all participating centres could be compared centrally 
to identify factors that contribute to variability. In the undesirable case that 
considerable differences exist, centres could attempt to harmonise image quality and 
signal characteristics further by either using similar hardware (particularly RF coils) 
and by adjusting sequence parameters other than those determining voxel size (for 
example, TR, TE, NSA and rBW). Gradient nonlinearities are normally minute at very 
small distances from the magnet’s isocentre and will affect the size of infarcts in 
rodents very little when centred in the scanner. In some gradient coil systems, 
however, nonlinearities could increase rapidly at further distances and potentially 
confound larger ROIs; if phantom imaging suggests that this is the case, a more 
advanced—albeit cumbersome—method could be implemented to correct data for 
this distortion (Jovicich et al., 2006; O'Callaghan et al., 2014; Teh et al., 2016). 
Assuming that no intermediate changes in scanner software and equipment take 
place, QA performed every six months should maintain geometric accuracy at 
acceptable levels. However, if multicentre studies are assessing infarct size at time 
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points when vasogenic oedema is prevalent (necessitates measurement of 
hemispheric volumes), scanners should be monitored weekly according to 
recommendations for clinical QA (American College of Radiology, 2015). In reality, 
the quality of MRI data can be influenced by a range of additional factors, therefore 
procedures described here must be considered the minimum set of QA tests 
performed. Additional tests may be needed if scanners are used routinely for 
advanced stroke MRI, such as DWI and functional MRI that place even higher 
demands on system performance, but characterization of their effects was beyond the 
scope of this thesis. QA procedures including phantom placement, slice positioning, 
scanning and preparation of data should be clearly defined and disseminated across 
centres in advance. Multicentre studies could also benefit from staff training 
beforehand to reduce variability in the collection of data. 
As emphasised numerous times in the past, a priori sample size calculations are 
essential in any study that draws conclusions based on statistical comparisons; 
studies that do not report a sample size calculation may overstate the reduction in 
infarct volume (Dirnagl, 2006; Fisher et al., 2009). This thesis demonstrated the 
dramatic effects of using few animals on group comparisons and suggests the use of 
an appropriate sample size to reduce the uncertainty in combined estimates of 
efficacy and group comparisons. The hardware, software and pulse sequences 
optimised in QA should be used for in vivo scanning as well. Slices should be 
positioned at the same location in each animal relative to an anatomical feature, such 
as the bregma or the rostral end of the rhinal fissure, consistently for each scan. 
Depending on the species and strain used, a sufficient number of slices should be 
used to cover the whole MCA territory; this should be identical for all centres. An 
imaging session including various MRI sequences should typically last about one 
hour, in order to minimise the confounding effects of anaesthesia and ensure the 
welfare of animals. Acquired images should be collected at one centre and evaluated 
by an experienced radiologist for concordance in quality and slice positioning; the 
same or a different rater should then analyse them to measure infarct volume, blinded 
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to the centre and group allocation. The data analysis software should ideally be semi-
automated to improve reliability and speed, while allowing visual inspection of 
segmented lesions and manual refinement where deemed necessary. Work presented 
in this thesis indicates that such an approach is entirely viable, and Chapter 5 
provides the grounds for its implementation. 
Infarct volume should be estimated and combined in each animal group as an 
absolute estimate (for example, in mm3). For animals scanned at the subacute or the 
early chronic stage of stroke (typically 1 to 7 days post MCAO in the majority of 
rodent models of stroke), correction of infarct volume for brain swelling using 
published formulae is required (Gerriets et al., 2004). Swelling leads to apparent 
changes in the brain that are sufficient to indicate if a correction is necessary; effects 
include the shift of the midline between the hemispheres and enlargement of brain 
ventricles in the lesioned ipsilateral hemisphere. 
Recommendations arising from this thesis are summarised in Table 7.1. Most of these 
could potentially favour use of MRI for the assessment of various types of 
abnormalities at different time points, such as areas of decreased diffusion of water 
and perfusion of blood using DWI and PWI respectively. Some recommendations 
may even apply to preclinical consortia focussing on other diseases where 
morphological MRI outcomes are primarily used, though relevant studies are needed 
to determine this. They should complement other contemporary guidelines for the 
conduct and reporting of experimental research (Kilkenny et al., 2010; Stout et al., 
2013; Stroke Therapy Academic Industry Roundtable (STAIR), 1999). It is believed 
that careful consideration of these recommendations by scientists will be vital for the 
improvement of the validity and generalisability of experimental findings towards 
the identification of new and efficacious neuroprotective drugs, as well as the 
reduction of the resources and the number of animals used. This will also bring 
improvements to the validity in other post hoc exploratory analyses using acquired 
data and will permit exact replication of the experiments. 
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Table 7.1 Recommendations regarding the use of MRI for the assessment of infarct size in 
multicentre studies in rodent models of stroke. 
FOV indicates field of view; MCA, middle cerebral artery; PVE, partial volume effect; QA, 
quality assurance; RF, radiofrequency; SNR, signal-to-noise ratio; T2WI, T2-weighted imaging. 
Category   Recommendation 
Hardware  
and software 
 Minimise hardware and software differences. Scanners of the same 
vendor and RF coils of the same type are ideal; RF reception should be 
performed preferably using phased array surface coils. 
Quality  
assurance 
 Define standard QA procedures including phantom placement, slice 
positioning, scanning and data preparation. At least one scan per 
imaging plane should be acquired. 
  Use an identical structural phantom allowing thorough assessment of 
geometric accuracy (distance; volume is complementary but useful). 
  Use in vivo T2WI sequences of identical type, matrix size, FOV and slice 
thickness. Slice thickness should be small to reduce PVE, while other 
parameters should be adjusted so that SNR is 20 or higher and scanning 
time is 10 minutes or less. 
  Perform reproducible positioning of slices. 
  Analyse data in each centre using an identical automated software. 
  Collect data at one centre and compare image quality. Hardware and/or 
sequence parameters (except those defining voxel size) could be 
modified for each centre to ensure consistency. 
  Perform QA for optimising geometric accuracy weekly and after 
hardware and software updates. If the study does not involve 
assessment of brain size or other longitudinally stable structures, 
biannual QA is sufficient.  
In vivo 
imaging   
 Estimate an appropriate sample size based on the expected difference in 
infarct volume between groups and the desired power. 
  Define standard imaging procedures including animal placement, slice 
positioning, scanning and data preparation.  
  Use the in vivo sequences optimised during QA. An identical number of 
slices covering the whole MCA territory should be acquired. 
  Perform reproducible positioning of slices relative to an anatomical 
feature (bregma or the rostral end of the rhinal fissure). 
Image  
analysis 
 Assemble all the data at one centre and perform analysis by a single 
experienced rater, blinded to the centre and group allocation. The data 
analysis software could be semi-automated to allow manual refinement 
of the segmented infarct. 
  Correct infarct volume for brain swelling if scanning is performed 1–7 
days after induction of stroke; Gerriets’ formula is appropriate for T2WI 
(Gerriets et al., 2004). Visually inspect brains at all time points to 
determine the presence of swelling. The volume of brain hemispheres 
should be measured across all slices.  
  Combine absolute corrected infarct volumes across centres to estimate 
treatment effect.   
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7.3 Limitations and Further Considerations 
Further to the discussion at the end of each chapter of the thesis, other limitations that 
might have confounded the results and emerging considerations are discussed in this 
section. 
7.3.1 Systematic review and meta-analysis 
The systematic review described in Chapter 3 intended to provide an initial 
appreciation of the variability in the use of MRI in experimental stroke and aid in the 
design of subsequent studies performed as part of this project. Only a small number 
of representative articles were reviewed, that were identified in a single database 
(CAMARADES). However, potentially hundreds of such studies have been 
performed over the years and the systematic review might have obscured the true 
extent of variability. Including papers from more sources could have enabled the 
execution of effective stratified meta-analysis or multivariate meta-regression to 
explore the impact of individual imaging criteria on the relationship between MRI 
and histological outcomes. This could have helped, for example, in the identification 
of the optimal parameters for the standardised sequence used in the multicentre QA 
study and allow sequence-specific recommendations to be made, which are missing 
from Table 7.1. 
7.3.2 Multicentre quality assurance 
Designing and carrying out a large multicentre study involving six different MRI 
scanners located at six different institutions across Europe is very challenging, to say 
the least. 7 T scanners were selected to reduce field-specific variations (particularly in 
SNR). However, other variations were inevitable, including differences in scanner 
manufacturer, gradient strength, scanner software and version, and types of imaging 
coils, which arguably resulted in differences in SNR between centres and 
consequently differences in volumetric measurements (Figures 6.4 and 6.5). 
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Preclinical MRI scanners are still rather scarce, therefore identifying entirely identical 
systems or homogenising selected systems was practically and financially impossible. 
Nevertheless, the primary aim of this study was to evaluate the variability in 
geometric accuracy in the context of experimental stroke imaging across centres and 
not the inherent variability between the systems themselves, which implies taking 
into account the use of centre-specific equipment. 
To reduce the overall duration of the study, identical phantoms were constructed and 
sent to each participating centre to permit simultaneous scanning. I travelled and 
contributed to imaging in centres ‘A’ and ‘B’ (Table 6.1), but phantoms in all other 
centres were scanned by local staff without my supervision. Staff could have had 
various degrees of experience and the conduct of MRI at each centre might have 
deviated from the predefined QA protocol (Appendix D), contributing to variability 
in measured geometric errors. Instructions given were comprehensive and covered 
phantom placement, slice positioning, scanning, data preparation and naming, while 
visual assessment of images did not reveal any apparent deviations. Furthermore, 
imaging consisted of six scans using each pulse sequence in various imaging planes 
in order to perform multiple measurements per direction and improve the reliability 
of assessment. 
The contrast solution used to fill the phantoms was a Gd-DOTA solution of an 
appropriate concentration to obtain a T2 relaxation time similar to that in the rat brain 
at 7 T. While this contrast agent has been used before for the same purpose (Teh et al., 
2016), its main effect is the reduction of T1 relaxation time; this was not measured for 
the phantoms used, but was pivotal in the reduction of scanning time with the 
standardised protocol ‘a’ (Table 6.2). As a paramagnetic agent, Gd-DOTA might have 
contributed to an increase in magnetic susceptibility effects around the phantom, 
causing spatial distortions. These could have been further overstated by the cuboid 
shape of the phantoms themselves. An object placed in a scanner becomes magnetised 
and produces an induced field that perturbs 𝐵0. This perturbation should be as little 
as possible; ellipsoidal objects with uniform susceptibility produce a homogeneous 
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external field and are ideal for use as MRI phantoms (Schenck, 1996). Therefore, the 
shape of the phantom could partially explain the nonlinearities in images from Bruker 
systems and the bias in encoding directions in the Agilent scanner (Figures 6.6 and 
6.7). A potential solution could have been to submerge the phantoms in cylindrical 
plastic or glass tubes filled with the same Gd-DOTA solution, but this would have 
resulted in aliasing artefacts for sequences using small FOV and would not allow 
automated analysis of images using the developed tool. None of these were a concern 
before the start of the multicentre study, simply because images acquired during 
preliminary tests using the Agilent scanner had great quality overall and were free of 
any nonlinearities, while the small difference in encoding directions could not be 
minimised by attempted sequence modifications (Figure 4.1 d). Furthermore, the 
cuboid phantom design permitted reproducible placement and alignment in each 
scanner. Despite the antithetical effect of nonlinearities on each side of the phantom, 
it may have contributed to measurement errors in the frequency direction. To the 
staff’s knowledge, no software of any of the evaluated preclinical scanners applies a 
geometric distortion correction to the data, which poses serious questions about the 
underlying differences between systems or system-specific sequences that cause this 
discrepancy in geometric distortions. 
7.3.3 Image processing 
In this thesis, particular attention was paid to image analysis; automated or semi-
automated tools were developed where possible to improve the accuracy and 
reliability of measurements and hence the validity of each study. An additional 
criterion was processing time; only simple and computationally inexpensive 
approaches were considered. Both major processing tools described in this thesis 
(Chapters 4 and 5) were developed for use as specified only. However, small changes 
in the source codes could permit analysis of similar T2WI data, such as those of other 
cuboid phantoms using the automated QA tool, or rodent brains with other types of 
lesions using the semi-automated infarct segmentation tool—tumours, global 
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ischaemic or multiple sclerosis lesions could be plausible examples. 
Both tools were validated by comparison against gold standard manual tracing. Intra-
rater reliability and inter-rater reproducibility was performed for the semi-automated 
infarct segmentation tool and for manual tracing. A large number of scans were used 
to validate the automated QA tool for the measurement of the internal dimensions of 
the phantom (𝑛 =  60; 40 measurements per direction). However, volumetric 
pipelines in both tools were validated based on 10 scans each; these are too few to 
make reliable population inferences. The considerable burden and time required for 
manual analysis were the main reasons for the small sample, which precluded 
analysis of more data within a reasonable time frame. It should be emphasised that 
the performance of the semi-automated infarct segmentation tool depends on the 
accuracy of manual analysis, the results of which were used as ground truth for 
optimisation. There is no specific and widely accepted approach to determine ground 
truth in biological data, other than by employing an experienced rater to perform 
manual analysis. 
Correction of bias field in qualitative MRI data can be formidable, particularly when 
there are prominent abnormalities due to diseases that distort the global intensity 
homogeneity in the images. In our case, the hyperintense lesion in the ipsilateral 
hemisphere was causing significant correction issues when default methods were 
used. It was found that the contralateral hemisphere is a good reference area for the 
bias field correction algorithm, due to the fact that the signal in tissues within this 
hemisphere is largely homogeneous. However, the presence of the hyperintense 
ventricles was not taken into account, which may have slightly affected the correction 
and confounded further analyses. 
The variability in infarct volume might have been overstated by the quality of images. 
Phantom scanning using the scanner and coils used to acquire the in vivo data point 
at a potentially poor quality (Figure 6.5 a). Using data from other centres could have 
improved the reproducibility of infarct segmentation. It should be noted that a clear 
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definition of the infarct boundary in MRI data is lacking from literature; descriptions 
of image analysis in articles are either too vague or entirely absent. The semi-
automated segmentation tool was based upon criteria devised by myself based on 
previous observations and solely for the dataset examined, though this is 
representative of current preclinical stroke practice. 
7.3.4 Statistics 
Chapter 6 of this thesis described a simulation study assessing the impact of scanners’ 
linear scaling errors and voxel size in the measurement of infarct volume between 
scanners. Distributions of infarct volumes were compared using repeated measures 
ANOVA, which takes into account the within-subject variability across scanners and 
has a higher power than cross-sectional designs; this allows detection of very small 
differences between means (Guo, Logan, Glueck, & Muller, 2013). It was observed 
that in comparisons of infarct volumes expressed as relative estimates ANOVA 
results were more conservative, despite an apparent difference in means. This is 
probably because within-subject variability was high, giving the impression that a 
specific bias in measurements does not exist. As done in this study, careful 
interpretation of the results requires consideration of the effect size of ANOVA (𝜂2) 
indicating the proportion of variance in measurements explained by variation 
between scanners.  
The use of a small number of animals is typical in preclinical research (Vesterinen et 
al., 2011); inevitably, this was the case for the post hoc analyses described here. 
Ideally, analyses should have been performed on images acquired in a preclinical 
stroke study assessing the efficacy of a drug. However, collaborators could not 
provide such data, whereas carrying out an animal study in Edinburgh was not 
feasible due to the lack of research staff specialising in stroke models. Combining data 
from other studies was not possible either, due to the large heterogeneity in study 
design and imaging performance between and within centres. Regardless of the 
concordance between studies, no data are readily available for reuse. The 
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development of standardised and useful paradigms for structural and functional MRI 
in experimental stroke requires prospective collection and dissemination of data. 
Images and other recorded information could be collected using predetermined 
definitions and deposited in a publicly available repository. These can be used by 
researchers worldwide to evaluate the performance of analysis tools and perform 
post hoc exploratory analyses or sample size calculations, which will accelerate the 
establishment of standardised imaging methodologies. 
7.4 Future Work 
Many of the findings of this thesis were unsurprising, as the variability in MRI 
findings in the clinical setting is well characterised. Even so, the use of the modality 
in preclinical studies has been overlooked despite decades of use, rendering the 
quality of studies relatively poor. This thesis stresses the impact of a range of factors 
in the acquisition and processing of MRI data in experimental stroke, but at the same 
time raises additional concerns that warrant further investigation. 
Instead of performing an assessment of studies employing a range of MRI methods, 
future systematic reviews could focus on individual imaging methods or endpoints 
and perform a thorough identification of relevant studies. This will increase meta-
analysis flexibility and help refine the relationship between T2WI and gold standard 
histology, which can be decisive in the determination of optimal imaging parameters 
for future use. 
This thesis focussed solely on the impact of T2WI variability on infarct volume 
measurements. Future studies could emulate the proposed approaches for 
multicentre QA and data simulation to a range of other MRI morphological outcomes 
in stroke or other diseases. An important outcome would be the increase in 𝑉𝐼𝐻 due 
to oedema; this is well correlated with infarct volume and is often used to assess the 
integrity of BBB and distinguish between the acute and subacute stages of stroke 
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(Gerriets et al., 2004; Macrae, 2011). Other outcomes of particular interest in rodent 
models of stroke include the volume of diffusion or perfusion abnormalities and the 
widely assessed ischaemic penumbra using the PWI/DWI mismatch (Duong, 2013; 
Farr & Wegener, 2010). The accuracy and concordance of preclinical scanners when 
these outcomes are quantified will provide further insights into the validity of the 
current conduct of preclinical MRI in stroke and allow identification of refinement 
strategies. Simulation studies could further assess the effect of variability on statistical 
comparisons when different animals or stroke models are used, to provide the 
grounds for performing power calculations in local or multicentre MRI studies. 
However, it could be important to first refine the simulation procedure by using high 
resolution reference data and applying 3D non-rigid geometric transformations. 
Alternatively, development of computational methods for creating digital rodent 
brain phantoms with realistic stroke lesions and precisely known anatomical and 
signal characteristics could be the way forward. 
The multicentre study presented in Chapter 6 hinted that volumes of structures in 2D 
sMRI data are overestimated due to PVE. In addition to oedema correction, formulae 
should be defined to correct infarct volume for PVE, such as those used in ex vivo 
(Liu et al., 2009; Rosen & Harry, 1990) and in vivo determination of various biological 
structures (Sahin et al., 2003). This can be accomplished by scanning animals using 
basic 2D and high-resolution 3D sequences within the same session; infarct volume 
quantified in the former can then be optimised based on ground truth estimates 
determined with the latter, though 3D imaging with acceptable SNR and contrast 
could require very long acquisition times. 
The semi-automated infarct segmentation tool used in this thesis lacks methods for 
automated segmentation of brain hemispheres and bias field correction. Future work 
must address this deficiency in order to bring the tool a step closer to routine 
preclinical utility. Accurate rodent brain detection constitutes a mission for relatively 
many research groups, though no available algorithm can segment each hemisphere 
separately or be applied on ischaemic brains (Chou et al., 2011; Oguz et al., 2014; 
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Zhang et al., 2009). Segmentation using computer vision approaches does not rely 
explicitly on assumptions of global intensity homogeneity and is a potential 
candidate for this task, but will require large datasets for model training and 
validation (Babalola et al., 2008; Wells et al., 1996). 
7.5 Conclusions 
Multicentre preclinical stroke studies utilising the diagnostic and prognostic strength 
of MRI are likely to prove vital in the translation of experimental findings to the clinic 
and the development of new and effective treatments. This thesis aimed to assess MRI 
variability in the measurement of infarct volume and highlight contributing 
methodological issues. Despite that the studies carried out towards this goal were 
simple in terms of design and implementation, the acquired data and the variability 
in measurements were more complex and multifaceted than expected. Findings 
should not be regarded as being prejudicial to experimental stroke MRI and should 
not discourage its use by any means. Rather, the thesis aims to enlighten researchers 
about factors that can influence the accuracy and comparability of infarct volume 
measurements and encourage them to take simple actions that can improve the use 
of the modality and allow effective comparison of data between centres. This thesis 
established strategies to improve the consistency in data acquisition and analysis, and 
maximize across-centre sensitivity to true biological change by identification of the 
sources of errors and understanding of the underlying mechanisms. Collectively, 
recommendations arising from this work will contribute to the replacement, 
reduction and refinement of the use of animals in experimental stroke (the 3Rs). 
However, a thorough appreciation of the issues involved requires further effort from 
the preclinical stroke community, but will help establish a comprehensive and 
rigorous multimodal MRI protocol for use in large multicentre studies and move 
experimental research forward. 
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218 A.1  Estimating Effect Size  
The formulae described below are used for the meta-analysis of continuous data, and 
were used in Chapter 3 to analyse infarct size measurements extracted from 
systematically reviewed studies. They were adapted from Vesterinen et al. (2014) and 
Borenstein, Hedges, Higgins, and Rothstein (2009), who provide guidance for  meta-
analysis of additional types of data. 
A.1 Estimating Effect Size 
A meta-analysis aims to pool systematically extracted data by weighting individual 
study measurements (in this case the mean infarct volume) according to the sample 
size of each study and the variance of the measurement. Each study may compare 
measurements between various treatment and control groups to determine the ES 
representing the impact of a treatment on measured outcome. For deriving this, the 




𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑔𝑟𝑜𝑢𝑝𝑠 𝑠𝑒𝑟𝑣𝑒𝑑
                                 (A.1) 
where 𝑛𝑐 is the total number of animals in the control group. The total number of 
animals involved in the comparison is then 
𝑁 = 𝑛𝑟𝑥 + 𝑛𝑐
′                                                               (A.2) 
where 𝑛𝑟𝑥 is the number of animals in the treatment group. If a study reports the SEM 
of a measurement for the control or treatment groups, 𝑆𝐸𝑐 or 𝑆𝐸𝑟𝑥 respectively, this is 
converted to SD according to 
𝑆𝐷𝑐 = 𝑆𝐸𝑐√𝑛𝑐
′     and    𝑆𝐷𝑟𝑥 = 𝑆𝐸𝑟𝑥√𝑛𝑟𝑥                                    (A.3) 
respectively. The ES of a comparison is estimated as an NMD, describing the 
percentage improvement in the treated group compared to the control group: 
𝐸𝑆𝑖 =
(?̅?𝑐 − ?̅?𝑠ℎ𝑎𝑚) − (?̅?𝑟𝑥 − ?̅?𝑠ℎ𝑎𝑚)
?̅?𝑐 − ?̅?𝑠ℎ𝑎𝑚
100%                                 (A.4) 
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where ?̅?𝑐 and ?̅?𝑟𝑥 are the mean values of measurements in the control and treatment 
groups respectively, ?̅?𝑠ℎ𝑎𝑚 is the mean value for a normal and untreated group of 
animals (sham group), if used, and 𝑖 the index of each individual comparison. NMD 
was preferred over alternative approaches used in—the highly heterogeneous—
studies in animal models, such as the simple mean difference or the standardised 
mean difference, as it allows outcomes measured on different scales to be combined 
and it is not given in units of SD. NMD values range usually between -100% and 
100%, denoting doubling (worsening of outcome) or halving (improvement of 
outcome) of the mean infarct size in the treated group compared to the control group, 
respectively. The standard deviations for both groups are also expressed as a 




100%    and    𝑆𝐷𝑟𝑥∗ =
𝑆𝐷𝑟𝑥
?̅?𝑟𝑥 − ?̅?𝑠ℎ𝑎𝑚
100%                  (A.5) 









                                                      (A.6) 
A.2 Pooling Effect Sizes  
Each ES is weighted based on its SEM, which effectively represents the precision of 
each estimate; the less variance in the estimate the more it will contribute to the 




2                                                                  (A.7) 
and the weighted ES by 
𝑊𝐸𝑆𝑖 = 𝐸𝑆𝑖𝑊𝑖                                                               (A.8) 
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Normally, the ES is calculated based on a single comparison from each study. 
However, if a study reports infarct size measurements by various methods in the 
same cohort of animals at the same time, these can be combined into a nested ES 
before proceeding to pooling estimates from different studies. In Chapter 3 of this 
thesis, this was used to examine the accuracy of multiparametric MRI for determining 
infarct size-based treatment effects using meta-regression (described in section A.3). 









                                                          (A.9) 
where 𝑗 is the index of each comparison/ES contributing to the nested ES and 𝑚 their 
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∗                                                           (A.12) 
There are two methods that can be used to pool ESs from different studies. The fixed 
effects model is the simplest method and assumes that ESs vary only slightly between 
studies due to random error (within-study variance), thus the effect is considered to 
be fixed. The random effects model assumes that ESs differ significantly between 
studies, mostly due to differences in study design (between-study variance); this 
model takes into consideration both the within- and between-study variance.  
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                                                    (A.13) 
where 𝑘 is the total number of comparisons in the meta-analysis. This formula implies 
that for studies where non-nested ESs are used, equations A.7 and A.8 are used to 
estimate individual 𝑊𝑖
∗ and 𝑊𝐸𝑆𝑖
∗, respectively. The SEM and the 95% CI of the fixed 






                                                     (A.14) 
95% 𝐶𝐼𝑓𝑖𝑥𝑒𝑑 = 𝐸𝑆𝑓𝑖𝑥𝑒𝑑 ± 1.95996 𝑆𝐸𝑓𝑖𝑥𝑒𝑑                                   (A.15) 
To get an indication of how much the ESs vary between studies, the tau-squared value 
is calculated (𝜏2), quantifying the amount of variance beyond that expected by 





                                                              (A.16) 
where  






                                              (A.17) 
df = 𝑘 − 1                                                               (A.18) 











                                                    (A.19) 
If 𝜏2 = 0, there is no between-study variance and the fixed and random effects models 
are equivalent; the larger the value the larger the between-study variance. The 
random effects model takes 𝜏2 into account to estimate more conservative weighted 
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                                                  (A.22) 
The SEM and the 95% CI of the random effects estimate are calculated using the 






                                                   (A.23) 
95% 𝐶𝐼𝑟𝑎𝑛𝑑𝑜𝑚 = 𝐸𝑆𝑟𝑎𝑛𝑑𝑜𝑚 ± 1.95996 𝑆𝐸𝑟𝑎𝑛𝑑𝑜𝑚                           (A.24) 
𝑄 in equation A.17 follows a 𝜒2 distribution with df given by equation A.18.  
Therefore, the 𝜒2 statistic can be used to test the significance of differences between 
𝑄 and the expected variation due to within-study variance. In Microsoft Excel 
(version 2010 or later), this is given by the right-tailed probability of the 𝜒2 
distribution, calculated using the following function: 
𝑝 = CHISQ. DIST. RT(𝑄,   df)                                             (A.25) 
While 𝑄 can be used as an estimate of between-study heterogeneity (it is the sum of 
weighted individual effects without the random error contribution), its value is 
dependent on the number of comparisons included in the calculation.  
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An alternative but related approach is to estimate the proportion of total variance that 




100%                                                          (A.26) 
This lies between 0% and 100%, denoting that all variance is due to chance alone and 
that all variance is due to between-study heterogeneity, respectively. A random 
effects model is normally used when 𝐼2 > 50%; this was the case for all combined ESs 
in the meta-analysis of Chapter 3. 
A.3 Meta-Regression 
Dedicated meta-analysis techniques can be used to examine the differences between 
studies or the impact of study characteristics on ES. Stratified meta-analysis is used 
when studies can be grouped according to a study design criterion in a number of 
strata with the criterion being, for example, the use of a different method for assessing 
outcome; strata can then be compared to examine the influence of that criterion on 
outcome. Unfortunately, the number of studies included in meta-analysis in Chapter 
3 was small and their heterogeneity was very high, thus this technique was not 
employed. Instead, meta-regression was used. This is a type of weighted linear 
regression that takes into account the within- and between-measurement variance to 
estimate how much heterogeneity in the dependent variable is explained by one or 
more independent variables. In Stata software (version 8 or later), the function 
metareg can be used as shown: 
metareg   𝑦   𝑥,   wsse(𝑠𝑒𝑦)                                               (A.27) 
where 𝑦 is the list of ESs (dependent variable), 𝑥 the list/s of corresponding values of 
the independent variable/s and 𝑠𝑒𝑦 the list of corresponding SEs estimated using 
equation A.10, the variance in each study (Harbord & Higgins, 2008). Independent 
variables can be other ESs calculated based on measurements of a different outcome 
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or measurements collected using a different method in the same cohort of animals, or 
absolute variables such as the time point following stroke. In Chapter 3, MRI-based 
ESs and the time of infarct size measurement following stroke were used as 






                                                          (A.28) 
where 𝜏2 is calculated using the restricted maximum likelihood approach to account 
for multiple covariates (Thompson & Sharp, 1999). The meta-regression model 
produces a coefficient of determination which represents the proportion of variance 
in the dependent variable that is accounted by the independent variables, and is 
estimated by the following equation: 




2                                                 (A.29) 
In addition, Stata outputs an 𝐹-ratio assessing the improvement in model 
predictability by the addition of covariates (larger values indicate better prediction), 
the meta-regression coefficient 𝛽 for each independent variable (slope of the 
regression line), the 95% CI of 𝛽 and a p-value from a 𝑡-test testing the null hypothesis 
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B.1 Extracted Information 
Table B.1 Basic characteristics of articles included in the systematic review. 





Umemura 1994 Rat Thrombotic Tirilazad 
Quast 1995 Rat Transient NOS inhibitor 
Tatlisumak 1996 Rat Permanent Growth factor 
Wei 1998 Rat Transient NOS inhibitor 
Wiessner 1999 Mouse Permanent Transgenics 
Mancuso 2000 Rat Permanent Hypothermia 
Saarelainen 2000 Mouse Transient Transgenics 
Yenari 2000 Rat Transient Hypothermia 
Zhang 2000 Rat Thrombotic Growth factor 
Cash 2001 Rat Transient Aminoguanidine 
Lee 2001 Rat Transient Hypothermia 
Schabitz* 2001 Rat Transient Growth factor 
Shi 2001 Rat Transient Estradiol 
Sinha 2001 Rat Transient Melatonin 
Wiessner 2001 Mouse Permanent Transgenics 
Goto* 2002 Mouse Transient Transgenics 
Hughes 2002 Mouse Permanent Transgenics 
Koistinaho 2002 Mouse Permanent Transgenics 
Mack 2003 Baboon Transient Hypothermia 
Sironi 2003 Rat Permanent Simvastatin 
Veldhuis 2003 Rat Permanent Dizocilpine 
Wagner 2003 Rat Transient Hypothermia 
Kurozumi 2004 Rat Transient Stem cells 
Shyu 2004 Rat Transient Growth factor 
Cimino 2005 Rat Permanent Simvastatin 
Koistinaho 2005 Mouse Permanent Transgenics 
Kurozumi 2005 Rat Transient Stem cells 
Nomura* 2005 Rat Permanent Stem cells 
van der Weerd 2005 Mouse Permanent Transgenics 
Yrjänheikki 2005 Rat Permanent Atorvastatin 
Boltze 2006 Rat Permanent Stem cells 
Ding* 2006 Rat Permanent Atorvastatin 
Honma* 2006 Rat Transient Stem cells 
Horita* 2006 Rat Permanent Stem cells 
Jiang 2006 Rat Transient Stem cells 
Liu* 2006 Rat Permanent Stem cells 
Kameda 2007 Rat Transient Stem cells 
Pialat 2007 Mouse Permanent Transgenics 
Shimamura 2007 Rat Permanent Fluvastatin 
Ukai* 2007 Rat Permanent Stem cells 
Uno 2007 Mouse Transient Edaravone 
Wei 2007 Rat Transient Stem cells 
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Esneault 2008 Rat Transient Stem cells 
Kim 2008 Rat Transient Stem cells 
Koh 2008 Rat Transient Stem cells 
Li* 2008 Rat Transient Stem cells 
Omori* 2008 Rat Permanent Stem cells 
Onda* 2008 Rat Permanent Stem cells 
Schmerbach 2008 Rat Transient Pioglitazone 
Yoo 2008 Rat Transient Stem cells 
Li 2009 Rat Thrombotic Erythropoietin 
Modo 2009 Rat Transient Stem cells 
Toyama* 2009 Rat Permanent Stem cells 
van der Weerd 2010 Mouse Permanent Transgenics 
NOS indicates nitric oxide synthase. 
*Studies that measured infarct size with both MRI and histology and were included in meta-
analysis. 
 
Table B.2 Reporting of study quality items. 
First author Year 1 2 3 4 5 6 7 8 9 10 Score 
Umemura 1994 + + +  + +     5 
Quast 1995 + +    +   +  4 
Tatlisumak 1996 + + + +  +   +  6 
Wei 1998 + +    + +    4 
Wiessner 1999 + +    +     3 
Mancuso 2000 + + +   +     4 
Saarelainen 2000 + +    +   +  4 
Yenari 2000 + +   + +     4 
Zhang 2000 + +   + +   +  5 
Cash 2001 + + +  + +   +  6 
Lee 2001  +    +     2 
Schabitz* 2001 + + +  + +     5 
Shi 2001 + +       +  3 
Sinha 2001 + +    +   +  4 
Wiessner 2001 + +    +   +  4 
Goto* 2002 + + +  + +   +  6 
Hughes 2002 + +    +   +  4 
Koistinaho 2002 + +    +   +  4 
Mack 2003 + +       +  3 
Sironi 2003 + + +   +   +  5 
Veldhuis 2003 + +    +   +  4 
Wagner 2003 + +    +   +  4 
Kurozumi 2004 + + +      +  4 
Shyu 2004 + +   + +     4 
Cimino 2005 +          1 
Koistinaho 2005 + +    +   +  4 
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First author Year 1 2 3 4 5 6 7 8 9 10 Score 
Kurozumi 2005 +  +        2 
Nomura* 2005 + +       +  3 
van der Weerd 2005 + +   + +   +  5 
Yrjänheikki 2005 + +   + +   +  5 
Boltze 2006 + + +  +  +  +  6 
Ding* 2006 +  +   +   +  4 
Honma* 2006 + +         2 
Horita* 2006 +        +  2 
Jiang 2006 + + +  + +   +  6 
Liu* 2006 + +         2 
Kameda 2007 +     +   +  3 
Pialat 2007 + +   +    +  4 
Shimamura 2007 +         + 2 
Ukai* 2007 +        +  2 
Uno 2007           0 
Wei 2007 + + +   +     4 
Esneault 2008 + +    +   +  4 
Kim 2008 + + + +     + + 6 
Koh 2008 + +   + +   +  5 
Li* 2008 + + +  +      4 
Omori* 2008 +  +      +  3 
Onda* 2008 +        +  2 
Schmerbach 2008 +  +  + +   +  5 
Yoo 2008 + + +   +   +  5 
Li 2009 + +   + +   +  5 
Modo 2009 +        + + 3 
Toyama* 2009 +        +  2 
van der Weerd 2010 + +   + +   +  5 
Studies were assessed according to a checklist by Macleod et al. (2004). The quality items 
are: (1) peer-reviewed publication, (2) control of temperature, (3) random allocation to 
treatment or control, (4) blinded induction of ischaemia, (5) blinded assessment of outcome, 
(6) use of anaesthetic without significant intrinsic neuroprotective activity, (7) use of comorbid 
animals (aged, diabetic, or hypertensive), (8) sample size calculation, (9) compliance with 
animal welfare regulations and (10) statement of potential conflict of interests. 
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Details of reported parameters, 
n/N (%) 
Ischaemic brain side 42/54 (78) Left: 12/42 (29) 
Right: 30/42 (71) 
Animal positioning method 
in scanner 
22/54 (41) Carriage/cradle: 15/22 (68) 
Stereotaxic: 7/22 (32) 
Anaesthetic used during 
scanning 
36/54 (67) Fentanyl-Fluanisone-Midazolame: 1/36 (3) 
Halothane: 10/36 (28) 
Isoflurane: 10/36 (28) 
Ketamine: 12/36 (33) 
Pentobarbital: 3/36 (8) 
Monitoring of physiological 
parameters during scanning 
16/54 (30) Temperature only: 7/16 (44) 
Temperature & other: 6/16 (38) 
Other: 3/16 (19) 
Scanner equipment 
manufacturer 
51/54 (94) Bruker: 14/51 (27) 
General Electric: 9/51 (18) 
Medinus: 2/51 (4) 
Otsuka Electronics: 1/51 (2) 
Philips: 1/51 (2) 
Spectroscopy Imaging Systems: 1/51 (2) 
Varian: 1/51 (2) 
Multiple: 22/51 (43) 
Scanner field strength (T) 51/54 (94) 1.5: 5/51 (10) 
2: 4/51 (8) 
2.3: 4/51 (8) 
3: 7/51 (14) 
4.7: 15/51 (29) 
7: 15/51 (29) 
9.4: 1/51 (2) 
Type of radiofrequency coil 31/54 (57) Volume: 17/31 (55) 
Surface: 7/31 (23) 
Volume and surface: 7/31 (23) 
Software for image analysis 40/54 (74) Academic: 17/40 (43) 
Commercial: 16/40 (40) 
Custom-made: 7/40 (17) 
Method of lesion size 
determination* 
51/78 (65) Manual tracing: 10/51 (20) 
Thresholding: 39/51 (76) 
Automated algorithm: 2/51 (4) 










Details of reported parameters, 
n/N (%) 
How the lesion size is 
presented* 
77/78 (99) Lesion volume: 45/77 (58) 
Lesion area at one slice: 1/77 (1) 
Change from baseline: 7/77 (9) 
Fraction/percent of ipsilateral side: 14/77 (18) 
Fraction/percent of contralateral side: 6/77 (8) 
Percent of brain: 4/77 (5) 
Oedema correction method 
for infarct size† 
11/44 (25) Swanson’s method: 9/11 (82) 
Leach’s method: 2/11 (18) 
n indicates the number of protocols for which the parameter is reported; N, total number of 
protocols for which the parameter is relevant.  
*Post-processing parameters, applicable to each of the 78 imaging protocols. 
†Applied on T2-weighted images acquired at the subacute and early chronic stages of 
stroke (relevant to 44 out of 45 protocols). 
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Table C.1 Shapiro–Wilk test for normality. 
Variable Dataset W p-value 
Chapter 4    
      Analysis time, in seconds Manual 0.97 0.902 
            Thresholding 0.88 0.140 
 k-means (2) 0.97 0.863 
 k-means (3) 0.91 0.299 
 Canny 0.89 0.168 
Chapter 5 
   
      Analysis time, in minutes Manual 0.97 0.686 
            Point counting 0.97 0.659 
 Semi-automated 0.95 0.281 
      Uncorrected infarct volume, in mm3 Manual 0.95 0.329 
            Point counting 0.96 0.576 
 Semi-automated 0.97 0.783 
      Corrected infarct volume, in mm3 Manual 0.98 0.882 
            Point counting 0.98 0.878 
 Semi-automated 0.99 0.988 
Chapter 6    
      Linear scaling errors, in % Frequency encoding 0.93 < 0.001 
            
Phase encoding 0.93 < 0.001 
      Uncorrected, in mm3 1  A 0.96 0.569 
   B 0.97 0.634 
   C 0.96 0.507 
   D 0.96 0.597 
   E 0.97 0.703 
   F 0.96 0.532 
 2  A 0.96 0.565 
   B 0.96 0.502 
   C 0.96 0.475 
   D 0.97 0.725 
   E 0.96 0.571 
   F 0.97 0.708 
 3  A 0.96 0.530 
   B 0.96 0.543 
   C 0.96 0.578 
   D 0.96 0.488 
   E 0.96 0.605 
   F 0.96 0.562 
      Corrected based on all slices,  1  A 0.98 0.953 
      in mm3   B 0.98 0.901 
   C 0.98 0.894 
   D 0.98 0.872 
   E 0.98 0.910 
   F 0.97 0.713 
      2  A 0.98 0.939 
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Variable Dataset W p-value 
   B 0.98 0.897 
   C 0.97 0.774 
   D 0.98 0.874 
   E 0.98 0.932 
   F 0.97 0.816 
 3  A 0.97 0.655 
   B 0.98 0.953 
   C 0.97 0.807 
   D 0.97 0.796 
   E 0.98 0.855 
   F 0.97 0.848 
      Corrected based on all slices,  1  A 0.97 0.808 
      as % of brain   B 0.97 0.717 
   C 0.97 0.810 
   D 0.97 0.775 
   E 0.97 0.756 
   F 0.97 0.676 
      2  A 0.98 0.850 
   B 0.97 0.808 
   C 0.97 0.654 
   D 0.97 0.666 
   E 0.97 0.789 
   F 0.97 0.639 
 3  A 0.96 0.631 
   B 0.97 0.821 
   C 0.97 0.813 
   D 0.97 0.742 
   E 0.97 0.661 
   F 0.97 0.773 
      Corrected based on all slices, 1  A 0.97 0.764 
      as % of ipsilateral hemisphere   B 0.96 0.603 
   C 0.97 0.691 
   D 0.97 0.683 
   E 0.97 0.709 
   F 0.96 0.585 
       2  A 0.97 0.777 
   B 0.97 0.734 
   C 0.96 0.575 
   D 0.96 0.532 
   E 0.97 0.707 
   F 0.96 0.507 
 3  A 0.96 0.527 
   B 0.97 0.792 
   C 0.97 0.684 
   D 0.96 0.611 
   E 0.96 0.586 
   F 0.97 0.671 
240   
Variable Dataset W p-value 
      Corrected based on all slices, 1  A 0.98 0.897 
      as % of contralateral hemisphere   B 0.97 0.838 
   C 0.98 0.886 
   D 0.98 0.877 
   E 0.97 0.825 
   F 0.97 0.761 
       2  A 0.98 0.901 
   B 0.98 0.861 
   C 0.97 0.714 
   D 0.97 0.795 
   E 0.98 0.871 
   F 0.97 0.802 
      3  A 0.97 0.761 
   B 0.98 0.933 
   C 0.98 0.892 
   D 0.98 0.850 
   E 0.97 0.763 
   F 0.98 0.885 
      Corrected based on slices   1  A 0.99 0.983 
      including the infarct, in mm3   B 0.98 0.956 
   C 0.98 0.866 
   D 0.98 0.885 
   E 0.99 0.986 
   F 0.97 0.725 
      2  A 0.98 0.918 
   B 0.97 0.848 
   C 0.98 0.897 
   D 0.98 0.957 
   E 0.98 0.921 
   F 0.98 0.878 
 3  A 0.97 0.814 
   B 0.98 0.961 
   C 0.98 0.867 
   D 0.97 0.847 
   E 0.98 0.942 
   F 0.98 0.881 
      Corrected based on slices  1  A 0.97 0.682 
      including the infarct, as % of brain   B 0.95 0.345 
   C 0.96 0.461 
   D 0.94 0.220 
   E 0.97 0.650 
   F 0.94 0.231 
      2  A 0.95 0.374 
   B 0.96 0.556 
   C 0.98 0.960 
   D 0.94 0.259 
   E 0.96 0.438 
 241 
Variable Dataset W p-value 
   F 0.94 0.194 
 3  A 0.95 0.361 
   B 0.96 0.452 
   C 0.96 0.465 
   D 0.95 0.348 
   E 0.95 0.414 
   F 0.96 0.548 
      Corrected based on slices  1  A 0.97 0.682 
      including the infarct, as % of ipsilateral    B 0.95 0.316 
      hemisphere   C 0.96 0.463 
   D 0.94 0.210 
   E 0.97 0.649 
   F 0.93 0.151 
       2  A 0.95 0.356 
   B 0.95 0.412 
   C 0.98 0.974 
   D 0.94 0.202 
   E 0.95 0.352 
   F 0.93 0.149 
 3  A 0.95 0.311 
   B 0.96 0.454 
   C 0.95 0.375 
   D 0.95 0.285 
   E 0.95 0.313 
   F 0.96 0.542 
      Corrected based on slices  1  A 0.96 0.607 
      including the infarct, as % of    B 0.95 0.419 
      contralateral hemisphere   C 0.95 0.409 
   D 0.94 0.275 
   E 0.97 0.734 
   F 0.95 0.283 
       2  A 0.95 0.364 
   B 0.96 0.602 
   C 0.98 0.891 
   D 0.95 0.404 
   E 0.96 0.495 
   F 0.95 0.282 
      3  A 0.95 0.423 
   B 0.95 0.407 
   C 0.96 0.516 
   D 0.95 0.425 
   E 0.96 0.497 
   F 0.96 0.551 
p-values less than 0.05 are shown in bold. A set of measurements for each scanner ‘A’–‘F’ 
and each case 1–3 is used in Chapter 6. 
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Table C.2 Mauchly’s sphericity test. 
Variable Case df χ2 p-value ε 
Chapter 4      
      Analysis time, in seconds N/A 9 96.07 < 0.001 0.43 
Chapter 5 
     
      Analysis time, in minutes N/A 2 2.90 0.235 - 
      Uncorrected infarct volume, in mm3 N/A 2 7.35 0.025 0.76 
      Corrected infarct volume, in mm3 N/A 2 2.86 0.239 - 




      Uncorrected, in mm3 1 14 51.78 < 0.001 0.39 
 2 14 84.03 < 0.001 0.35 
 3 14 24.53 0.041 0.67 
      Corrected based on all slices 
            in mm3 1 14 29.43 0.010 0.55 
      2 14 63.69 < 0.001 0.43 
 3 14 36.95 < 0.001 0.58 
            as % of brain 1 14 12.44 0.575 - 
      2 14 44.52 < 0.001 0.49 
 3 14 36.60 < 0.001 0.57 
            as % of ipsilateral hemisphere 1 14 13.13 0.520 - 
       2 14 43.77 < 0.001 0.49 
 3 14 40.80 < 0.001 0.53 
            as % of contralateral hemisphere 1 14 11.63 0.640 - 
       2 14 45.71 < 0.001 0.48 
      3 14 33.01 0.003 0.60 
      Corrected based on slices including the infarct 
            in mm3 1 14 35.22 < 0.001 0.56 
      2 14 63.81 < 0.001 0.49 
 3 14 48.29 < 0.001 0.51 
            as % of brain 1 14 22.10 0.079 - 
      2 14 80.19 < 0.001 0.45 
 3 14 49.64 < 0.001 0.52 
            as % of ipsilateral hemisphere 1 14 21.28 0.097 - 
             2 14 79.38 < 0.001 0.45 
 3 14 51.64 < 0.001 0.50 
            as % of contralateral hemisphere 1 14 22.88 0.064 - 
             2 14 81.08 < 0.001 0.45 
      3 14 47.31 < 0.001 0.55 
p-values less than 0.05 are shown in bold. ε is the Greenhouse–Geisser factor used to correct 
the degrees of freedom (df) for analysis of variance; where p > 0.05 a correction was not used. 
N/A indicates not applicable. 
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Table C.3 p-values for Bonferroni pairwise comparisons. 
Infarct volume measure Case  A B C D E 
Uncorrected, in mm3 1 B < 0.001     
  C < 0.001 < 0.001    
  D < 0.001 1.000 < 0.001   
  E < 0.001 0.089 < 0.001 1.000  
  F < 0.001 < 0.001 1.000 < 0.001 < 0.001 
 2 B < 0.001     
  C < 0.001 0.639    
  D < 0.001 < 0.001 < 0.001   
  E < 0.001 1.000 0.595 < 0.001  
  F < 0.001 0.003 0.024 0.082 < 0.001 
 3 B 0.168     
  C 1.000 0.456    
  D 1.000 0.198 1.000   
  E 0.249 1.000 0.892 0.135  
  F 1.000 0.239 1.000 1.000 0.453 
Corrected based on all slices,  1 B < 0.001     
in mm3  C < 0.001 0.003    
  D < 0.001 1.000 0.146   
  E < 0.001 1.000 < 0.001 0.240  
  F < 0.001 < 0.001 0.886 0.004 < 0.001 
 2 B < 0.001     
       C < 0.001 1.000    
  D < 0.001 0.182 0.269   
  E < 0.001 1.000 1.000 0.876  
  F < 0.001 1.000 1.000 0.082 1.000 
 3 B 0.002     
  C 1.000 0.007    
  D 1.000 0.002 1.000   
  E 0.016 1.000 0.072 0.003  
  F 1.000 < 0.001 1.000 1.000 0.064 
Corrected based on all slices,  1 B 1.000     
as % of brain  C 1.000 0.959    
  D < 0.001 < 0.001 < 0.001   
  E 1.000 1.000 0.441 0.007  
  F < 0.001 0.005 < 0.001 1.000 0.070 
 2 B < 0.001     
  C 0.003 0.068    
  D 1.000 < 0.001 0.004   
  E < 0.001 0.003 < 0.001 < 0.001  
       F 0.300 < 0.001 < 0.001 0.036 < 0.001 
 3 B < 0.001     
  C 1.000 < 0.001    
  D 1.000 < 0.001 1.000   
  E 0.005 0.429 0.025 < 0.001  
  F 1.000 < 0.001 1.000 1.000 0.020 
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Infarct volume measure Case  A B C D E 
Corrected based on all slices, 1 B 1.000     
as % of ipsilateral hemisphere  C 1.000 1.000    
  D < 0.001 < 0.001 < 0.001   
  E 1.000 1.000 0.519 0.008  
  F < 0.001 0.006 < 0.001 1.000 0.090 
 2 B < 0.001     
  C 0.003 0.062    
  D 1.000 < 0.001 0.005   
  E < 0.001 0.003 < 0.001 < 0.001  
  F 0.358 < 0.001 < 0.001 0.040 < 0.001 
 3 B < 0.001     
  C 1.000 0.002    
        D 1.000 < 0.001 1.000   
  E 0.004 0.327 0.023 < 0.001  
  F 1.000 < 0.001 1.000 1.000 0.019 
Corrected based on all slices, 1 B 1.000     
as % of contralateral  C 1.000 0.620    
hemisphere  D < 0.001 < 0.001 < 0.001   
  E 1.000 1.000 0.362 0.005  
  F < 0.001 0.005 < 0.001 1.000 0.052 
 2 B < 0.001     
  C 0.003 0.077    
  D 1.000 < 0.001 0.003   
  E < 0.001 0.003 < 0.001 < 0.001  
  F 0.238 < 0.001 < 0.001 0.032 < 0.001 
 3 B < 0.001     
  C 1.000 < 0.001    
  D 1.000 < 0.001 1.000   
  E 0.007 0.676 0.031 < 0.001  
  F 1.000 < 0.001 1.000 1.000 0.022 
Corrected based on slices   1 B < 0.001     
including the infarct, in mm3  C < 0.001 < 0.001    
  D < 0.001 1.000 0.009   
  E < 0.001 1.000 < 0.001 0.315  
  F < 0.001 < 0.001 1.000 < 0.001 < 0.001 
 2 B < 0.001     
       C < 0.001 1.000    
  D < 0.001 0.010 0.038   
  E < 0.001 1.000 1.000 0.049  
  F < 0.001 0.607 1.000 0.031 1.000 
 3 B 0.006     
  C 1.000 0.031    
  D 1.000 0.009 1.000   
  E 0.012 1.000 0.082 0.009  
  F 1.000 0.004 1.000 1.000 0.148 
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Infarct volume measure Case  A B C D E 
Corrected based on slices  1 B 1.000     
including the infarct,   C 1.000 1.000    
as % of brain  D 1.000 1.000 1.000   
  E 1.000 1.000 1.000 1.000  
  F 0.189 0.003 0.021 1.000 0.048 
 2 B 0.325     
  C 0.063 1.000    
  D 1.000 1.000 1.000   
       E < 0.001 0.023 1.000 1.000  
  F 1.000 1.000 0.989 0.459 0.625 
 3 B 0.185     
  C 1.000 0.490    
  D 1.000 0.769 1.000   
  E 0.668 1.000 1.000 1.000  
  F 1.000 0.090 1.000 1.000 0.845 
Corrected based on slices  1 B 1.000     
including the infarct, as % of   C 1.000 1.000    
ipsilateral hemisphere  D 1.000 1.000 1.000   
  E 1.000 1.000 1.000 1.000  
  F 0.189 0.003 0.025 1.000 0.049 
 2 B 0.308     
  C 0.066 1.000    
  D 1.000 1.000 1.000   
  E < 0.001 0.029 1.000 1.000  
  F 1.000 1.000 1.000 0.427 0.608 
 3 B 0.128     
        C 1.000 0.353    
  D 1.000 0.530 1.000   
  E 0.546 1.000 1.000 1.000  
  F 1.000 0.059 1.000 1.000 0.816 
Corrected based on slices  1 B 1.000     
including the infarct, as % of   C 1.000 1.000    
contralateral hemisphere  D 1.000 1.000 1.000   
  E 1.000 1.000 1.000 1.000  
  F 0.192 0.003 0.018 1.000 0.049 
 2 B 0.358     
  C 0.060 1.000    
  D 1.000 1.000 1.000   
  E < 0.001 0.017 1.000 1.000  
  F 1.000 1.000 0.894 0.507 0.644 
 3 B 0.318     
  C 1.000 0.784    
  D 1.000 1.000 1.000   
  E 0.860 1.000 1.000 1.000  
  F 1.000 0.172 1.000 1.000 0.899 
All values are p-values except for ‘Case’. Corresponding analysis of variance statistics are 
given in Table 6.5. p-values less than 0.05 are shown in bold. ‘A’–‘F’ indicate the scanner. 
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Table C.4 U statistics for Mann–Whitney U tests. 
All values are U statistics except for ‘Case’. Corresponding p-values are given in Table 6.7. 
‘A’–‘F’ indicate the scanner. 
 
Infarct volume measure Case A B C D E F 
Uncorrected, in mm3 1 13 11 14 12 13 14 
 2 12 13 13 11 13 11 
 3 12 14 12 11 12 14 
Corrected based on all slices        
      in mm3 1 12 10 13 11 13 13 
      2 12 13 12 9 13 9 
 3 13 15 12 11 14 13 
      as % of brain 1 14 12 14 13 15 14 
      2 13 14 14 12 14 12 
 3 14 20 13 13 15 14 
      as % of ipsilateral 1 14 11 14 13 17 14 
      hemisphere 2 13 14 14 12 14 14 
 3 14 20 13 13 16 15 
      as % of contralateral 1 14 13 14 13 15 14 
      hemisphere 2 12 15 14 12 15 13 
      3 13 15 13 13 13 14 
Corrected based on slices including the infarct 
      in mm3 1 13 10 13 10 13 9 
      2 13 13 12 10 13 9 
 3 10 14 10 10 12 13 
      as % of brain 1 19 18 21 19 30 17 
      2 21 21 16 20 22 22 
 3 18 23 19 16 26 19 
      as % of ipsilateral 1 19 19 23 21 31 17 
      hemisphere 2 23 21 17 22 22 23 
 3 18 26 18 17 28 20 
      as % of contralateral 1 17 17 21 17 27 17 
      hemisphere 2 20 20 17 20 22 21 
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Form for Structural Phantom Scanning in  
Preclinical MRI Centres 
Please follow the instructions below for scanning the structural MRI phantom and complete the 
fields in grey. The whole procedure should normally take around 2 hours. The completed form along 
with the sets of scout scans and the 12 sets of protocol scans in the standard DICOM format should 
be saved in a Dropbox folder named ‘Phantom scanning, <your centre>, <date>’. Share this folder 
with [email address].  
 
Centre:  Enter name of MRI centre. Country:  Enter country. 
MR scanner manufacturer:  Enter 
manufacturer. 
Model:  Enter model of the scanner. 
Magnetic field strength (T):  Enter field 
strength. 
Software, version:  Enter software and 
version. 
 
Phantom positioning and alignment 
1. The phantom should be tightly attached on the radiofrequency (RF) coil using tape or 
otherwise, with its four knobs facing upwards (anterior direction). It must be perfectly 
aligned so that the three orthogonal directions in the MRI system are perpendicular to 
the sides of the phantom. Do not place the phantom into another object with solution 
(e.g. a tube); only the phantom’s internal volume must be visible in the images. 
Exemplar datasets are shown in Figures 1–3. 
2. Place the RF coil in the gradient coil, so that the phantom is at the magnet’s isocentre. 
Perform shimming and localisation (see recommended sequence below). If scout 
images indicate that the phantom is malposed or misaligned, adjust accordingly and re-
scan.  
3. Save the images in a separate folder for each scan. Name the folders ‘Scout_<scan 
number>’. 
Correct positioning and alignment are necessary for accurate and reliable analysis of the 
acquired images. 
 
Scout (localiser) imaging 
A gradient echo sequence with the following parameters is proposed. However, you may 
use an alternative. 
Type of sequence   Gradient echo   
TR (ms) 20 FOV (mm×mm) 25×25 
TE (ms) 3 Matrix (pixels×pixels) 128×128 
Flip angle (°) 20 Slice thickness (mm) 2 (gap 2) 
NSA/NEX 1 Number of slices 3×3 planes 
Receive bandwidth 
(kHz) 






Imaging using two different protocols 
1. The phantom must be in the centre of the acquired slices, which must be of a sufficient 
number to cover the whole phantom volume. For this reason, the middle slice (e.g. no. 
9 for 17 slices) must be at the centre of the phantom (see Figures 1–3). 
2. Scan the phantom using two different protocols (A and B below). The sequence for 
each protocol must be repeated six times, corresponding to different combinations of 
imaging planes and signal encoding directions. Specifically, scan the phantom in the 
axial, coronal, and sagittal planes. Then, swap the frequency and phase encoding 
directions for each of these and scan the phantom again (here called axial90, coronal90, 
and sagittal90 planes respectively). Figures 1–3 show exemplar images acquired using 
protocol A.  
3. Save the images in a separate folder for each plane, named ‘Protocol<A or B>_<plane>’. 
 
A. Standardised structural protocol 
Scan the phantom using the type of RF coil and the exact sequence indicated below. If, for 
any reason, this type of coil or any of the prescribed parameters cannot be used, replace 
with a similar one. In this case, report the value used and briefly the reason for substitution, 
as well as the new scan time (if different) in the ‘Comments’ field at the bottom of this page. 
However, please retain the suggested imaging resolution (voxel size). 
COILS: Set-up the scanner for rat brain imaging using a surface RF coil. Provide the 
details below. 
Gradient Radiofrequency (RF) 
Maker, model:  Enter maker and model. Maker, model:  Enter maker and model. 
Outer/inter diameter (mm):  Enter OD/ID. Type and specifications (transmit and 
receive):  Enter coil(s) details (e.g. 72mm ID 
birdcage transmit, 2 channel rat brain 
phased-array surface receive). 
Max gradient amplitude (mT/m):  Enter 
Gmax. 
Max slew rate (T/m/s):  Enter SlewRatemax. 
 
SEQUENCE: 
Type of sequence Fast Spin Echo (FSE) / Rapid acquisition with Relaxation 
Enhancement (RARE) 
TR (ms) 1600 FOV (mm×mm) 19.2×19.2 
TEeff (ms) 20 Matrix (pixels×pixels) 256×256 
Echo train length 4 Slice thickness (mm) 1 (gapless) 
NSA/NEX 2 Number of slices 17 
Receive bandwidth (kHz) 100 Scan time (m:s) 3:28 






250   
B. Centre’s favourite protocol for infarct size assessment in a rat stroke 
model 
Scan the phantom using a scanning protocol commonly used in your centre for assessing 
the infarct size in a rat stroke model. Use a different RF coil from the above, if relevant. Use 
a sufficient number of slices to cover the whole phantom; this number should be odd so 
that a middle slice is placed at the centre of the phantom. 
COILS: Use your preferred set-up for rat brain imaging. Provide the details below where 
different from above. 
Gradient Radiofrequency (RF) 
Maker, model:  Enter maker and model. Maker, model:  Enter maker and model. 
Outer/inter diameter (mm):  Enter OD/ID. Type and specifications (transmit and 
receive):  Enter coil(s) details (e.g. 72mm ID 
birdcage transmit, 2 channel rat brain 
phased-array surface receive). 
Max gradient amplitude (mT/m):  Enter 
Gmax. 
Max slew rate (T/m/s):  Enter SlewRatemax. 
 
SEQUENCE: 
Type of sequence Enter type of sequence. 
TR (ms) Enter TR. FOV (mm×mm) Enter FOV. 
TE or TEeff (ms) Enter TE. Matrix (pixels×pixels) Enter matrix 
size. 
Echo train length Enter ETL, if 
relevant. 
Slice thickness (mm) Enter slice 
thickness. 
NSA/NEX Enter averages. Number of slices Enter number 
of slices. 
Receive bandwidth (kHz) Enter 
bandwidth. 
Scan time (m:s) Enter scan 
time. 
Additional scan options:  Enter other important information (e.g. flip angle), if relevant. 
 
Comments:  Enter your comments, if any. 
 
Scanned by:  Enter your full name. Date:  Select date of scanning. 












Figure 1. Scout images showing the slice selection for imaging in the axial and axial90 planes 
using protocol A (a–c), and an example set of acquired slices (1–17). The middle slice (9) 
should intersect the centre of the phantom. The red arrow shows the position of the orientation 
mark. Due to possible gradient scaling differences between scanners the phantom volume 
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Figure 2. Scout images showing the slice selection for imaging in the coronal and coronal90 
planes using protocol A (a–c), and an example set of acquired slices (1–17). The middle slice 
(9) should intersect the centre of the phantom. The red arrow shows the position of the 
orientation mark. Due to possible gradient scaling differences between scanners the phantom 





Figure 3. Scout images showing the slice selection for imaging in the sagittal and sagittal90 
planes using protocol A (a–c), and an example set of acquired slices (1–17). The middle slice 
(9) should intersect the centre of the phantom. The red arrow shows the position of the 
orientation mark. Due to possible gradient scaling differences between scanners the phantom 
volume might look slightly different, while small air bubbles inevitably can be present in the 
phantom. 
 
